Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi
Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi
Vol 9 No1 - Journal of Cell and Molecular Biology - Haliç Üniversitesi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />
•Notch in apoptosis<br />
<strong>Molecular</strong> <strong>Biology</strong><br />
<strong>Vol</strong>ume 9 · No 1 · June 2011<br />
http://jcmb.halic.edu.tr<br />
Xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />
MMP1 <strong>and</strong> MMP2 polymorphisms in TMJ disorder<br />
Silencing suppressors <strong>of</strong> PVM<br />
Bio-database compression using enhanced suffix array
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />
<strong>Molecular</strong> <strong>Biology</strong><br />
<strong>Vol</strong>ume 9 · Number 1<br />
June 2011<br />
İstanbul-TURKEY
<strong>Haliç</strong> University<br />
Faculty <strong>of</strong> Arts <strong>and</strong> Sciences<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />
Founder<br />
Gündüz GEDİKOĞLU<br />
President <strong>of</strong> Board <strong>of</strong> Trustee<br />
Rights held by<br />
A. Sait SEVGENER<br />
Rector<br />
Correspondence Address:<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />
<strong>Haliç</strong> <strong>Üniversitesi</strong><br />
Fen-Edebiyat Fakültesi,<br />
Sıracevizler Cad. No:29 Bomonti 34394 Şişli<br />
İstanbul-Turkey<br />
Phone: +90 212 343 08 87<br />
Fax: +90 212 231 06 31<br />
E-mail: jcmb@halic.edu.tr<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> is<br />
indexed in ULAKBIM, EBSCO, DOAJ,<br />
EMBASE, CAPCAS, EM<strong>Biology</strong>, Socolar, Index<br />
COPERNICUS,Open J-Gate, Chemical<br />
Abstracts <strong>and</strong> Genamics <strong>Journal</strong>Seek<br />
ISSN 1303-3646<br />
Printed at MART Printing House<br />
Tuncay ALTUĞ, İstanbul, Turkey<br />
Canan ARKAN, Munich, Germany<br />
Aglaia ATHANASSIADOU, Patras, Greece<br />
Şehnaz BOLKENT, İstanbul, Turkey<br />
Nihat BOZCUK, Ankara, Turkey<br />
A. Nur BUYRU, İstanbul, Turkey<br />
Kemal BÜYÜKGÜZEL, Zonguldak, Turkey<br />
H<strong>and</strong>e ÇAĞLAYAN, İstanbul, Turkey<br />
İsmail ÇAKMAK, İstanbul, Turkey<br />
Adile ÇEVİKBAŞ, İstanbul, Turkey<br />
Beyazıt ÇIRAKOĞLU, İstanbul, Turkey<br />
Fevzi DALDAL, Pennsylvania, USA<br />
Zihni Demirbağ, Trabzon, Turkey<br />
Mustafa DJAMGÖZ, London, UK<br />
Aglika EDREVA, S<strong>of</strong>ia, Bulgaria<br />
Ünal EGELİ, Bursa, Turkey<br />
Advisory Board<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />
<strong>Molecular</strong> <strong>Biology</strong><br />
Published by<br />
<strong>Haliç</strong> University<br />
Faculty <strong>of</strong> Arts <strong>and</strong> Sciences<br />
Editor<br />
Nagehan ERSOY TUNALI<br />
Editorial Board<br />
M.Baki YOKEŞ<br />
M.Burcu IRMAK YAZICIOĞLU<br />
Kürşat ÖZDİLLİ<br />
Aslı BAŞAR<br />
Editorial Assistance<br />
Ozan TİRYAKİOĞLU<br />
Özlem KURNAZ<br />
Nermin GÖZÜKIRMIZI, İstanbul, Turkey<br />
Ferruh ÖZCAN, İstanbul, Turkey<br />
Füsun GÜMÜŞEL, İstanbul, Turkey<br />
C<strong>and</strong>an JOHANSEN, İstanbul, Turkey<br />
Asım KADIOĞLU, Trabzon, Turkey<br />
Maria V. KALEVITCH, Pennsylvania, USA<br />
Valentine KEFELİ, Pennsylvania, USA<br />
Meral KENCE, Ankara, Turkey<br />
Uğur ÖZBEK, İstanbul, Turkey<br />
Sevtap SAVAŞ, Toronto, Canada<br />
Müge TÜRET SAYAR, İstanbul, Turkey<br />
İsmail TÜRKAN, İzmir, Turkey<br />
Mehmet TOPAKTAŞ, Adana, Turkey<br />
Meral ÜNAL, İstanbul, Turkey<br />
Selma YILMAZER, İstanbul, Turkey<br />
Ziya ZİYLAN, İstanbul, Turkey
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />
CONTENTS <strong>Vol</strong>ume 9 · Number 1 · June 2011<br />
Review Articles<br />
Decision making mechanism influences the regulatory function <strong>of</strong> Notch in<br />
Apoptosis<br />
1<br />
A.NAIR<br />
Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />
5<br />
N.ERSOY TUNALI <strong>and</strong> N.O.TİRYAKİOĞLU<br />
Research Articles<br />
Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />
R.KRYLDAKOV, R.AKBERGENOV, T.HOHN <strong>and</strong> B.ISKAKOV<br />
Identification <strong>of</strong> a novel dehydration responsive transcript from tossa jute<br />
(Corcohrus olitorius L.)<br />
S.SHARMIN, M.M.MOOSA, Md.S.ISLAM, I.KABIR, A.AKTER <strong>and</strong> H.KHAN<br />
Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon toxicity in<br />
Swiss albino mice<br />
P.SINGH, P.MOGRA, V.SANKHLA <strong>and</strong> K.DEORA<br />
In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal herb<br />
J.ANBURAJ, C.R.SINGH, S.SUNDARRAJ <strong>and</strong> S.KANNAN<br />
Bio-database compression using enhanced suffix array for pairwise sequence<br />
alignment<br />
A.KUNTHAVAI <strong>and</strong> S.VASANTHA RATHNA<br />
Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene in E. coli<br />
<strong>and</strong> characterization <strong>of</strong> the recombinant enzyme<br />
S.TAIPAKOVA, B.SMAILOV, G.STANBEKOVA <strong>and</strong> A.BISSENBAEV<br />
Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in<br />
temporom<strong>and</strong>ibular joint disorder<br />
N.TASKIN, K.ULUCAN, G.DEGIN, A.AKCAY, B.KARATAS <strong>and</strong> T.AKCAY<br />
Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin during gestation<br />
<strong>and</strong> lactation in Swiss albino mice<br />
I. BARBER, R. SHARMA, S. MOGRA, K. PANWAR <strong>and</strong> U. GARU<br />
The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia amygdalina on<br />
some vital organs in adult Wistar rats<br />
S.NWANGWU, D.A.OFUSORI, S.JOSIAH, O.F.AMEGOR, H.NJOYA <strong>and</strong><br />
A.O.AYOKA<br />
Short Communication<br />
Investigation <strong>of</strong> the EGFR gene variations in bladder cancer patients using<br />
INFINITI TM Analyzer<br />
N.O.TİRYAKİOĞLU, Ö.KURNAZ, Ö.O.ÇAKIR <strong>and</strong> N.ERSOY TUNALI<br />
Instructions for Authors<br />
15<br />
21<br />
31<br />
37<br />
45<br />
53<br />
63<br />
69<br />
75<br />
83<br />
87
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 1-4, 2011 Review Article 1<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Decision making mechanism influences the regulatory function <strong>of</strong><br />
Notch in apoptosis<br />
Ajay NAIR*<br />
Laboratory for Evolution <strong>and</strong> Development, Department <strong>of</strong> Biochemistry, University <strong>of</strong> Otago, Dunedin<br />
9054, New Zeal<strong>and</strong><br />
(* author for correspondence; rudraaj14@gmail.com)<br />
Received: 24 January 2011; Accepted: 28 February 2011<br />
Abstract<br />
The anti-apoptotic role <strong>of</strong> Notch <strong>and</strong> its interactors has been cited by many in the recent past. This intriguing<br />
phenomenon however involves a non-canonical pathway that is independent <strong>of</strong> the usual nuclear-<br />
localization <strong>of</strong> the Notch intracellular domain (NICD) which is formed following a series <strong>of</strong> cleavage events<br />
set <strong>of</strong>f by the lig<strong>and</strong> dependent activation <strong>of</strong> the Notch receptor. This finding has in turn led to the general<br />
postulation that there is perhaps a membrane-tethered or cytoplasm localized form <strong>of</strong> NICD which is<br />
responsible for its non-canonical pathway. However, this notion has been a subject <strong>of</strong> scrutiny from the<br />
moment <strong>of</strong> its origin. This review will make an attempt to compile most <strong>of</strong> these current ambiguities <strong>and</strong> will<br />
furthermore try to substantiate, a likely evolutionary significance <strong>of</strong> the regulatory function <strong>of</strong> Notch on<br />
apoptosis, by using the theory <strong>of</strong> Natural Selection to intervene.<br />
Keywords: Notch, nuclear localization, Notch intracellular domain, apoptosis, natural selection.<br />
Karar verme mekanizması Notch'un apoptozdaki düzenleyici rolünü etkiler<br />
Özet<br />
Notch ve etkileşimde bulunduğu proteinlerin anti-apoptotik rollerinden yakın geçmişte fazlaca<br />
bahsedilmiştir. Ancak bu ilgi çekici fenomen, Notch reseptörünün lig<strong>and</strong> bağımlı aktivasyonuyla başlayan<br />
kesilme olayları sonucunda gerçekleşen Notch intrasellüler bölgesinin nükleer lokalizasyonundan bağımsız<br />
kanonik olmayan bir yolakla ilişkilidir. Bu bulgu kanonik olmayan bu yolaktan sorumlu NCID'nin<br />
membrana bağlı veya sitoplazmik bir formu olabileceği varsayımına yol açmıştır. Fakat bu görüş baştan<br />
itibaren detaylı incelemelere maruz kalmıştır. Bu derleme, bu konudaki belirsizlikleri toplamaya ve dahası<br />
doğal seleksiyon teorisi aracılığıyla Notch proteininin apoptozda düzenleyici işlevinin muhtemel evrimsel<br />
önemini göstermeye çalışacaktır.<br />
Anahtar Sözcükler: Notch, nükleer lokalizasyon, Notch intraselüler bölgesi, apoptoz, doğal seleksiyon.<br />
Introduction<br />
The Notch protein is a transmembrane receptor<br />
possessing distinct extracellular <strong>and</strong> intracellular<br />
domains. Specific lig<strong>and</strong> proteins (single pass<br />
transmembrane proteins belonging to the<br />
Delta/Serrate/ LAG-2 family <strong>of</strong> proteins) bind to<br />
the extracellular domain which in turn triggers<br />
successive proteolytic cleavage events starting with<br />
that <strong>of</strong> the extracellular domain, catalyzed by a<br />
metalloprotease, TACE (Tumor Necrosis Factor<br />
Alpha Converting Enzyme). This is then followed<br />
by the cleavage <strong>of</strong> the remaining notch protein<br />
catalyzed by γ-secretase (Perumalsamy et al.,<br />
2009). Once cleaved, it is referred as the Notch<br />
intracellular domain <strong>and</strong> migrates to the nucleus to<br />
influence gene expression. This is the conventional<br />
Notch signaling pathway. Apart from the canonical<br />
pathway <strong>of</strong> Notch signaling there also an
2 Ajar NAIR<br />
alternative pathway which culminates in the release<br />
<strong>of</strong> anti-apoptotic factors <strong>and</strong> the inactivation <strong>of</strong> proapoptotic<br />
proteins, especially in T cells (Sade et al.,<br />
2004). However, this unorthodox pathway avoids<br />
the usual nuclear localization. Recent research on<br />
the same has engendered the possibility <strong>of</strong> a<br />
membrane-tethered or cytoplasm- localized form,<br />
something that has been a subject <strong>of</strong> intense<br />
research since then. Now the question regarding the<br />
membrane or cytoplasmic localization <strong>of</strong> the Notch<br />
intracellular domain during its anti-apoptotic non<br />
canonical signal transduction is certainly puzzling.<br />
But what is utmost intriguing is that the structural<br />
composition <strong>of</strong> NICD doesn’t completely <strong>and</strong><br />
substantially support a membrane tethered or<br />
cytosolic form separately. This assertion can be<br />
made more explicit with the following findings<br />
from various works done in this regard:<br />
1. The existence <strong>of</strong> a nuclear localization sequence,<br />
intact in the NICD.<br />
2. Notch intracellular domain construct with a<br />
partially truncated PEST (P (Proline), E (Glutamic<br />
acid), S (Serine), T (Threonine)) domain is<br />
abbreviated as NIC (Figure 1); whereas the active,<br />
full-length Notch intracellular domain is<br />
abbreviated as NICD. While investigating the<br />
regulatory function <strong>of</strong> Notch-1 on apoptosis, one<br />
anti-apoptotic protein in particular is significantly<br />
upregulated in NICD-expressing Jurkat cells: the<br />
XIAP (X-linked inhibitor <strong>of</strong> apoptosis). A nearly<br />
three-fold increase <strong>of</strong> XIAP protein was detected in<br />
NICD-expressing T cells. Over expression <strong>of</strong> the<br />
full-length Notch intracellular domain also resulted<br />
in elevated levels <strong>of</strong> XIAP (Liu WH et al., 2007).<br />
3. Notch increases XIAP stability through<br />
downregulation <strong>of</strong> proteasome-mediated protein<br />
degradation <strong>and</strong> upregulation <strong>of</strong> XIAP by Notch<br />
activation is not Akt-dependent (Liu et al., 2007;<br />
Dan et al., 2004).<br />
4. NICD is composed <strong>of</strong> a RAM domain at the N<br />
terminal, then followed by six repeats <strong>of</strong> Ankyrin<br />
(ANK) followed by a NLS. This is ensued by a<br />
Transactivation domain (TAD) <strong>and</strong> the NICD<br />
structure ends at the C terminal, by a PEST domain<br />
(Figure 1). Deletions in the RAM or ANK repeat<br />
domains, do not affect the binding <strong>of</strong> NICD to<br />
XIAP. Truncation <strong>of</strong> the TAD from NICD on the<br />
other h<strong>and</strong> abolishes its association with His-XIAP,<br />
indicating that TAD is the XIAP binding region on<br />
NICD. NICD directly binds XIAP, where the Cterminal<br />
domain on NIC <strong>and</strong> the RING-finger<br />
domain <strong>of</strong> XIAP are critical for such interaction<br />
(Liu et al., 2007).<br />
5. NICD interacts with XIAP in the cytoplasm;<br />
which was confirmed by the finding that coexpression<br />
<strong>of</strong> XIAP decreases NIC-directed HES5<br />
(Hairy <strong>and</strong> enhancer <strong>of</strong> split5) trans-activation (Liu<br />
et al., 2007).<br />
6.TAD dictates the transcription activity <strong>of</strong> NICD.<br />
Partial deletion <strong>of</strong> TAD domain retains most <strong>of</strong> the<br />
NICD transcription activity, shown by activation <strong>of</strong><br />
the HES5 promoter, yet completely eliminating the<br />
capacity <strong>of</strong> NICD to bind XIAP (Figure 2) (Liu et<br />
al. 2007). If there is an independent membrane<br />
tethered form, then the canonical pathway must not<br />
get influenced by any means.<br />
Figure 1. Structural makeup <strong>of</strong> NICD. RAM<br />
domain at the N terminal is followed by six ANK<br />
repeats, a nuclear localization sequence, a TAD<br />
(Trans-activation domain) <strong>and</strong> a PEST domain at<br />
the C terminal. Truncation <strong>of</strong> the TAD affects<br />
NICD’s association with XIAP; altering NICD’s<br />
anti-apoptotic function.
The aforesaid, thus, strongly suggests that there<br />
is more to be added to complete the puzzle. From<br />
the above points it seems that there exists a<br />
decision making mechanism, within the cytoplasm<br />
which decides the fate <strong>of</strong> the NICD, which either<br />
complies with its usual nuclear retention or NCID<br />
gets stabilized in the cytoplasm. And certainly this<br />
point out to the possibility <strong>of</strong> an alternate<br />
modification <strong>of</strong> the NICD, other than those<br />
mentioned above, that perhaps answers for such a<br />
diversity seen in Notch, in terms <strong>of</strong> its action.<br />
Figure 2. Activation <strong>of</strong> transcription, via NICD’s<br />
usual nuclear retention in a cell. A) activated notch<br />
receptor. B) cleaved NICD with intact TAD. C)<br />
XIAP. D) NICD with truncated or deleted TAD;<br />
NICD fails to bind XIAP. E) HES5; NICD<br />
localizes to nucleus <strong>and</strong> associates with HES-5 to<br />
turn on transcription.<br />
An evolutionary rationale<br />
This perplexing behavioral change exhibited by<br />
Notch receptors <strong>and</strong> its signaling cascade may<br />
perhaps be explained in an alternate fashion, by<br />
observing it from an angle that concentrates on<br />
reasoning out the advantage <strong>of</strong> a T cell that may<br />
hold when urged to respond to an environmental<br />
stimulus like neglect or etoposide or DNA damage<br />
induced death signals. It’s recognized that energy is<br />
consumed for two central processes in any<br />
biological cell; one is for reproduction <strong>and</strong> the other<br />
for cell-maintenance. Although indirectly, the notch<br />
canonical pathway is responsible for meeting the<br />
requirements pertaining to development,<br />
Processing <strong>of</strong> Notch rescues cells from apoptosis 3<br />
reproduction etc. But a situation like neglect or<br />
other antagonist stimulus poses an unfavorable<br />
condition. Hence it is certainly in a cell’s interest to<br />
switch to a mode which would momentarily<br />
conserve much <strong>of</strong> the cells free energy for cell<br />
maintenance by promoting cell survival signaling<br />
pathways rather than promoting the customary<br />
transcriptional activities (developmental <strong>and</strong><br />
metabolic); for it is utterly uneconomical to spend<br />
the same energy on reproducing the cells in an<br />
attempt to revitalize the cell population. Therefore,<br />
notch signaling in entirety is bound to have a<br />
decision making mechanism from the time <strong>of</strong> its<br />
activation. But does notch directly respond to the<br />
dem<strong>and</strong> or the environmental stimulus. Perhaps<br />
there is more than a straight intrusion from Notch.<br />
Notch interactors, other than the canonical <strong>and</strong> noncanonical,<br />
are mostly playing a pivotal role in<br />
answering this question which still st<strong>and</strong>s<br />
challengeable inspite <strong>of</strong> the various breakthroughs<br />
made in the context <strong>of</strong> Notch <strong>and</strong> its regulatory<br />
function on apoptosis. The question that continues<br />
to seek an answer is, why does a mechanism like<br />
the Notch signaling pathway, which is one <strong>of</strong> the<br />
highly conserved cell signaling systems present in<br />
most multicellular organisms in terms <strong>of</strong> involving<br />
gene regulation mechanisms that control multiple<br />
cell differentiation processes, incorporate a<br />
different role such as anti apoptosis? Because notch<br />
holds the potential to influence cell fate decisions,<br />
it is imperative that there be a decision making<br />
mechanism that can modulate this omnipotent<br />
transmembrane protein <strong>and</strong> its actions, depending<br />
upon the need <strong>of</strong> the hour from a toll <strong>of</strong> billion<br />
deaths (Neglect or DNA damage induced).<br />
Probably cells have earned <strong>and</strong> evolved towards<br />
this non conventional Notch pathway, that rescues<br />
cells from self flattening. This postulation finds<br />
support from a concept called- The Selfish Gene<br />
Theory or Gene Selection Theory, according to<br />
which “adaptations are the phenotypic effects <strong>of</strong><br />
genes to maximize their own representation <strong>and</strong><br />
continued survival in the future generations”.<br />
Genes build vehicles to meet their mutual interests<br />
<strong>of</strong> jumping into the next generation <strong>of</strong> vehicles<br />
(Dawkins, 2006). <strong>Cell</strong>s are the survival machines <strong>of</strong><br />
genes. So it is important that there exist a sequential<br />
set <strong>of</strong> events which end up modulating the NICD in<br />
response to an apoptotic stimulus; this change will<br />
ensure cell survival <strong>and</strong> as a consequence, promote<br />
the perpetuation <strong>of</strong> genes.<br />
Neglect like situation, (known to activate antiapoptotic<br />
factors via Notch, in T cells (Sade et al.,
4 Ajar NAIR<br />
2004)) is extremely stressful; leading to a shift in<br />
the cell’s energy. The cell prepares itself for<br />
apoptosis; apoptosis promoting factors are<br />
activated. Such an event forces mitochondria<br />
towards an immediate fragmentation which marks<br />
the onset <strong>of</strong> apoptosis; fragmentation induces<br />
release <strong>of</strong> intrinsic pro-apoptotic factors (for e.g.<br />
cytochrome-c) (Suen et al., 2008). Perhaps an<br />
apoptotic distress signal, such as the one mentioned<br />
above, prevents the usual processing <strong>of</strong> NICD,<br />
which causes the partial or complete deletion <strong>of</strong> its<br />
trans-activation domain; in so doing prevent its<br />
nuclear localization <strong>and</strong> its ability to stimulate<br />
transcription by associating with transcription<br />
factors (for e.g. HES5). Possibly, a decision making<br />
mechanism in the form <strong>of</strong> an additional physical<br />
modification <strong>of</strong> NICD, in the cytoplasm, changes<br />
its typical course, so as to meet the need, which is<br />
to respond to the induced stress. Besides activating,<br />
anti-apoptotic factors like XIAP, this tailored NICD<br />
may well be acting upstream to the factors which<br />
promote mitochondrial connectivity (for e.g.<br />
Mit<strong>of</strong>usin (Mfn) 1&2), causing a delay in bax<br />
activation, cytochrome-c release <strong>and</strong> eventually halt<br />
cell demolition (Figure 3).<br />
Figure 3. Proposed alteration in notch activity<br />
during cell neglect. A) Notch receptor. B) Induced<br />
stress leads to, a shift in the energy metabolism,<br />
<strong>and</strong> the release pro-apoptotic factors (shown as<br />
blue circles); this results in mitochondrial<br />
fragmentation. C) This might act as an alarm<br />
upstream notch to stop its usual course to the<br />
nucleus; HES5 (shown in blue inside the nucleus)<br />
remains unbound to trigger transcription. D)<br />
Cleaved NICD binds to XIAP via its intact TAD.<br />
E) This interaction might activate other antiapoptotic<br />
factors <strong>and</strong> also release factors (for e.g.<br />
Mfn) to restore mitochondrial connectivity.<br />
Conclusion<br />
For each <strong>and</strong> every phenomenon or process that<br />
exists, there must in every case be a reason for its<br />
occurrence in terms <strong>of</strong> the benefit it provides to a<br />
cell. This leads to a specific adaptation with respect<br />
to the cell’s requirement at a particular instance<br />
(such as the long term survival <strong>of</strong> Memory T cells<br />
due to the regulatory function <strong>of</strong> Notch-1 on<br />
apoptosis). Through rigorous selective pressures on<br />
a cell, several individual molecular processes are<br />
scrutinized. The one that makes a cell evermore<br />
specialized with respect to the immediate dem<strong>and</strong>,<br />
is selected by natural selection. It is this long<br />
evolutionary history that, in all probabilities,<br />
endowed notch with this non-canonical<br />
mechanism. Hence, notions that speculate a<br />
discrete membrane localized form for Notch, do<br />
not seem to hold up.<br />
References<br />
Liu WH, Hsiao HW, Tsou WI <strong>and</strong> Lai MZ. Notch<br />
inhibits apoptosis by direct interference with<br />
XIAP ubiquitination <strong>and</strong> degradation. The<br />
EMBO <strong>Journal</strong>. 26: 1660–1669, 2007.<br />
Perumalsamy LR, Nagala M, Banerjee P <strong>and</strong> Sarin<br />
A. A hierarchical cascade activated by noncanonical<br />
Notch signaling <strong>and</strong> the mTOR–<br />
Rictor complex regulates neglect-induced death<br />
in mammalian cells. <strong>Cell</strong> Death <strong>and</strong><br />
Differentiation. 16: 879-889, 2009.<br />
Sade H, Krishna S <strong>and</strong> Sarin A. The Anti-apoptotic<br />
Effect <strong>of</strong> Notch-1 Requires p56lck-dependent<br />
Akt/PKB-mediated Signaling in T <strong>Cell</strong>s, The<br />
<strong>Journal</strong> <strong>of</strong> Biological Chemistry. 279: 2937–<br />
2944, 2004.<br />
Suen DF, Norris KL <strong>and</strong> Youle RJ. Mitochondrial<br />
dynamics <strong>and</strong> apoptosis. Genes & Development.<br />
22: 1577-1590, 2008.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 5-13, 2011 Review Article 5<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to<br />
bladder cancer<br />
Nagehan ERSOY TUNALI* <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />
<strong>Haliç</strong> University, Department <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul, TURKEY<br />
(* author for correspondence; nagehanersoy@halic.edu.tr)<br />
Received: 13 May 2011; Accepted: 20 June 2011<br />
Summary<br />
It is thought that the interaction between genetic <strong>and</strong> environmental factors accounts for the different levels<br />
<strong>of</strong> susceptibilities to the development <strong>of</strong> bladder cancer. The well known etiological risk factors <strong>of</strong> bladder<br />
cancer are occupational exposure to certain carcinogens <strong>and</strong> cigarette smoking. Therefore, polymorphisms in<br />
the genes coding for the xenobiotic-metabolizing enzymes may cause individual variations in metabolizing<br />
the exposed carcinogens. Here we aimed to review the metabolising genes <strong>and</strong> respective polymorphisms<br />
<strong>and</strong> to demonstrate the association between xenobiotic-metabolising gene polymorphisms <strong>and</strong> bladder<br />
cancer. Among metabolizing enzymes, we will introduce N-acetyltransferases (NAT), glutathione-Stransferases<br />
(GST), sulphotransferases (SULT), NAD(P)H dehydrogenase quinone 1 (NQO1),<br />
methylenetetrahydr<strong>of</strong>olate reductase (MTFR), cytochrome P-450 (CYP) <strong>and</strong> aldo-Ketoreductases (AKR)<br />
with special emphasis on the last two enzyme group.<br />
Keywords: Bladder cancer, xenobiotic metabolism, metabolising genes, genetic susceptibility, genetic<br />
polymorphism<br />
Ksenobiyotik genlerdeki polimorfizmler ve mesane kanserine yatkınlık<br />
Özet<br />
Genetik ve çevresel faktörler arasındaki etkileşimin mesane kanseri oluşumu için farklı seviyelerde<br />
yatkınlık oluşturduğu düşünülmektedir. En iyi bilinen etiyolojik risk faktörleri, meslek sebebi ile<br />
maruz kalınan kanserojenler ve sigara içimidir. Bu nedenle, ksenobiyotik-metabolize edici<br />
enzimlerdeki polimorfizmler maruz kalınan karsinojelerin metabolize edilmesinde kişisel<br />
varyasyonlara sebep olabilir. Biz burada metabolize edici genleri ve ilgili polimorfizmleri derlemeyi<br />
ve ksenobiyotik-metabolize edici gen polimorifzmleri ile mesane kanseri arasındaki bağlantıyı<br />
göstermeyi amaçladık. Metabolize edici genlerden N-asetiltransferazları (NAT), glutatyon-Stransferazları<br />
(GST), sulfotransfeazları, NAD(P)H dehidrogenaz kinon 1’i (NQO1),<br />
metilentetrahidr<strong>of</strong>olat redüktazı, sitokrom P-450’yi (CYP) ve aldo-ketoredüktazları (AKR), son iki<br />
enzim grubuna özel vurgu yaparak tanıtacağız.<br />
Anahtar kelimeler: Mesane kanseri, ksenobiyotik mekanizma, metabolize edici genler, genetik<br />
yatkınlık, genetik polimorfizm<br />
Introduction<br />
Cancer is regarded as a multifactorial disorder<br />
affected both by genetic <strong>and</strong> environmental factors,<br />
which culminate in dysregulated cell cycle.<br />
Although environmental risk factors are considered<br />
as the most important among others,<br />
epidemiological studies have shown that a certain<br />
part <strong>of</strong> the population is in fact more prone to<br />
develop cancers despite being exposed to the same<br />
type <strong>and</strong> amount <strong>of</strong> environmental risks. This
6 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />
finding has led the molecular epidemiology studies<br />
to focus on predisposition to cancer via genetic<br />
factors. It has been speculated that either the<br />
polymophisms in the DNA repair genes or those in<br />
carcinogen metabolizing genes should primarily be<br />
questioned as possible c<strong>and</strong>idates <strong>of</strong> genetic<br />
modifiers. The polymorphisms in the DNA repair<br />
genes may alter the function <strong>of</strong> the related enzyme<br />
<strong>and</strong> thereby affect the repair capacity <strong>of</strong> the<br />
individual. This kind <strong>of</strong> alteration in the DNA<br />
repair mechanism may get the individual more<br />
sensitive to carcinogens <strong>and</strong> more susceptible to<br />
cancer formation (Franekova et al., 2008).<br />
Likewise, polymorphisms in the genes coding for<br />
the xenobiotic-metabolizing enzymes may cause<br />
individual variations in metabolizing the exposed<br />
carcinogens (Longuemaux et al., 1999). As a result,<br />
individuals with a certain genetic background may<br />
become more susceptible to develop cancer.<br />
Xenobiotic metabolism<br />
Xenobiotic metabolism (from the Greek xenos<br />
"stranger" <strong>and</strong> biotic "related to living beings") is<br />
composed <strong>of</strong> several metabolic pathways that<br />
modify the chemical structure <strong>of</strong> xenobiotics, e.g.<br />
drugs, carcinogens, poisons. Upon their intake by<br />
an organism, xenobiotics undergo several metabolic<br />
Metabolising genes <strong>and</strong> susceptibility to bladder<br />
Cancer<br />
Polymorphisms in the xenobiotic-metabolising<br />
genes are pivotal to the above-mentioned<br />
alterations <strong>and</strong> therefore have been intensively<br />
investigated in many cancer types. Foremost <strong>of</strong><br />
Figure 1. Activation pathways <strong>of</strong> carcinogens<br />
conversions to facilitate their solubility in order to<br />
expedite their removal from the organism. These<br />
so-called biotransformation processes consists <strong>of</strong><br />
two consecutive steps; an initiation phase, where<br />
carcinogens are modified to accept reactive groups<br />
(Phase I) via the action <strong>of</strong> cytochrome P450<br />
oxidases; <strong>and</strong> a second phase where they are<br />
converted into more easily extractable molecules by<br />
conjugation reactions (Phase II) via transferase<br />
enzymes. The xenobiotic metabolism can be<br />
regarded as a detoxification mechanism consisting<br />
<strong>of</strong> two phases, however, conversion reactions<br />
catalyzed by xenobiotic-metabolising enzymes can<br />
also activate potential carcinogens (Figure 1.).The<br />
reason for this is the vastly diverse chemical<br />
structures <strong>of</strong> carcinogens which can not be<br />
compensated by the limited number <strong>of</strong> conversion<br />
reactions catalyzed by xenobiotic enzymes. The<br />
capability <strong>of</strong> the xenobiotic metabolism to either<br />
activate or detoxify carcinogens constitute a fragile<br />
balance between activation <strong>and</strong> detoxification <strong>of</strong><br />
carcinogens, which defines the amount <strong>of</strong> DNA<br />
damage accumulated in the cells. Alterations<br />
affecting enzyme activity shifts this balance<br />
towards either detoxification or activation <strong>of</strong><br />
carcinogens.<br />
these cancers is the bladder cancer, for which the<br />
well-known etiological risk factors are occupational<br />
exposure to certain carcinogens <strong>and</strong> cigarette<br />
smoking. In fact, smoking is proved to be the<br />
primary cause <strong>of</strong> approximately 70% <strong>of</strong> the bladder<br />
cancer cases (Parkin 2008). It is thought that the<br />
interaction between genetic <strong>and</strong> environmental
factors accounts for the different levels <strong>of</strong><br />
susceptibilities to the development <strong>of</strong> bladder<br />
cancer. Bladder cancer incidence varies highly<br />
between distinct regions worldwide, with<br />
developed countries having the highest incidence<br />
(Silverman et al., 1999; Parkin et al., 2002). Higher<br />
bladder cancer incidence in developed countries<br />
despite increased awareness against risk factors<br />
indicates the existence <strong>of</strong> genetic factors affecting<br />
bladder cancer susceptibility. Thereby,<br />
polymorphisms with possible association to bladder<br />
cancer have been widely investigated. Many<br />
metabolizing genes <strong>and</strong> their polymorphisms have<br />
been identified as responsible for individual<br />
susceptibility to cause BC.<br />
This review is written as an attempt to<br />
demonstrate the association between xenobioticmetabolising<br />
gene polymorphisms <strong>and</strong> bladder<br />
cancer. Among metabolizing enzymes, we will<br />
introduce N-acetyltransferases (NAT), Glutathione-<br />
S-transferases (GST), Sulphotransferases (SULT),<br />
NAD(P)H dehidrogenase Quinone 1 (NQO1),<br />
Methylenetetrahydr<strong>of</strong>olate reductase (MTFR),<br />
Cytochrome P-450 (CYP) <strong>and</strong> Aldo-Ketoreductases<br />
(AKR) with special emphasis on the last two<br />
enzyme group <strong>and</strong> related polymorphisms.<br />
N-acetyltransferases<br />
In humans, genetic locus for the two isoenzymes <strong>of</strong><br />
NAT, NAT1 <strong>and</strong> NAT2, resides at chromosome<br />
8p22. NAT1 <strong>and</strong> NAT2 are polymorphic <strong>and</strong> both<br />
catalyze N- <strong>and</strong> O-acetylation <strong>of</strong> aromatic <strong>and</strong><br />
heterocyclic amines (Franekova et al., 2008).<br />
NAT2, one <strong>of</strong> the Phase II enzymes, play roles in<br />
the bio-conversion <strong>of</strong> heterocyclic amines to<br />
electrophilic nitrenium ions. NAT2 catalyzes the<br />
activation <strong>and</strong> deactivation <strong>of</strong> various aromatic<br />
amines, heterocyclic amines <strong>and</strong> hydrazin drugs.<br />
Polymorphisms in the NAT2 gene have been<br />
strongly associated with bladder cancer. Based on<br />
the 13 SNPs, 30 different NAT2 alleles have been<br />
defined<br />
(http://louisville.edu/medschool/pharmacology/NA<br />
T.html). Depending on the effects <strong>of</strong> the<br />
polymorphisms, NAT2 alleles have been<br />
categorised in two groups as slow <strong>and</strong> fast<br />
acetylators. Individuals who lack both <strong>of</strong> the two<br />
functional NAT2 alleles have been designated as<br />
slow acetylators. A meta-analysis with combined<br />
results from 31 different studies has shown that<br />
NAT2 slow acetylation alleles increase the risk <strong>of</strong><br />
Genetic susceptibility to bladder cancer 7<br />
bladder cancer (OR=1,4; %95CI=1,2-1,7) (Garcia-<br />
Closas et al., 2005).<br />
NAT1 enzyme transfers one acetyl group from<br />
acetyl-coA to arylamine <strong>and</strong> hydrazin substrates.<br />
Many NAT1 variants have been defined to date<br />
(http://louisville.edu/medschool/pharmacology/NA<br />
T.html), however studies have revealed conflicting<br />
results (Hung et al., 2004) <strong>and</strong> their functional<br />
significance could not be fully identified yet.<br />
Since aromatic amines are present in cigarette<br />
smoke are the major risk factors for bladder cancer<br />
<strong>and</strong> are metabolized by NAT enzymes, it is for sure<br />
that the polymorphisms <strong>of</strong> the NAT genes have<br />
important roles in predisposing the individuals to<br />
bladder cancer (Franekova et al., 2008).<br />
Glutathione-S-transferases<br />
Cytosolic GSTs belong to a superfamily <strong>of</strong> Phase II<br />
enzymes, which contain sub-families <strong>and</strong><br />
polymorphic isoenzymes. The genetic<br />
polymorphisms <strong>of</strong> these enzymes affect the<br />
individual susceptibility to cancer, cardiovascular<br />
<strong>and</strong> respiratory diseases. GSTs facillitate the<br />
detoxification <strong>of</strong> electrophilic compounds by<br />
gluthathione conjugation. They interact with a wide<br />
variety <strong>of</strong> substrates including polycyclic aromatic<br />
hydrocarbon (PAH) epoxides <strong>and</strong> oxidative stress<br />
by-products. GSTM1 detoxifies carcinogenic PAHlike<br />
benzopyrene. A common deletion<br />
polymorphism in GSTM1 gene causes the loss <strong>of</strong><br />
enzyme activity <strong>and</strong> has been shown to be strongly<br />
associated with increased risk for bladder cancer<br />
(Jiang et al., 2011, Salinas-Sánchez et al., 2010)<br />
According to a meta-analysis conducted to show<br />
the overall effect <strong>of</strong> this polymorphism, an odds<br />
ratio (OR) <strong>of</strong> 1,5 has been calculated (%95CI=1,3-<br />
1,6) (Garcia-Closas et al., 2005). GSTT1 detoxifies<br />
smaller reactive hydrocarbons, like ethylene oxide.<br />
GSTT1 deletions, which have high frequency in<br />
Caucasians, have been associated with increased<br />
risk for bladder cancer (Abdel- Rahman et al.,1998;<br />
Srivastava et al., 2004). GSTP1 is involved in the<br />
conjugation <strong>and</strong> detoxification <strong>of</strong> many<br />
xenobiotics. The results <strong>of</strong> the studies investigating<br />
GSTT1 <strong>and</strong> GSTP1 gene polymorphisms are<br />
generally conflicting (Brockmoller et al., 1996;<br />
Lee et al., 2002.).<br />
In summary, polymorphisms <strong>of</strong> GSTM1,<br />
GSTT1 <strong>and</strong> GSTP1 constitute risk factors for many<br />
cancer types. Especially the null alleles <strong>of</strong> GSTM1
8 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİĞLU<br />
<strong>and</strong> GSTT1 are risk factors for bladder cancer in<br />
chain smokers.<br />
Sulphotransferases<br />
SULTs are encoded by a supergene family <strong>and</strong><br />
catalyze the sulphonation <strong>of</strong> many xenobiotic<br />
compounds, including drugs <strong>and</strong> carcinogens.<br />
SULT enzymes play role as one <strong>of</strong> the main<br />
detoxification systems in adults <strong>and</strong> in developing<br />
human fetuses. This gene family is not very<br />
polymorphic, except SULT1A1. SULT1A1<br />
Arg213His polymorphism, which causes a decrease<br />
in enzyme activity <strong>and</strong> thermal stability, has been<br />
suggested as a protective factor for bladder cancer<br />
(Zheng et al., 2003).<br />
NAD(P)H dehidrogenase, Quinone 1<br />
NQO1 enzyme protects the cell against<br />
electrophilic <strong>and</strong> oxidizing metabolites <strong>of</strong><br />
xenobiotic <strong>and</strong> endogenous quinone compounds.<br />
The gene coding for the NQO1 enzyme harbors<br />
several polymorphisms affecting enzyme activity.<br />
A187C transition results in the replacement <strong>of</strong><br />
proline with serine <strong>and</strong> decreases enzyme activity.<br />
Accordingly, Ser187 allele has been shown to<br />
increase bladder cancer risk (Franekova et al.,<br />
2008).<br />
Methylenetetrahydr<strong>of</strong>olate reductases<br />
MTHFR converts 5,10-methylenetetrahydr<strong>of</strong>olate<br />
(a methyl donor in deoxythymidine monophosphate<br />
synthesis) to 5-methyltetrahydr<strong>of</strong>olate. Folate<br />
deficiency is related to breakage <strong>of</strong> DNA str<strong>and</strong>s<br />
<strong>and</strong> binding <strong>of</strong> urasil to DNA. If an MTHFR variant<br />
causes a decrease in the folate levels by decreasing<br />
the enzyme activity; one can expect a tendency to<br />
DNA str<strong>and</strong> breakage <strong>and</strong> cancer formation. On the<br />
other h<strong>and</strong>, variant MTHFR activity alters the<br />
amount <strong>of</strong> methyl donors <strong>and</strong> thereby involves in<br />
bladder cancer formation by changing the status <strong>of</strong><br />
promotor methylation. MTHFR 677C>T <strong>and</strong><br />
1298A>C polymorphisms are proved to decrease<br />
enzyme activity. However, the relationship between<br />
the mentioned polymorphisms, enzyme activity <strong>and</strong><br />
susceptibility to bladder cancer should be more<br />
extensively studied to seek for confirming results<br />
(Karagas et al., 2005).<br />
Cytochrome P-450 genes<br />
CYP enzymes catalyze Phase I reactions <strong>and</strong><br />
belong to the microsomal enzyme super family.<br />
CYP enzyme system consists <strong>of</strong> over 20 highly<br />
polymorphic CYP enzymes<br />
(http://www.cypalleles.ki.se/). Human CYP1A1<br />
enzyme is expressed in epithelium <strong>and</strong> plays a key<br />
role in the activation <strong>of</strong> many procarcinogens<br />
including PAHs <strong>and</strong> aromatic amines arising from<br />
tobaccco-related products. Ile-Val (m2) mutation<br />
located in heme-binding domain <strong>and</strong> MspI (m1)<br />
mutation has been shown to increase enzyme<br />
activity. White blood cells <strong>of</strong> smokers harboring a<br />
Ile-Val mutation have been shown to contain more<br />
PAH-DNA adducts in comparison to non-smokers.<br />
Expression <strong>of</strong> CYP1A1 has been shown to elevate<br />
in bladder cancer patients in correlation with<br />
increased tumour stage (Bartsch et al., 2000). m1<br />
<strong>and</strong> m2 mutations, on the other h<strong>and</strong>, are directly<br />
associated with increased risk for lung cancer<br />
(Aynacioglu et al., 1998). CYP1A1 mutations<br />
exhibit variations among different ethnic groups. In<br />
contrast to Causians, prevalances <strong>of</strong> m1 <strong>and</strong> m2 are<br />
high among Asian populations. M3 mutation was<br />
identified only in Africans. In molecular <strong>and</strong><br />
epidemiologic studies, CYP1A1*2B allele,<br />
harboring m1 <strong>and</strong> m2 mutations, was found to be<br />
correlated with increased risk for lung cancer.<br />
Figure 2 shows the localisation <strong>of</strong> these four<br />
important mutations (m1, m2, m3, m4) on CYP1A1<br />
gene. Human CYP1B1 gene is located at<br />
chromosome 2p21 <strong>and</strong> contains three exons in a<br />
10kb region. It codes for the 543 amino acid long<br />
enzyme (Figure 3). It was found to be<br />
overexpressed in many cancer types including,<br />
colon, lung, skin, brain cancers in contrast to its<br />
lower expression in normal somatic tissues (Thier<br />
et al., 2002). CYP1B1 activates PAHs, aromatic<br />
<strong>and</strong> heterocyclic amines. It also catalyzes the<br />
conversion <strong>of</strong> benzo[a]pyrene to carcinogenic<br />
metabolite diol epoxide-2, which indicates its<br />
significant role in the activation <strong>of</strong> tobacco<br />
carcinogens. Studies conducted so far indicate that<br />
CYP1B1 polymorphisms, especially codon 432<br />
polymorphism, change enzyme activity <strong>and</strong><br />
contribute to carcinogenesis. CYP1B1 codon 432<br />
polymorphism increases risk for smokers for head<br />
<strong>and</strong> neck cancers (Thier et al., 2002).<br />
CYP2D6 gene codes for debrisoquine<br />
hydroxylase. Its subtrates include aromatic amines<br />
<strong>and</strong> tobacco nitrosamines. The existence <strong>of</strong><br />
homozygous recessive mutations in this gene<br />
results in the inability <strong>of</strong> metabolising certain<br />
compounds. Individuals with these mutations
compromise nearly 5-10% <strong>of</strong> the Caucasian<br />
population which are categorised as poor<br />
metabolizers (PM) because <strong>of</strong> their inability to<br />
metabolise certain compunds. The PM phenotype is<br />
Genetic susceptibility to bladder cancer 9<br />
associated with increased susceptibility to cancer,<br />
indicating a possible role for this enzyme in the<br />
conversion <strong>of</strong> procarcinogens to active carcinogens.<br />
Figure 2. m1, m2, m3 <strong>and</strong> m4 mutations in the CYP1A1 gene<br />
Most common mutations responsible for the PM<br />
phenotype have been identified. G/A transition<br />
located on exon3-intron4 conjunction creates an<br />
early stop codon resulting in defective mRNA. This<br />
CYP2E1 metabolizes many procarcinogens, e.g.<br />
N´-nitrosonornicotine, 4-methylnitrosamino-1,3pyridyl-1-butanone<br />
<strong>and</strong> other volatile nitrosamines,<br />
which are inhaled via cigarette smoking.<br />
Inter-individual expression variants <strong>of</strong> human<br />
CYP2E1 gene have been identified. The most<br />
frequently studied RFLPs on the CYP2E1 gene are<br />
those residing at the 5’ end <strong>of</strong> the gene which are<br />
proved to alter enzyme activity. Among them,<br />
PstI/RsaI (mutant allele: CYP2E1*5B) <strong>and</strong> DraI<br />
(mutant allele: CYP2E1*6) polymorphisms. These<br />
two polymorphisms together constitute the<br />
CYP2E1*5A allele. In addition to this, RsaI (G-<br />
1259C) <strong>and</strong> PstI (C-1091T) alleles are in complete<br />
linkage disequilibrium with eachother. CYP2E1*6<br />
allele variant is present in nearly 10% <strong>of</strong> the<br />
European population. Recently, Haufroid et al.<br />
(2002) have shown that people with at least one<br />
CYP2E1*6 allele have lower chlorzoxazone than<br />
homozygous wild type individuals. There are ethnic<br />
variations in CYP2E1*5A allele frequencies among<br />
Figure 3. Structure <strong>of</strong> the CYP1B1 gene (Thier et al., 2002)<br />
mutation accounts for 80% <strong>of</strong> the PM phenotype.<br />
While the deletion <strong>of</strong> the whole CYP2D6 gene<br />
accounts for the 15% <strong>of</strong> PM phenotypes (Sobti et<br />
al., 2005; Febbo et al., 1998).<br />
Asians <strong>and</strong> Europeans. Europeans are 5%<br />
heterozygous; Asians are 37% heterozygous <strong>and</strong><br />
6% homozygous for this allele. Because <strong>of</strong> the<br />
certain inter-ethnic variations <strong>of</strong> the CYP2E1*5A<br />
allele, genetic polymophisms, enzyme expression<br />
<strong>and</strong> alterations in the chemical metabolism are still<br />
not clear <strong>and</strong> the studies are conflicting each other<br />
(Bolt et al., 2003).<br />
Aldo-Ketoreductases<br />
AKRs catalyze the conversion <strong>of</strong> carbonyl groups<br />
to alcohol derivatives. Their most common<br />
endogenic substrates are lipid aldehydes, steroids<br />
<strong>and</strong> prostogl<strong>and</strong>ines. They also activate prodrugs<br />
<strong>and</strong> polycyclic aromatic hydrocarbons (PAHs). In<br />
addition, they have been shown to induce resistance<br />
against chemotherapeutic agents like cysplatine <strong>and</strong><br />
doxorubicin. The essential function <strong>of</strong> AKRs is to<br />
convert aldehydes to primary <strong>and</strong> secondary<br />
alcohols by reduction (Flynn <strong>and</strong> Green 1993;<br />
Penning et al., 2004). This conversion enables the
10 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />
conjugation reactions <strong>and</strong> therefore aldoketoreductases<br />
are considered as Phase I enzymes.<br />
Human AKRs interact with various substrates<br />
including drugs, carcinogens <strong>and</strong> reactive<br />
aldehydes. Their important role in the metabolism<br />
<strong>of</strong> these substrates signifies them as key enzymes in<br />
designating the carcinogenicity <strong>of</strong> these substrates.<br />
There are 15 AKR families discovered so far.<br />
Human AKRs are categorised into 3 families as<br />
AKR1, AKR6 <strong>and</strong> AKR7. 8 <strong>of</strong> the 13 discovered<br />
human AKRs belong to the AKR1 family<br />
(AKR1A1, AKR1B1, AKR1B10, AKR1C1,<br />
AKR1C2, AKR1C3, AKR1C4 <strong>and</strong> AKR1D1).<br />
Most <strong>of</strong> the AKR enzymes are 34-37 kDa<br />
monomeric proteins with a catalytic tetrade region,<br />
conserved among family members. Their substrate<br />
binding domains, on the other h<strong>and</strong>, show great<br />
variety, representing the diversity <strong>of</strong> their substrates<br />
(Jin <strong>and</strong> Penning, 2007).<br />
AKRs <strong>and</strong> activation <strong>of</strong> PAHs<br />
There are three different pathways <strong>of</strong> PAH<br />
activation. These are P-450 peroxidase induced<br />
formation <strong>of</strong> radical cations, P-450 induced<br />
formation <strong>of</strong> diol-epoxides <strong>and</strong> AKR induced<br />
formation <strong>of</strong> reactive o-quinones. The latter are<br />
highly reactive molecules which can bind to most<br />
macrobiomolecules including DNA, RNA <strong>and</strong><br />
proteins preemminently (Jin <strong>and</strong> Penning, 2007).<br />
The formation <strong>of</strong> o-quinones generates reactive<br />
oxygen species as by-products, which activate RAS<br />
targets by inducing the expression <strong>of</strong> antioxidant<br />
response element (ARE) containing genes. Since<br />
RAS pathway is responsible for transmitting the<br />
extracellular growth signals to nucleus, o-quinones<br />
produced by AKRs are considered to effect both the<br />
induction <strong>and</strong> progress <strong>of</strong> carcinogenesis (Jin <strong>and</strong><br />
Penning, 2007).<br />
Function <strong>and</strong> tissue specific expression <strong>of</strong> Aldo-<br />
Ketoreductases<br />
Human AKR1C family members; AKR1C1,<br />
AKR1C2, AKR1C3 <strong>and</strong> AKR1C4; show great<br />
homology to each other. They all contain 9 exons<br />
<strong>and</strong> are located on chromosome 10. The expression<br />
<strong>of</strong> AKR1C genes are regulated by AREs located in<br />
their promoters.<br />
AKR1C1 <strong>and</strong> AKR1C2 have been shown to be<br />
expressed 50-fold more in lung tumors (Hsu et al.<br />
2001). To confirm these results Palackal <strong>and</strong><br />
colleagues have measured the expression levels <strong>of</strong><br />
AKR1C1, AKR1C2 <strong>and</strong> AKR1C3 is<strong>of</strong>orms in lung<br />
adenocarcinoma cells <strong>and</strong> obtained similar results<br />
(Palackal et al., 2002). Furthermore a study<br />
conducted by Dozmorov et al. have shown that<br />
increased AKR1C3 expression induce angiogenesis<br />
<strong>and</strong> increase cell survival (Dozmorov et al., 2010)<br />
.AKR polymorphisms<br />
Even though the structural difference between<br />
AKR1C1 <strong>and</strong> AKR1C2 arises only from 7 different<br />
aminoacids, they have vastly different functions.<br />
Nonhomologous aminoacids are T38V, R47H,<br />
L54V, C87S, V151M, R170H <strong>and</strong> Q1721 which<br />
are highly polymorphic. Common polymorphisms<br />
in the AKR1C1 gene are T38A, T38I <strong>and</strong> R47H,<br />
whilst H47R, S87C, L172Q <strong>and</strong> V38A are common<br />
polymorphisms in AKR1C2. There have been 17<br />
polymorphisms identified in the coding regions <strong>of</strong><br />
AKR1C3. Nine <strong>of</strong> these polymorphisms results in<br />
amino acid changes while the other eight are<br />
synonymous (Table 1.).<br />
One <strong>of</strong> the nonsynonymous polymorphisms, the<br />
G106T polymorphism, has been shown to produce<br />
truncated protein; <strong>and</strong> another nonsynonymous<br />
polymorphism, A230G, has been associated with<br />
decreased cholesterol levels in the blood<br />
(Jakobsson et al., 2007). AKR1C4*5 (L311V)<br />
polymorphism is located on the C-terminal <strong>and</strong> has<br />
been shown to affect substrate binding specifity<br />
(Kume et al., 1999).<br />
There are a few studies conducted to investigate<br />
the association between the AKR polymorphisms<br />
<strong>and</strong> cancer. AKR polymorphisms have been<br />
investigated in Non-Hodgkin lymphoma <strong>and</strong><br />
AKR1A1 rs2088102 polymorphism has been<br />
shown to be associated with increased risk (Lan et<br />
al., 2004). Another study, where the association<br />
between prostate cancer <strong>and</strong> AKR1C3<br />
polymorphism have been investigated has shown an<br />
increased risk for rs7741 polymorphism<br />
(Cunningham et al., 2007).<br />
Studies concerning rs12529 polymorphism gave<br />
conflicting results. rs12529 has been shown to be<br />
associated with increased lung cancer (OR=1,84,<br />
%95CI= 0,98-3,45), while it has been shown to<br />
confer protection for bladder cancer (Lan et al.,<br />
2007; Figuerova et al., 2008; Tiryakioğlu, 2011).<br />
Figuerova et al.(2008) investigated 8<br />
polymorphisms located in two regions <strong>of</strong> AKR1C3<br />
gene, which are likely to affect bladder cancer risk<br />
(Table2).
Genetic susceptibility to bladder cancer 11<br />
Table 1. Exonic polymorphisms <strong>of</strong> AKR1C3 gene (http://www.med.upenn.edu/akr/polymorphisms.shtml)<br />
Exon Polymorphism Function Nucleotide change Aminoacid change Allele<br />
3 rs7741 synonymous G90A P30 AKR1C3*1A<br />
4 rs12387 synonymous G312A K104 AKR1C3*1B<br />
6 rs1131124 synonymous G495A V165 AKR1C3*1C<br />
3 rs1804061 synonymous A117G K39 AKR1C3*1D<br />
6 rs1937839 synonymous G459A K153 AKR1C3*1E<br />
8 rs7342072 synonymous C705T L235 AKR1C3*1F<br />
6 rs17849485 synonymous C546T L182 AKR1C3*1G<br />
3 rs28943574 synonymous A231G E77 AKR1C3*1H<br />
1 rs12529 nonsynonymous C15G Q5H AKR1C3*2<br />
6 rs1131132 nonsynonymous C525G M175I AKR1C3*3<br />
3 rs1804062 nonsynonymous G106T E36term AKR1C3*4<br />
9 rs1804059 nonsynonymous G879T M293I AKR1C3*5<br />
4 rs4987102 nonsynonymous G316A A106T AKR1C3*6<br />
3 rs11551177 nonsynonymous A230G E77G AKR1C3*7<br />
9 rs11551178 nonsynonymous G883T A295S AKR1C3*8<br />
5 rs28943579 nonsynonymous G434A C145Y AKR1C3*9<br />
5 rs28943580 nonsynonymous C772T R258C AKR1C3*10<br />
In this study, rs3763676, rs12775701 <strong>and</strong><br />
rs1937843 polymorphisms were found to be<br />
associated with increased bladder cancer risk;<br />
rs1937845, rs12529, rs4881400 <strong>and</strong> rs4641368<br />
polymorphisms were found to confer protection<br />
against bladder cancer. Recently, rs12529<br />
polymorphism has been shown to be associated<br />
with decreased bladder cancer risk (Tiryakioğlu,<br />
2011). According to this retrospective study,<br />
Conclusion<br />
homozygous GG variant genotype protects against<br />
bladder cancer (OR=0,255; %95CI=0,101-0,644),<br />
which supports the findings <strong>of</strong> Figuerova et<br />
al.(2008), where OR=0,78; %95CI= 0,52-1,18.<br />
Upon adjustment <strong>of</strong> these figures according to<br />
important risk factors in bladder cancer, namely,<br />
sex <strong>and</strong> cigarette smoking status, Tiryakioğlu<br />
(2001) have shown that rs12529 GG genotype still<br />
conserves its protective effect (OR=0,243).<br />
Table 2. AKR1C3 polymorphisms associated with bladder cancer<br />
Polymorphism Genotype Odds Ratio<br />
rs12529 GG OR= 0,78; %95CI= 0,52-1,18<br />
rs1937845 GG OR=0,74; %95CI= 0,57-0,96<br />
rs3763676 AG OR=1,28; %95CI= 1,05-1,55<br />
rs4881400 GG OR=0,53; %95CI= 0,33-0,85<br />
rs461368 TT OR=0,42; %95CI= 0,20-0,91<br />
rs127755701 GG OR=1,41; %95CI= 1,05-1,90<br />
The genetic variations in the human genome is truly<br />
a powerful source for the investigation <strong>of</strong> the<br />
complex disesases where genetic <strong>and</strong><br />
environmental factors interact to characterize the<br />
final outcome. Over the past ten years, researchers<br />
agreed on that rare genetic defects imputed to<br />
certain populations are not usually responsible for<br />
ever increasing cancer cases; rather polymorphic
12 Nagehan ERSOY TUNALI <strong>and</strong> Necip Ozan TİRYAKİOĞLU<br />
variations in the DNA sequences confer individual<br />
susceptibilities. This notion has been accepted for<br />
many cancer promoting mechanisms, including<br />
bladder cancer (Kim <strong>and</strong> Quan, 2005). Bladder<br />
cancer still conserves its importance regarding<br />
genetic <strong>and</strong> epidemiologic studies, since<br />
environmental factors, mainly cigarette smoking<br />
<strong>and</strong> occupational exposure to certain carcinogens<br />
play major roles in the formation <strong>of</strong> this cancer<br />
type. There are reasons for the high importance <strong>of</strong><br />
this cancer type in terms <strong>of</strong> molecular research. In<br />
the first place, genetic polymorphisms in the<br />
metabolizing genes may alter the functions <strong>of</strong> the<br />
related enzymes, which will result in abnormalities<br />
in the xenobiotic functions <strong>of</strong> the cell. As an<br />
outcome, the environmental carcinogens may not<br />
be detoxified properly <strong>and</strong> hence cause bladder<br />
cancer. Identification <strong>of</strong> the polymorphisms in the<br />
xenobiotic genes <strong>and</strong> their functional relevance to<br />
bladder cancer formation will certainly highlight<br />
the importance <strong>of</strong> inter-individual genetic<br />
variations <strong>and</strong> the phenomenon <strong>of</strong> genetic<br />
susceptibility, which can be adapted easily to other<br />
genetic conditions. Looking at the same view from<br />
another direction we can still come up with the<br />
importance <strong>of</strong> genetic polymorphisms in defining<br />
disease risks. Since bladder cancer is caused mainly<br />
by environmental factors, people living at the same<br />
st<strong>and</strong>ards in terms <strong>of</strong> cigarette smoking, diet <strong>and</strong><br />
other environmental exposures can be investigated<br />
for the frequency <strong>of</strong> occurrence <strong>of</strong> bladder cancer.<br />
Keeping the environmental factors constant, the<br />
only remaining factor will be the genetic variations.<br />
Comparing the frequencies <strong>of</strong> the genetic<br />
polymorphisms among bladder cancer cases <strong>and</strong><br />
healthy controls exposed to the same environments,<br />
genetic polymorphims responsible for the bladder<br />
cancer formation can be identified. There are for<br />
sure hundreds <strong>of</strong> genetic loci to investigate,<br />
however, it will be wise to begin with the genes<br />
coding for the xenobiotic-metabolizing enzymes.<br />
On the other h<strong>and</strong>, the above-mentioned studies<br />
should be performed for each ethnic <strong>and</strong><br />
geographic population in order to delineate<br />
genotypic distributions <strong>and</strong> to define genetic<br />
susceptibility loci. Using the accumulated data,<br />
researchers can establish diagnostic <strong>and</strong> even presymptomatic<br />
criteria on the basis <strong>of</strong> genetic<br />
polymorphisms. Until now, the prognostic <strong>and</strong><br />
diagnostic value <strong>of</strong> the current accumulated data<br />
prove to be problematic to utilize. The main reason<br />
for this is the conflicting results in addition to<br />
overlooked environmental <strong>and</strong> demographic<br />
factors. Another reason is the small scope <strong>of</strong> the<br />
most studies, focusing on a few genes instead <strong>of</strong><br />
taking the whole metabolic systems into account.<br />
Also, sample sizes <strong>of</strong> the studies are one <strong>of</strong> the<br />
major problems; wider retrospective research<br />
studies including hundreds <strong>of</strong> samples should be<br />
constructed. With the ever reducing time <strong>and</strong><br />
money costs <strong>of</strong> whole genome association studies,<br />
it becomes rapidly easier to perform wide-range<br />
studies, paving the way for more rewarding<br />
research.<br />
References<br />
Abdel-Rahman SZ, Anwar Wa, Abdel-Aal WE,<br />
Mostafa HM <strong>and</strong> Au WW. GSTM1 <strong>and</strong> GSTT1<br />
genes are potential risk modifiers for bladder<br />
cancer. Cancer Detection <strong>and</strong> Prevention<br />
22:129-138, 1998.<br />
Aynacıoglu AS, Cascorbi I, Mrozikiewicz PM <strong>and</strong><br />
Roots I. High frequency <strong>of</strong> CYP1A1 mutations<br />
in a Turkish population. Arch. Toxicol. 72: 215-<br />
218, 1998.<br />
Bartsch H, Nair U, Risch A, Rojas M, Wikman H<br />
<strong>and</strong> Alex<strong>and</strong>rov K. Genetic polymorphism <strong>of</strong><br />
CYP genes, alone or in combination, as a risk<br />
modifier <strong>of</strong> tobacco-related cancers. Cancer<br />
Epidemio. Biomarkers Prev. 9: 3-28, 2000.<br />
Bolt HM, Roos PH <strong>and</strong> Thier R. The cytochrome<br />
P-450 isoenzyme CYP2E1 in the biological<br />
processing <strong>of</strong> industrial chemicals:<br />
consequences for occupational <strong>and</strong><br />
environmental medicine. Int. Arch Occup<br />
Environ Health. 76: 174-185, 2003.<br />
Brockmoller J, Cascorbi I, Kerb R <strong>and</strong> Roots I.<br />
Combined analysis <strong>of</strong> inherited polymorphisms<br />
in arylamine N-acetyltransferase 2, glutathione<br />
S-transferase M1 <strong>and</strong> T1, microsomal epoxide<br />
hydrolase <strong>and</strong> cytochrome P450 enzymes as<br />
modulators bladder cancer risk. Cancer<br />
Research. 56: 3915-3925, 1996.<br />
Cascorbi I, Brockmoller J <strong>and</strong> Roots I. A C4887A<br />
polymorphism in exon 7 <strong>of</strong> human CYP1A1:<br />
population frequency, mutation linkages, <strong>and</strong><br />
impact on lung cancer susceptibility. Cancer<br />
Research. 4965-4969, 1996.
Cunningham JM. SJ Hebbring SJ, McDonnell SK,<br />
Cicek MS, Christensen GB, Wang L, Jacobsen<br />
SJ, Cerhan JR, Blute ML, Schaid DJ <strong>and</strong><br />
Thibodeau SN. Evaluation <strong>of</strong> genetic variations<br />
Dozmorov MG, Azzarello JT, Wren JD, Fung KM,<br />
Yang Q, Davis JS, Hurst RE, Culkin DJ,<br />
Penning TM <strong>and</strong> Lin HK. Elevated AKR1C3<br />
expression promotes prostate cancer cell<br />
survival <strong>and</strong> prostate cell-mediated endothelial<br />
cell tube formation: implications for prostate<br />
cancer progression. BMC Cancer.10: 672, 2010.<br />
Febbo PG, Kant<strong>of</strong>f PW, Giovannucci E, Brown M,<br />
Chang G, Hennekens CH <strong>and</strong> Stampfer M.<br />
Debrisoquine Hydroxylase (CYP2D6) And<br />
Prostate Cancer. Cancer Epidemiol Biomarkers<br />
Prev. 7: 1075-1078, 1998.<br />
Figuerova JD, Malats N, Garci-Closas M, Real FX,<br />
Silverman D, Kogevinas M, Chanock S, Welch<br />
R, Dosemeci M, Lan Q, Tardón A, Serra C,<br />
Carrato A, García-Closas R, Castaño-Vinyals G<br />
<strong>and</strong> Rothman N. Bladder cancer risk <strong>and</strong><br />
genetic variation in AKR1C3 <strong>and</strong> other<br />
metabolizing genes. Carcinogenesis.<br />
29(10):1955-1962, 2008.<br />
Flynn TG <strong>and</strong> Green NC. The aldo-keto reductases:<br />
an overview. Adv Exp Med Biol. 328:251-7,<br />
1993.<br />
Franekova M, Halasova E, Bukovska E, Luptak J<br />
<strong>and</strong> Dobrota D. Gene polymorphisms in bladder<br />
cancer. Urologic Oncology. 26(1):1-8, 2008.<br />
García-Closas M, Malats N, Silverman D,<br />
Dosemeci M, Kogevinas M, Hein DW, Tardón<br />
A, Serra C, Carrato A, García-Closas R, Lloreta<br />
J, Castaño-Vinyals G, Yeager M, Welch R,<br />
Chanock S, Chatterjee N, Wacholder S,<br />
Samanic C, Torà M, Fernández F, Real FX <strong>and</strong><br />
Rothman N. NAT2 slow acetylation, GSTM1<br />
null genotype, <strong>and</strong> risk <strong>of</strong> bladder cancer:<br />
results from the Spanish Bladder Cancer Study<br />
<strong>and</strong> meta-analyses. Lancet. 366(9486):649-59,<br />
2005.<br />
Hein DW, Boukouvala S, Grant DM, Minchin RF<br />
<strong>and</strong> Sim E. Human Arylamine N-<br />
Acetyltransferase Gene Nomenclature.<br />
Retrieved August 21, 2009 from<br />
http://louisville.edu/medschool/pharmacology/N<br />
AT.html<br />
Genetic susceptibility to bladder cancer 13<br />
in the <strong>and</strong>rogen <strong>and</strong> estrogen metabolic<br />
pathways as risk factors for sporadic <strong>and</strong><br />
familial prostate cancer. Cancer Epidemiology,<br />
Biomarkers <strong>and</strong> Prevention. 16: 969–978. 2007.<br />
Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS,<br />
Wang LS <strong>and</strong> Tsai CM. Overexpression <strong>of</strong><br />
dihydrodiol dehydrogenase as a prognostic<br />
marker <strong>of</strong> non-small cell lung cancer. Cancer<br />
Res. 61(6):2727-31, 2001.<br />
Hung RJ, B<strong>of</strong>fetta P, Brennan P, Malaveille C,<br />
Hautefeuille A, Donato F, Gelatti U, Spaliviero<br />
M, Placidi D, Carta A, Scotto di Carlo A <strong>and</strong><br />
Porru S. GST, NAT, SULT1A1, CYP1B1<br />
genetic polymorphisms, interactions with<br />
environmental exposures <strong>and</strong> bladder cancer<br />
risk in a high-risk population. International<br />
<strong>Journal</strong> <strong>of</strong> Cancer. 110(4):598-604, 2004.<br />
Hyndman D <strong>and</strong> Penning TM. Single Nucleotide<br />
Polymorphisms in Human AKR Genes.<br />
Retrieved October 19, 2010 from<br />
http://www.med.upenn.edu/akr/polymorphisms.<br />
shtml<br />
Jakobsson J. Palonek E, Lorentzon M, Ohlsson C,<br />
Rane A <strong>and</strong> Ekström L. A novel polymorphism<br />
in the 17beta-hydroxysteroid dehydrogenase<br />
type 5 (aldo-keto reductase 1C3) gene is<br />
associated with lower serum testosterone levels<br />
in caucasian men. The Pharmacogenomics<br />
<strong>Journal</strong>. 7: 282–289, 2007.<br />
Jiang Z, Li C <strong>and</strong> Wang X. Glutathione Stransferase<br />
M1 polymorphism <strong>and</strong> bladder<br />
cancer risk: a meta-analysis involving 33<br />
studies. Exp Biol Med. 236(6):723-8, 2011.<br />
Jin Y <strong>and</strong> Penning TM. Aldo-keto reductases <strong>and</strong><br />
bioactivation/detoxication. Annual Reviews<br />
Pharmacology <strong>and</strong> Toxicology. 47:263-92,<br />
2007.<br />
Karagas MR, Park S, Nelson HH, Andrew AS,<br />
Mott L, Schned A <strong>and</strong> Kelsey KT.<br />
Methylenetetrahydr<strong>of</strong>olate reductase (MTHFR)<br />
variants <strong>and</strong> bladder cancer: a population-based<br />
case-control study. Int J Hyg Environ Health.<br />
208: 321-327, 2005.<br />
Kim WJ <strong>and</strong> Quan C. Genetic <strong>and</strong> epigenetic<br />
aspects <strong>of</strong> bladder cancer. J <strong>Cell</strong> Biochem. 95:<br />
24-33, 2005.
14<br />
Kume T, Iwasa H, Shiraishi H, Yokoi T,<br />
Nagashima K, Otsuka M, Terada T, Takagi<br />
T, Hara A <strong>and</strong> Kamataki T. Characterization<br />
<strong>of</strong> a novel variant (S145C/L311V) <strong>of</strong><br />
3alpha-hydroxysteroid/dihydrodiol<br />
dehydrogenase in human liver.<br />
Pharmacogenetics. 9(6):763-71, 1999.<br />
Lan Q, Mumford JL, Shen M, Demarini DM,<br />
Bonner MR, He X, Yeager M, Welch R,<br />
Chanock S, Tian L, Chapman RS, Zheng T,<br />
Keohavong P, Caporaso N <strong>and</strong> Rothman N.<br />
Oxidative damage-related genes AKR1C3<br />
<strong>and</strong> OGG1 modulate risks for lung cancer<br />
due to exposure to PAH-rich coal<br />
combustion emissions. Carcinogenesis.<br />
25:2177–2181, 2004.<br />
Lan Q, Zheng T, Shen M, Zhang Y, Wang SS,<br />
Zahm SH, Holford TR, Leaderer B, Boyle P<br />
<strong>and</strong> Chanock S. Genetic polymorphisms in<br />
the oxidative stress pathway <strong>and</strong><br />
susceptibility to non-Hodgkin lymphoma.<br />
Human Genetics. 121:161–168, 2007.<br />
Lee SJ, Cho SH, Park SK, Kim SW, Park MS,<br />
Choi HY, Choi JY, Lee SY, Im HJ, Kim JY,<br />
Yoon KJ, Choi H, Shin SG, Park TW,<br />
Rothman N, Hirvonen A <strong>and</strong> Kang D.<br />
Combined effect <strong>of</strong> glutathione S-transferase<br />
M1 <strong>and</strong> T1 genotypes on bladder cancer<br />
risk. Cancer Letters. 177(2):173-9, 2002.<br />
Longuemaux S, Delomenıe C, Gallou C,<br />
Mejean A, Vincent-viry M, Bouvier R, Droz<br />
D, Krishnamoorthy R, Galteau MM, Junien<br />
C, Beroud C <strong>and</strong> Dupret JM. C<strong>and</strong>idate<br />
genetic modifiers <strong>of</strong> individual susceptibility<br />
to renal cell carcinoma: a study <strong>of</strong><br />
polymorphic human xenobioticmetabolizing<br />
enzymes. Cancer Res. 59:<br />
2903-2908, 1999.<br />
Palackal NT, Lee H, Harvey R, Blair I, <strong>and</strong><br />
Penning TM. Activation <strong>of</strong> polycyclic<br />
aromatic hydrocarbon trans-dihydrodiol<br />
proximate <strong>and</strong> their functional<br />
overexpression in human lung carcinoma<br />
(A549) cells. <strong>Journal</strong> <strong>of</strong> Biological<br />
Chemistry. 277(27):24799-24808, 2002.<br />
Parkin DM, Whelan S, Ferlay J, Leppo L <strong>and</strong><br />
Thomas DB. Cancer incidence in five<br />
continents. IARC Publication, Lyon, 2002.<br />
Parkin DM. The global burden <strong>of</strong> urinary<br />
bladder cancer. Sc<strong>and</strong>inavian <strong>Journal</strong> <strong>of</strong><br />
Urology <strong>and</strong> Nephrology. 218:12-20, 2008.<br />
Penning TM, Jin Y, Steckelbroeck S, Lanisnik<br />
Rizner T <strong>and</strong> Lewis M. Structure-function <strong>of</strong><br />
human 3 alpha-hydroxysteroid<br />
dehydrogenases: genes <strong>and</strong> proteins. Mol<br />
<strong>Cell</strong> Endocrinol. 215(1-2):63-72, 2004.<br />
Salinas-Sánchez AS, Sánchez-Sánchez F,<br />
Donate-Moreno MJ, Rubio-Del-Campo A,<br />
Gimenez-Bachs JM, Lorenzo-Romero JG,<br />
Serrano-Oviedo L <strong>and</strong> Escribano J.<br />
Polymorphic deletions <strong>of</strong> the GSTT1 <strong>and</strong><br />
GSTM1 genes <strong>and</strong> susceptibility to bladder<br />
cancer. BJU Int. 107(11):1825-32, 2011.<br />
Silverman DT, Rothman N, Devesa SS, Syrigos<br />
KN <strong>and</strong> Skinner DG. Bladder cancer:<br />
biology, diagnosis, <strong>and</strong> management.<br />
Oxford University Press, New York, 1999.<br />
Sobti RC, Al-badran, AI Sharma, S Sharma, SK<br />
Krishan A <strong>and</strong> Mohan H. Genetic<br />
polymorphisms <strong>of</strong> CYP2D6, GSTM1, <strong>and</strong><br />
GSTT1 genes <strong>and</strong> bladder cancer risk in<br />
North India. Cancer Genet. Cytogenet. 156:<br />
68-73, 2005.<br />
Srivastava DS, Kumar A, Mittal B <strong>and</strong> Mittal<br />
RD. GSTM1 <strong>and</strong> GSTT1 genes in bladder<br />
cancer: A study from North India. Archives<br />
<strong>of</strong> Toxicology 78:430-434, 2004.<br />
Thier R, Brüning T, Roos PH <strong>and</strong> Bolt HM.<br />
Cytochrome P450 1B1, a new keystone in<br />
gene-environment interactions related to<br />
human head <strong>and</strong> neck cancer? Toxicol. 76:<br />
249-256, 2002.<br />
Tiryakioğlu O. Investigation <strong>of</strong> aldoketoreductase<br />
1C3 rs12529 polymorphism in<br />
bladder cancer patients. MSc Thesis. <strong>Haliç</strong><br />
University, 2011.<br />
Zheng L, Wang Y, Schabath MB, Grossman<br />
H.B <strong>and</strong> Wu X. Sulfotransferase 1A1<br />
(SULT1A1) polymorphism <strong>and</strong> bladder<br />
cancer risk: A case-control study. Cancer<br />
Letters. 202:61-69, 2003.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 15-20, 2011 Research Article 15<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />
Ruslan KRYLDAKOV 1* , Rashid AKBERGENOV 2 , Thomas HOHN 2 <strong>and</strong> Bulat<br />
ISKAKOV 1<br />
1<br />
Laboratory <strong>of</strong> Proteins <strong>and</strong> Nucleic Acids Research, M.A. Ajtkhozhin Institute <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong><br />
Biochemistry, Almaty, Kazakhstan<br />
2<br />
Laboratory <strong>of</strong> <strong>Molecular</strong> Plant Virology, Botanical Institute, University <strong>of</strong> Basel, Basel, Switzerl<strong>and</strong><br />
(* author for correspondence; kryldakov@yahoo.com)<br />
Received: 10 May 2010; Accepted: 20 January 2011<br />
Abstract<br />
Gene silencing is an important regulatory <strong>and</strong> defense mechanism in plants. Plant viruses evolved some<br />
proteins that suppress cellular RNA interference mechanism. In this work identification <strong>of</strong> silencing<br />
suppressors <strong>of</strong> potato virus M (PVM) is reported. The cDNA sequences <strong>of</strong> different PVM open reading<br />
frames were cloned into the Gateway-compatible binary T-DNA destination vector pMDC32, harboring a<br />
double 35S promoter. Each <strong>of</strong> these constructs was electroporated into Agrobacterium tumefaciens C58C1<br />
which then were agroinfiltrated into Nicotiana benthamiana 16C line. It was shown that viral coat protein<br />
(34K) as well as some other PVM proteins (12K, 11K) possessed suppressor properties <strong>of</strong> cellular silencing<br />
activity.<br />
Keywords: Gene silencing, suppressors <strong>of</strong> silencing, potato virus M, agroinfiltration, Nicotiana benthamiana<br />
16C line<br />
Patates virüsü M’nin susturucu baskılayıcılarının tayini<br />
Özet<br />
Gen susturma bitkilerde önemli bir düzenleme ve savunma mekanizmasıdır. Bitki virüsleri hücresel RNA<br />
müdehalesi mekanizmalarını baskılayan bazı proteinler evrimleştirmiştir. Bu çalışmada patates virüsü M’nin<br />
(PVM) susturucu baskılayıcılarının belirlenmesi rapor edilmiştir. Farklı PVM açık okuma çerçevesi olan<br />
cDNA dizileri çift 35S promotor içeren ikili T-DNA hedef vektörü pMDC32’ye klonl<strong>and</strong>ı. Bu düzeneklerin<br />
herbiri elektroporasyon ile Agrobacterium tumefaciens C58C1’e verilip daha sonra agroinfiltrasyon ile<br />
Nicotiana benthamiana 16C hattına süzdürüldü. Viral kılıf proteininin (34K) yanı sıra bazı diğer PVM<br />
proteinlerinin (12K, 11K) hücresel susturma aktivitesinin baskılayıcı özelliklerine sahip oldukları gösterildi.<br />
Anahtar Sözcükler: Gen susturma, susturmanın baskılayıcıları, patates virüsü M, agroinfiltrasyon, Nicotiana<br />
benthamiana 16C hattı<br />
Introduction<br />
Recently a new defense system was detected that<br />
does function in plants, namely post-transcriptional<br />
gene silencing (PTGS) or RNA interference<br />
(RNAi). In response to virus infection, this<br />
“adaptive immune-system” is induced based on the<br />
recognition <strong>of</strong> double-str<strong>and</strong>ed (ds) RNA or<br />
excessive quantities <strong>of</strong> RNA (Jorgensen, 2003).<br />
RNAi is an evolutionary conserved mechanism in<br />
many, if not all, eukaryotes, to target <strong>and</strong> degrade<br />
aberrant endogenous or exogenous RNA molecules<br />
(Sontheimer, 2005; Voinnet, 2005).<br />
Due to this silencing defense system, plant<br />
viruses are thought to need a counter defense<br />
mechanism to successfully infect a plant.<br />
Depending on the virus, such PTGS suppression<br />
can be a secondary function <strong>of</strong> almost any type <strong>of</strong><br />
viral protein. In plants, RNA silencing has been<br />
demonstrated to be one <strong>of</strong> the most important
16<br />
Ruslan KRYLDAKOV et al.<br />
antiviral mechanisms (Li <strong>and</strong> Ding, 2001; Ding et<br />
al., 2004). As a response to this highly efficient<br />
antiviral RNA silencing pathway, plant viruses<br />
have evolved specific suppressor proteins. Many <strong>of</strong><br />
these proteins were previously described as<br />
virulence factors or pathogenicity determinants. It<br />
has been reported that many plant viruses encode<br />
suppressor proteins to combat against RNA<br />
silencing (Voinnet, Pinto <strong>and</strong> Baulcombe, 1999; Li<br />
<strong>and</strong> Ding, 2001). Identification <strong>of</strong> silencing<br />
suppressors <strong>of</strong> different viruses is a crucial step in<br />
direction <strong>of</strong> development <strong>of</strong> resistance against viral<br />
infection (Ding <strong>and</strong> Voinnet, 2007).<br />
Silencing suppressors can interfere with several<br />
steps <strong>of</strong> the silencing pathway, i.e. dsRNA cleavage<br />
to produce siRNAs, destabilization <strong>of</strong> siRNAs,<br />
binding <strong>of</strong> siRNAs <strong>and</strong> siRNA usage as part <strong>of</strong><br />
RISC, which is required for target RNA<br />
elimination. Silencing suppressors are usually<br />
multifunctional viral proteins <strong>and</strong> in different virus<br />
families different viral proteins gain suppressor<br />
function as an additional property. Interference<br />
with suppressor function would inhibit the viral<br />
counter-defense system.<br />
The research <strong>and</strong> identification <strong>of</strong> silencing<br />
suppressors <strong>of</strong> PVM were carried out. Potato is one<br />
<strong>of</strong> the most important crops, <strong>and</strong> PVM, together<br />
with PVY, is responsible for 80% <strong>of</strong> all viruscaused<br />
losses <strong>of</strong> potato yields, especially in<br />
Kazakhstan (Sozinova et al., 2007). Thus the<br />
identification <strong>of</strong> PVM’s silencing suppressors<br />
points to the role <strong>of</strong> gene silencing as a natural<br />
antiviral defense system in plants.<br />
Materials <strong>and</strong> methods<br />
RNA isolation<br />
A PVM isolate was maintained in Nicotiana<br />
tabacum plants. Leaves <strong>of</strong> N. tabacum were<br />
harvested <strong>and</strong> frozen in liquid nitrogen, ground to a<br />
fine powder <strong>and</strong> mixed with Tri-reagent (“Sigma”),<br />
extracted once with 1/5 volume <strong>of</strong> chlor<strong>of</strong>orm.<br />
RNA was precipitated with the addition <strong>of</strong> an equal<br />
volume <strong>of</strong> isopropanol <strong>and</strong> incubated at +4°C for<br />
30 min. RNA was washed with 70% ethanol <strong>and</strong><br />
dissolved in water.<br />
Construction <strong>of</strong> PVM vectors<br />
The last 5 <strong>of</strong> 6 protein sequences <strong>of</strong> PVM were<br />
obtained with using SuperScript II Reverse<br />
Transcriptase according to manufacture protocol.<br />
PVM cDNA fragments encoding the 25kDa,<br />
12kDa, 7 kDa, coat protein (CP) <strong>and</strong> 11 kDa were<br />
PCR-amplified from cDNA <strong>and</strong> individually cloned<br />
using Gateway cloning kit (Invitrogen). First, the<br />
PCR products were cloned into pDONR207 vector<br />
using BP clonase, then they were re-cloned into<br />
pMDC32 destination vector harbouring double 35S<br />
promoter.<br />
Plant material <strong>and</strong> A. tumefaciens infiltration<br />
GFP transgenic 16C line <strong>of</strong> Nicotiana benthamiana<br />
plants were grown as described previously (Marano<br />
<strong>and</strong> Baulcombe, 1998; Voinnet et al. 1998).<br />
Recombinant Agrobacterium tumefaciens strain<br />
C58C1, carrying different constructs, were grown<br />
at 28°C in 2 ml <strong>of</strong> LB medium with 2,5 μg/ml<br />
tetracycline <strong>and</strong> 50 μg/ml kanamycin for two days,<br />
then transferred to 18 ml <strong>of</strong> fresh LB medium with<br />
appropriate antibiotics <strong>and</strong> were grown overnight at<br />
28°C. The bacteria were centrifuged at 4000 g for<br />
10 min. The pellet was resuspended in<br />
agroinfiltration solution (10mM MgCl2, 10 mM<br />
MES <strong>and</strong> 100 μM acetosyringone) up to desired<br />
optical density (OD600). The bacteria solution was<br />
left at room temperature for overnight before<br />
infiltration. Infiltration carried on underside leaves<br />
<strong>of</strong> 5-7-week-old N. benthamiana plants. For coinfiltration,<br />
equal volumes <strong>of</strong> indicated A.<br />
tumefaciens cultures (OD600=1) were mixed before<br />
infiltration. After 5-10 days post infiltration, plants<br />
were observed for silencing effect.<br />
GFP Imaging<br />
Visual detection <strong>of</strong> GFP fluorescence in whole<br />
plant was performed using a 100W h<strong>and</strong>-held longwave<br />
ultraviolet lamp. Plants were photographed<br />
with a yellow filter.<br />
Results<br />
Potato virus M belongs to the genus Carlavirus <strong>of</strong><br />
the Flexiviridae family. The PVM genome is a<br />
single positive-str<strong>and</strong> RNA <strong>of</strong> 8534 nucleotides.<br />
The sequence contains six open reading frames<br />
(ORFs) (Figure 1), <strong>and</strong> non-coding regions<br />
consisting <strong>of</strong> 75 nucleotides at the 5 ’ -end <strong>and</strong> 70<br />
nucleotides followed by a poly(A) tail at the 3 ’ -end<br />
(Zavriev et al., 1991).
Identification <strong>of</strong> silencing suppressors <strong>of</strong> PVM 17<br />
Figure 1. Scheme <strong>of</strong> PVM genome. Genes are shown as boxes <strong>and</strong> molecular masses <strong>of</strong> encoded proteins are<br />
indicated in kDa. (PRO: gene <strong>of</strong> polyprotein encoding for several peptides; CP: coat protein gene)<br />
The ORF beginning at the first initiation codon at nucleotide 74 encodes a polypeptide <strong>of</strong> 223K, virus<br />
RNA replicase (Table 1). The next coding block consists <strong>of</strong> three ORFs encoding polypeptides <strong>of</strong> 25K, 12K<br />
<strong>and</strong> 7K, which is responsible for viral cell-to-cell movement. The third block consists <strong>of</strong> two ORFs encoding<br />
polypeptides <strong>of</strong> 34K (coat protein) <strong>and</strong> 11K. The 11K polypeptide contains a pattern resembling the<br />
consensus for a metal-binding nucleic acid-binding zinc-finger motif.<br />
Table 1. Proteins <strong>of</strong> PVM <strong>and</strong> their sizes<br />
Symbol <strong>of</strong> protein Protein Start<br />
End<br />
Length<br />
(nt)<br />
(nt)<br />
(bp)<br />
ORF 1 polyprotein 74 5980 1968<br />
ORF 2 25kDa protein 6019 6708 229<br />
ORF 3 12kDa protein 6686 7015 109<br />
ORF 4 7kDa protein 7012 7203 63<br />
ORF 5 coat protein 7225 8139 304<br />
ORF 6 11kDa protein 8136 8462 108<br />
According to articles for last years (Chiba et al.,<br />
2006), the protein 11K is most putative silencing<br />
suppressor. The aim <strong>of</strong> our investigation was the<br />
check <strong>of</strong> suppressor activity <strong>of</strong> all PVM proteins<br />
except first one, largest polyprotein due to its size.<br />
The primers for cloning were designed using<br />
the GeneRunner programme version 3.0<br />
(ORF2sense 5 ’ -<br />
gggacaagtttgtacaaaaaagcaggctatggatgtgattgtagatttg-<br />
3 ’ <strong>and</strong> ORF2antisense 5 ’ -<br />
ggggaccactttgtacaagaaagctgggtctcaggcggcggtgtaagt<br />
gg-3 ’ for ORF2; ORF3sense 5 ’ -<br />
ggggacaagtttgtacaaaaaagcaggctatgccacttacaccgccgc<br />
c-3 ’ <strong>and</strong> ORF3antisense 5 ’ -<br />
ggggaccactttgtacaagaaagctgggtctcatgtgtgtgagcccgca<br />
c-3 ’ for ORF3; ORF4sense 5 ’ -<br />
ggggacaagtttgtacaaaaaagcaggctatgatagtgtatgtacttgta<br />
g-3 ’ <strong>and</strong> ORF4antisense 5 ’ -<br />
ggggaccactttgtacaagaaagctgggtcttatgacctaaaggaacca<br />
cac-3 ’ for ORF4; ORF5sense 5 ’ -<br />
ggggacaagtttgtacaaaaaagcaggctatgggagattcaacgaaga<br />
aag-3 ’ <strong>and</strong> ORF5antisense 5 ’ -<br />
ggggaccactttgtacaagaaagctgggtctcattttctattagactttac<br />
at-3 ’ for ORF5; ORF6sense 5 ’ -<br />
ggggacaagtttgtacaaaaaagcaggctatgaaggacgtaaccaag<br />
gtggctt-3 ’ <strong>and</strong> ORF6antisense 5 ’ -<br />
ggggaccactttgtacaagaaagctgggtcctactctcgcttgttgatga<br />
c-3 ’ for ORF6). The Gateway-kit (Invitrogen) was<br />
used for cloning. The DNA <strong>of</strong> the different PVM<br />
ORFs were obtained by RT-PCR, <strong>and</strong> cloned into<br />
the Gateway-compatible binary T-DNA destination<br />
vector pMDC32. Each <strong>of</strong> these constructs were<br />
electroporated into Agrobacterium tumefaciens<br />
C58C1 strain according to the manufacturer’s<br />
instructions. All constructs described above were<br />
verified by nucleotide sequencing.<br />
The Nicotiana benthamiana plant, constitutively<br />
expressing GFP transgene (line 16C; a gift from<br />
David Baulcombe), <strong>and</strong> the Agrobacterium<br />
infiltration operation have been described<br />
previously (Hamilton et al., 2002). The N.<br />
benthamiana line 16C were cultured in growth<br />
chambers at 22 to 24°C before <strong>and</strong> after infiltration.<br />
For coinfiltration, equal volumes <strong>of</strong> individual<br />
Agrobacterium cultures (OD600= 1) were mixed
18<br />
Ruslan KRYLDAKOV et al.<br />
prior to infiltration. HC-Pro <strong>of</strong> potato virus Y <strong>and</strong><br />
P19 <strong>of</strong> tombusviruses were used as a positive<br />
control. GFP fluorescence was observed under<br />
long-wavelength UV light <strong>and</strong> photographed using<br />
a digital camera with a yellow filter.<br />
GFP expression reached the highest level in all<br />
leaves infiltrated with GFP, as well as GFP plus<br />
other genes at 5 to 7 days postinfiltration (dpi), as<br />
shown by the enhanced green fluorescence in the<br />
infiltrated patches. The green fluorescence intensity<br />
remained strong in the patches coinfiltrated with<br />
ORF 3 <strong>and</strong> ORF 5 during the 7-9 dpi. Coinfiltration<br />
with ORF 6 also resulted in GFP fluorescence over<br />
a similar period <strong>of</strong> observations, but not as strong<br />
<strong>and</strong> clear as above described samples (Figure 2).<br />
On the other h<strong>and</strong>, GFP was silenced upon<br />
inoculation with OFR 2 <strong>and</strong> ORF 4.<br />
Figure 2. Effects <strong>of</strong> different ORFs <strong>of</strong> PVM on<br />
gene silencing in GFP transformants <strong>of</strong> Nicotiana<br />
benthamiana. Infiltrated leaves are shown.<br />
Silencing <strong>of</strong> GFP is manifested in red fluorescent.<br />
Green spots indicate suppression <strong>of</strong> silencing.<br />
Photographs were taken <strong>of</strong> UV-illuminated plants.<br />
1 <strong>and</strong> 2: HC-Pro <strong>and</strong> P19, respectively, are shown<br />
as control; 3: ORF2, 25K protein; 4: ORF3, 12K<br />
protein; 5: ORF4, 7K protein; 6: ORF5, coat<br />
protein; 7: ORF6, 11K protein<br />
According to these data the most promising<br />
c<strong>and</strong>idates as silencing suppressors are ORF 3 (12K<br />
protein; Table 1), ORF 5 (coat protein; Table 1)<br />
<strong>and</strong>, in lesser extent, ORF 6 (11K protein; Table 1),<br />
while ORF 2 <strong>and</strong> ORF 4 revealed no suppressor<br />
activity. We have repeated this experiment three<br />
times which yielded the same results.<br />
Discussion<br />
Most <strong>of</strong> the viruses have some sort <strong>of</strong> silencing<br />
suppressor system as an evolutionary counterresponse<br />
to the antiviral activity <strong>of</strong> the plant gene<br />
silencing defence. Gene silencing suppressors can<br />
inhibit silencing <strong>of</strong> transgenes or endogenous<br />
genes. Test for silencing suppression was based on<br />
a previously described experimental system<br />
(Brigneti et al., 1998). When leaves <strong>of</strong> N.<br />
benthamiana line 16C plants were agroinfiltrated<br />
with an A. tumefaciens C58C1 strain carrying the<br />
construct 35S GFP, the strong green fluorescent<br />
signal disappeared under UV light due to GFP<br />
silencing. However, if 35S-ds GFP <strong>and</strong> any strong<br />
silencing suppressor are co-agroinfiltrated, the<br />
fluorescent signal does not disappear <strong>and</strong> the area<br />
does not look dark under UV light. This is due to<br />
the inhibition <strong>of</strong> gene silencing caused by that<br />
suppressor.<br />
Thus, the result <strong>of</strong> experiments shows that<br />
ORF3 (12K protein; part <strong>of</strong> triple block, cell-to-cell<br />
movement), ORF5 (coat protein) <strong>and</strong> ORF6 (11K<br />
protein) <strong>of</strong> potato virus M has a suppressor activity.<br />
It corresponds to the results <strong>of</strong> recent articles about<br />
suppression activity <strong>of</strong> virus proteins responsible<br />
for long-distance movement (Voinnet, 2001), viral<br />
coat proteins (Roth, Pruss <strong>and</strong> Vance, 2004) <strong>and</strong><br />
10K-16K proteins with a conserved amino acid<br />
sequence motif encoded by diverse filamentous<br />
viruses (Chiba et al., 2006).<br />
The 12K protein encoded by the second ORF <strong>of</strong><br />
PVM triple gene block (TGB) which involved in<br />
the cell-to-cell <strong>and</strong> long-distance movement <strong>of</strong><br />
virus. This protein possesses conserved<br />
hydrophobic domain <strong>and</strong> plays significant role in<br />
TGB functions (Seppänen et al., 1997). TGBcontaining<br />
viruses have evolved special<br />
mechanisms to suppress RNA silencing (Voinnet et<br />
al., 2000; Morozov <strong>and</strong> Solovyev, 2003).<br />
The potex-like Carlavirus PVM requires the<br />
coat protein for virus cell-to-cell movement<br />
(Morozov <strong>and</strong> Solovyev, 2003; Verchot-Lubicz,<br />
2005). In RNA silencing assays, plant viral<br />
suppressors differ by their ability to suppress<br />
intracellular <strong>and</strong>/or intercellular silencing (Li <strong>and</strong><br />
Ding, 2001; Roth, Pruss <strong>and</strong> Vance, 2004).<br />
Spreading <strong>of</strong> silencing in plants occurs through<br />
plasmodesmata <strong>and</strong> results from a cell-to-cell<br />
movement <strong>of</strong> a short-range silencing signal, most<br />
probably 21-nt short interfering RNAs (siRNAs),<br />
that are produced by one <strong>of</strong> the plant Dicer<br />
enzymes (Kalantidis et al., 2008).<br />
11K protein had been shown to be a nonspecific<br />
nucleic acid-binding protein (Gramstat,<br />
Courtpozanis <strong>and</strong> Rohde, 1990), similar to p10<br />
which is silencing suppressor <strong>of</strong> Grapevine virus A<br />
(Zhou et al., 2006). Interestingly, 11K is supposed<br />
to be translated from the CP subgenomic RNA by a<br />
(-1) frameshift within the A-rich region
AAUAGAAAAUGA preceding the 12K AUG<br />
translational start codon (underlined) <strong>and</strong><br />
representing the 3’-terminus <strong>of</strong> the CP coding<br />
region (UGA stop codon in bold letters) (Gramstat,<br />
Courtpozanis <strong>and</strong> Rohde, 1990).<br />
This article describes the identification <strong>of</strong> viral<br />
suppressors <strong>of</strong> RNA silencing encoded by a natural<br />
pathogen. An exact role for any <strong>of</strong> the identified<br />
PVM suppressors in host infection remains to be<br />
established.<br />
The potential <strong>of</strong> using viral suppressors to help<br />
underst<strong>and</strong> the mechanism <strong>of</strong> RNA silencing in<br />
plants is largely unexplored, <strong>and</strong> these studies<br />
promise to be a fertile area <strong>of</strong> research. Viral<br />
suppressors <strong>of</strong> silencing also provide unique tools<br />
to underst<strong>and</strong> the mechanism <strong>of</strong> RNA silencing as<br />
well as interaction between virus <strong>and</strong> their hosts.<br />
Moreover, it became an extremely useful technique<br />
for molecular biology <strong>and</strong> very powerful<br />
biotechnological tool.<br />
Acknowledgement<br />
This work has been supported by funds from<br />
INTAS, Young Scientist Fellowship Nr. 06-<br />
1000014-6200.<br />
References<br />
Brigneti C, Voinnet O, Li WX, Ji LH, Ding SW<br />
<strong>and</strong> Baulcombe DC. Viral pathogenicity<br />
determinants are suppressors <strong>of</strong> transgene<br />
silencing in Nicotiana benthamiana. The<br />
EMBO <strong>Journal</strong>. 17: 6739-6746, 1998.<br />
Chiba M, Reed JC, Prokhnevsky AI, Chapman EJ,<br />
Mawassi M, Koonin EV, Carrington JC <strong>and</strong><br />
Dolja VV. Diverse suppressors <strong>of</strong> RNA<br />
silencing enhance agroinfection by a viral<br />
replicon. Virology. 346: 7-14, 2006.<br />
Ding SW, Li H, Lu R, Li F <strong>and</strong> Li WX. RNA<br />
silencing: a conserved antiviral immunity <strong>of</strong><br />
plants <strong>and</strong> animals. Virus Research. 102: 109-<br />
115, 2004.<br />
Ding SW <strong>and</strong> Voinnet O. Antiviral Immunity<br />
Directed by Small RNAs. <strong>Cell</strong>. 130: 413-426,<br />
2007.<br />
Gramstat A, Courtpozanis A <strong>and</strong> Rohde W. The 12<br />
kDa protein <strong>of</strong> potato virus M displays<br />
properties <strong>of</strong> a nucleic acid-binding regulatory<br />
protein. FEBS Letters. 276: 34-38, 1990.<br />
Identification <strong>of</strong> silencing suppressors <strong>of</strong> PVM 19<br />
Hamilton A, Voinnet O, Chappell L <strong>and</strong> Baulcombe<br />
D. Two classes <strong>of</strong> short interfering RNA in<br />
RNA silencing. The EMBO <strong>Journal</strong>. 21: 4671-<br />
4679, 2002.<br />
Jorgensen RA. RNA silencing in plants:<br />
mechanisms, methods, <strong>and</strong> applications. Plant<br />
& Animal Genomes XI Conference, USA.<br />
2003.<br />
Kalantidis K, Schumacher HT, Alexiadis T <strong>and</strong><br />
Helm JM. RNA silencing movement in plants.<br />
<strong>Biology</strong> <strong>of</strong> the <strong>Cell</strong>. 100: 13-26, 2008.<br />
Li WX <strong>and</strong> Ding SW. Viral suppressors <strong>of</strong> RNA<br />
silencing. Current Opinion in Biotechnology.<br />
12: 150-154, 2001.<br />
Marano MR <strong>and</strong> Baulcombe D. Pathogen-derived<br />
resistance targeted against the negative-str<strong>and</strong><br />
RNA <strong>of</strong> tobacco mosaic virus: RNA str<strong>and</strong>specific<br />
gene silencing? Plant <strong>Journal</strong>. 13:<br />
537-546, 1998.<br />
Morozov SYu <strong>and</strong> Solovyev AG. Triple gene block:<br />
modular design <strong>of</strong> a multifunctional machine<br />
for plant virus movement. <strong>Journal</strong> <strong>of</strong> General<br />
Virology. 84: 1351-1366, 2003.<br />
Roth BM, Pruss GJ <strong>and</strong> Vance VB. Plant viral<br />
suppressors <strong>of</strong> RNA silencing. Virus Research.<br />
102: 97-108, 2004.<br />
Seppдnen P, Puska R, Honkanen J, Tyulkina LG,<br />
Fedorkin O, Morozov SYu <strong>and</strong> Atabekov JG.<br />
Movement protein-derived resistance to triple<br />
gene block-containing plant viruses. <strong>Journal</strong> <strong>of</strong><br />
General Virology. 78: 1241-1246, 1997.<br />
Sontheimer EJ. Assembly <strong>and</strong> function <strong>of</strong> RNA<br />
silencing complexes. Nature Reviews. 6: 127-<br />
138, 2005.<br />
Sozinova L, Abay A, Ramankulov E, Nachmias A<br />
<strong>and</strong> Loebenstein G. Reducing Virus Incidence<br />
in Potato Seed Tubers by Rapid Propagation: A<br />
Pilot Scheme in Kazakhstan, The 28 th Congress<br />
<strong>of</strong> the Israeli Phytopathological Society, The<br />
<strong>Vol</strong>cani Center, Israel. 2007.<br />
Verchot-Lubicz J. A New <strong>Cell</strong>-to-<strong>Cell</strong> Transport<br />
Model for Potexviruses. <strong>Molecular</strong> Plant-<br />
Microbe Interactions <strong>Journal</strong>. 18: 283-290,<br />
2005.<br />
Voinnet O, Vain P, Angell S <strong>and</strong> Baulcombe DC.<br />
Systemic spread <strong>of</strong> sequence-specific transgene<br />
RNA degradation is initiated by localized
20<br />
Ruslan KRYLDAKOV et al.<br />
introduction <strong>of</strong> ectopic promoterless DNA.<br />
<strong>Cell</strong>. 95: 177-187, 1998.<br />
Voinnet O, Pinto YM <strong>and</strong> Baulcombe DC.<br />
Suppression <strong>of</strong> gene silencing: A general<br />
strategy used by diverse DNA <strong>and</strong> RNA<br />
viruses <strong>of</strong> plants. Proceedings <strong>of</strong> the National<br />
Academy <strong>of</strong> Sciences. 86: 14147-14152, 1999.<br />
Voinnet O, Lederer C <strong>and</strong> Baulcombe DC. A viral<br />
movement protein prevents spread <strong>of</strong> the gene<br />
silencing signal in Nicotiana benthamiana.<br />
<strong>Cell</strong>. 103: 157-167, 2000.<br />
Voinnet O. RNA silencing as a plant immune<br />
system against viruses. Trends in Genetics. 17:<br />
449-459, 2001.<br />
Voinnet O. Induction <strong>and</strong> suppression <strong>of</strong> RNA<br />
silencing: insights from viral infections. Nature<br />
Reviews Genetics. 6: 206-220, 2005.<br />
Zavriev SK, Kanyuka KV <strong>and</strong> Levay KE. The<br />
genome organization <strong>of</strong> potato virus M RNA.<br />
<strong>Journal</strong> <strong>of</strong> General Virology. 72: 9-14, 1991.<br />
Zhou ZSh, Dell’Orco M, Saldarelli P, Turturo C,<br />
Minafra A <strong>and</strong> Martelli GP. Identification <strong>of</strong> an<br />
RNA-silencing suppressor in the genome <strong>of</strong><br />
Grapevine virus A. <strong>Journal</strong> <strong>of</strong> General<br />
Virology. 87: 2387-2395, 2006.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 21-29, 2011 Research Article 21<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Identification <strong>of</strong> a novel dehydration responsive transcript from<br />
tossa jute (Corcohrus olitorius L.)<br />
Sazia SHARMIN 1,δ , Mahdi Muhammad MOOSA 1,δ , Md. Shahidul ISLAM 1,2 , Inamul<br />
KABIR 3 , Arzuba AKTER 1 1, *<br />
<strong>and</strong> Haseena KHAN<br />
1<br />
University <strong>of</strong> Dhaka, Department <strong>of</strong> Biochemistry & <strong>Molecular</strong> <strong>Biology</strong>, Dhaka 1000, Bangladesh<br />
2<br />
Bangladesh Jute Research Institute, Dhaka 1207, Bangladesh<br />
3<br />
University <strong>of</strong> Dhaka, Department <strong>of</strong> Genetic Engineering & Biotechnology, Dhaka 1000, Bangladesh<br />
δ<br />
Contributed equally to the study.<br />
(* author for correspondence; haseena@univdhaka.edu)<br />
Received: 18 January 2011; Accepted: 23 April 2011<br />
Abstract<br />
Water deficit stress is one <strong>of</strong> the major environmental stress conditions faced by sessile l<strong>and</strong> plants.<br />
Acquisition <strong>of</strong> resistance to this stress enabled plants to settle into terrestrial habitats. Dehydration stress is a<br />
specific form <strong>of</strong> water deficit stress. A number <strong>of</strong> functionally characterized genes are involved in<br />
dehydration response pathway. Here we report a novel dehydration responsive transcript from tossa jute<br />
(Corcohrus olitorius L.) which shows reduced expression under dehydration stress. Study <strong>of</strong> tissue specific<br />
expression revealed that the transcript is expressed in root, shoot <strong>and</strong> leaf under normal conditions. Search for<br />
known homologues <strong>of</strong> the transcript failed to identify functionally characterized counterparts in any other<br />
plant species.<br />
Keywords: Drought, stress tolerance, water deficit stress, dehydration responsive transcript, drp.<br />
Tossa jute‘den (Corcohrus olitorius L.) yeni bir dehidrasyon cevap transkripti<br />
tanımlanması<br />
Özet<br />
Su eksikliği stresi sapsız kara bitkilerince karşılaşılan en büyük çevresel stress koşullarından biridir. Bu<br />
strese dirençlilik kazanmak bitkilerin karasal yetişme ortamına yerleşmesini sağlamıştır. Dehidrasyon stresi<br />
su eksikliği stresinin özgün bir formudur. Birçok fonksiyonel olarak karakterize edilmiş gen dehidrasyon<br />
tepki yolağıyla ilişkilidir. Bu makalede hint kenevirinden (Corcohrus olitorius L.) dehidrasyon stresinde<br />
azalmış ifade gösteren yeni bir dehidrasyona cevap transkripti rapor etmekteyiz. Dokuya özgün ifade<br />
çalışması transkriptin kök, budak ve yaprakta ifade edildiğini ortaya koymuştur. Transkriptin bilinen<br />
homologlarının araştırılması sonucunda diğer başka bitkilerde fonksiyonel olarak karakterize edilmiş bir eşi<br />
bulunamamıştır.<br />
Anahtar Sözcükler: Kuraklık, stres toleransı, su eksikliği stresi, dehidrasyon cevap transkripti, drp<br />
Introduction<br />
Unlike their mobile animal counterparts, sessile<br />
plants have to adjust their gene expression pattern<br />
as well as metabolite pr<strong>of</strong>ile to cope with altered<br />
local environmental conditions (Kulheim et al.<br />
2002). A number <strong>of</strong> genes are involved in these<br />
pathways which can either be up-regulated (Hannah<br />
et al. 2005; Holappa <strong>and</strong> Walker-Simmons, 1995;<br />
Yan et al. 2005.) or down-regulated (Hannah et al.
22 Sazia SHARMIN et al.<br />
2005; Yan et al. 2005) based on their mode <strong>of</strong><br />
function. Identification <strong>of</strong> these genes may lead to<br />
the development <strong>of</strong> commercial crops, which are<br />
better suited to grow in a particular unfavourable<br />
condition. Due to cross-species transferability <strong>of</strong><br />
gene functions, this improvement can be achieved<br />
in non-source plant species as well.<br />
Jute (Corchorus olitorius L.) is the most<br />
important bast fibre producing plant (Kundu, 1956).<br />
It is the major fibre producing plant <strong>of</strong> Bangladesh<br />
(Hossain et al. 2003) <strong>and</strong> one <strong>of</strong> the major fibre<br />
crops <strong>of</strong> the Indian subcontinent (Basu et al. 2004).<br />
The production quality <strong>and</strong> yield <strong>of</strong> this<br />
economically important crop is affected by several<br />
biotic e.g. fungi, pest, insect, nematode, virus, mite<br />
(BBS, 2004; Ghosh, 1983; Keka et al. 2008) <strong>and</strong><br />
abiotic factors e.g. salinity, submergence <strong>and</strong> low<br />
temperature (Hossain et al. 2003; Samira et al.<br />
2010). Thus, development <strong>of</strong> jute varieties with<br />
increased resistance to both biotic <strong>and</strong> abiotic stress<br />
conditions have considerable economic importance.<br />
In spite <strong>of</strong> its enormous commercial value, only<br />
a few genes or part <strong>of</strong> genes from jute have been<br />
identified or sequenced (Ahmed et al. 2009; Alam<br />
et al. 2010; Islam et al. 2005; Mahmood et al.<br />
2010; Samira et al. 2010; Wazni et al. 2007). Here<br />
we report a novel transcript from Corchorus<br />
olitorus var. 9897 responsive to dehydration stress.<br />
Search for known homologues failed to identify<br />
functionally characterized counterparts in any other<br />
plant species.<br />
Materials <strong>and</strong> methods<br />
Stress treatment <strong>of</strong> plant seedlings<br />
Plant seeds were incubated at room temperature in<br />
the absence <strong>of</strong> light for two days in petri dishes in<br />
the presence <strong>of</strong> water only. Germinated plant<br />
seedlings were subjected to different stress<br />
conditions such as low temperature, dehydration,<br />
fungus <strong>and</strong> abscisic acid (ABA) beginning third<br />
day <strong>of</strong> their germination according to methods<br />
described by Alam <strong>and</strong> co-workers (Alam et al.<br />
2010). Fungus treatment was done by spraying<br />
suspension <strong>of</strong> Macrophomina phaseolina on the<br />
plate with germinated seedlings (Alam et al. 2010;<br />
Mahmood et al. 2010). For dehydration treatment,<br />
the seedlings were treated with 50 mM manitol to<br />
create an environment similar to water deficit<br />
condition. The concentration <strong>of</strong> manitol was<br />
increased to 100 mM on day 5 (Alam et al. 2010).<br />
Salt stress was applied by adding 50 mM NaCl to<br />
the plate on day 3. The concentration was increased<br />
by 50 mM per day, reaching to 150 mM NaCl on<br />
day 5 (Alam et al. 2010). Low temperature<br />
treatment was carried out by growing the seedlings<br />
at 14 O C in an incubator from day 3 (Alam et al.<br />
2010).<br />
Isolation <strong>of</strong> DNA <strong>and</strong> RNA<br />
Genomic DNA from different Corchorus species<br />
was isolated using the CTAB method (Murray <strong>and</strong><br />
Thompson, 1980). RNA was isolated using<br />
TRIZOL reagent (Invitrogen) according to the<br />
provided manual. For tissue specific RNA isolation,<br />
leaf, stem <strong>and</strong> root was cut into pieces, ground in<br />
liquid N2. RNA was isolated from ground tissue<br />
using TRIZOL reagent (Invitrogen) as per<br />
manufacturer’s instruction<br />
Identification <strong>of</strong> the dehydration responsive<br />
transcript<br />
The transcript was identified as an additional b<strong>and</strong><br />
while carrying out RT (Reverse Transcriptase)-<br />
PCR <strong>of</strong> a cold stress responsive gene, LDLP (Low<br />
density lipoprotein like protein) from C. olitorius<br />
using the primer RevP (unpublished result). RT-<br />
PCR was carried out using RNA isolated from C.<br />
olitorius grown under normal condition. This<br />
additional b<strong>and</strong> was extracted from agarose gel<br />
using QIAGEN MinElute Gel Extraction Kit <strong>and</strong><br />
sequenced (1 st Base PTE Singapore) using ForP<br />
<strong>and</strong> RevP as primers. Gene specific primers<br />
(GSPF1, GSPR1 <strong>and</strong> GSPR2) for the transcript was<br />
designed using Primer3Plus (Untergasser et al.<br />
2007). Sequences <strong>of</strong> primers are given in Table 1.<br />
These primers were used to sequence partial CDS<br />
(coding sequence) <strong>of</strong> drp from C. capsularis, C.<br />
tridens, C. aestuans, C. pseudo-olitorius, C.<br />
trilocularis.<br />
Table 1. Primers used in the study<br />
Primer Sequence<br />
ForP 5’- ATACTTATGGGAGAATGAAAG -3’<br />
RevP 5’- TACAGGTAAAATGTCACCAA -3’<br />
GSP-R1 5’- GAGGCTTTTCTTGGAAC -3’<br />
GSP-R2 5’- GTCCCGATCCCTTGAATTAC -3’<br />
GSP-F1 5’- CTTAATCGGAGCAGGGTGAG -3’
Semiquantitative RT-PCR<br />
Total RNA was isolated from jute seedlings <strong>and</strong><br />
quantified using a nanodrop (ND-1000). Poly (A)<br />
RNA was isolated from total RNA using mRNA<br />
extraction kit (SIGMA, MRN 10KT, 046k6879)<br />
<strong>and</strong> quantified. First str<strong>and</strong> cDNA was synthesized<br />
from 50 ng <strong>of</strong> mRNA using gene specific primer<br />
GSP-R2. PCR amplification <strong>of</strong> the cDNA was<br />
carried out for 25 cycles using primers GSP-F1 <strong>and</strong><br />
GSP-R2 (95°C for 40 s, 58°C for 40 s, <strong>and</strong> 72°C<br />
for 50 s). The housekeeping gene β-actin was used<br />
as the internal st<strong>and</strong>ard for reverse transcriptase<br />
polymerase chain reaction (Alam et al. 2010).<br />
5′ RACE<br />
277 bp sequence at the 5′ end <strong>of</strong> the transcript was<br />
determined by 5′- Rapid Amplification <strong>of</strong> cDNA<br />
Ends (RACE) protocol. The first str<strong>and</strong> cDNA was<br />
prepared from mRNA using the primer GSPR1.<br />
Purification <strong>of</strong> first str<strong>and</strong> cDNA <strong>and</strong> TdT tailing<br />
was carried out as recommended by the<br />
manufacturer (5′ RACE system, Invitrogen<br />
Corporation, Carlsbad, CA). First round PCR <strong>of</strong><br />
target cDNA was carried out using the primer<br />
GSPR2 for 35 cycles (95°C for 1 min, 55°C for 1<br />
min, <strong>and</strong> 72°C for 2 min).<br />
Southern blot<br />
15 μg DNA was digested with EcoRI <strong>and</strong> SacI <strong>and</strong><br />
size-fractionated on 1% agarose gel <strong>and</strong> then<br />
transferred onto a positively charged nylon<br />
membrane (Amersham Hybond-N). Probe was<br />
synthesized from RT-PCR product using primer<br />
GSP-F1 <strong>and</strong> GSPR2 <strong>and</strong> Dig nucleic acid labeling<br />
<strong>and</strong> detection kit (Roche, IN). Manufacturer’s<br />
guideline for highly stringent hybridization <strong>and</strong><br />
detection conditions was followed (probe 10<br />
ng/mL, stringency washes with 0.5X SSC, 0.1%<br />
SDS).<br />
Northern blot<br />
10 μg RNA was separated by electrophoreses in 1X<br />
MOPS <strong>and</strong> transferred to a positively charged<br />
nylon membrane (Amersham Hybond-N). Probe<br />
was synthesized from RT-PCR product by using<br />
primer GSPF <strong>and</strong> GSPR2 <strong>and</strong> Dig nucleic acid<br />
labelling <strong>and</strong> detection kit (Roche, Cat No.<br />
11175033910). Manufacturer’s guideline for highly<br />
stringent hybridization <strong>and</strong> detection conditions<br />
Novel dehydration responsive transcript from jute 23<br />
was followed (probe 10 ng/mL, stringency washes<br />
with 0.1X SSC, 0.1% SDS).<br />
Sequence assembly <strong>and</strong> analysis<br />
Sequences from gel extracted b<strong>and</strong> <strong>and</strong> 5′ RACE<br />
was assembled using CAP3 (Huang <strong>and</strong> Madan,<br />
1999) from PBIL web-server (Perriere et al. 2003).<br />
Coding sequences were identified using ESTScan2<br />
(Iseli et al. 1999). Phylogenetic tree was<br />
constructed using MEGA4 by UPGMA method<br />
with default parameters (Tamura et al. 2007).<br />
Multiple sequence alignment was done using<br />
Clustalx (Larkin et al. 2007). Protein secondary<br />
structure was predicted from NPS@ webserver<br />
(Combet et al. 2000).<br />
Results<br />
Identification <strong>of</strong> the transcript<br />
The dehydration responsive transcript was<br />
identified by sequencing <strong>of</strong> additional b<strong>and</strong><br />
obtained from RT-PCR <strong>of</strong> LDLP gene. The 396 bp<br />
sequenced transcript failed to show significant<br />
similarity to any <strong>of</strong> the so far functionally<br />
characterized proteins in blast search at NCBI<br />
database. An additional 277 bp sequence at the 5′<br />
end was determined by 5′ RACE. Partial CDS <strong>of</strong><br />
drp from five other Corchorus spp (C. capsularis,<br />
C. tridens, C. aestuans, C. pseudo-olitorius, C.<br />
trilocularis) were obtained using gene specific<br />
primer (GSP) pairs. Sequence information was<br />
deposited to DDBJ (Accession numbers<br />
AB571589-AB571594).<br />
Copy number determination<br />
To determine the copy number <strong>of</strong> the gene within<br />
the C. olitorius genome, isolated genomic DNA<br />
was digested EcoRI <strong>and</strong> SacI. Southern blot with<br />
both enzyme digests showed four distinct b<strong>and</strong>s<br />
(Figure 1). Thus, it is likely that C. olitorius<br />
genome has four copies <strong>of</strong> drp.<br />
Expression study: Tissue <strong>and</strong> stress specific<br />
expression<br />
Reverse transcriptase PCR (RT-PCR) from RNA<br />
isolated from leaf, stem <strong>and</strong> root suggested that drp<br />
was expressed in all three tissues (Figure 2).<br />
Semiquantitative RT-PCR showed reduced<br />
expression under dehydration stressed condition
24 Sazia SHARMIN et al.<br />
(Figure 3). Similar expression pattern was observed<br />
in Northern blot <strong>of</strong> C. olitorius transcript with a<br />
cDNA probe specific for the sequence (Figure 4).<br />
The transcript also showed somewhat reduced<br />
Figure 1. Southern blot <strong>of</strong> drp after EcoRI (a) <strong>and</strong><br />
SacI (b) digestion. Arrows indicate b<strong>and</strong>s to which<br />
probe was hybridized.<br />
Figure 3. Semiquantitative RT-PCR <strong>of</strong> drp (top)<br />
<strong>and</strong> actin control (bottom) under different stress<br />
conditions (N, L, S, D, F <strong>and</strong> A st<strong>and</strong>s for Normal,<br />
Experimental, Low temperature, Salt, Dehydration,<br />
Fungal <strong>and</strong> ABA treatment, respectively).<br />
Comparative analysis <strong>of</strong> drp from different<br />
Corchorus spp.<br />
Translated protein sequence alignment showed a<br />
highly conserved segment <strong>of</strong> 32 amino acid<br />
expression in low temperature <strong>and</strong> fungus treated<br />
plants (Figures 3 <strong>and</strong> 4).<br />
Figure 2. RT-PCR <strong>of</strong> RNA isolated from stem, root<br />
<strong>and</strong> leaf (S, R <strong>and</strong> L st<strong>and</strong>s for stem, root <strong>and</strong> leaf,<br />
respectively).<br />
Figure 4. Northern blot <strong>of</strong> drp under different<br />
stress conditions (N, L, S, D, F, A st<strong>and</strong>s for<br />
Normal, Experimental, Low temperature, Salt,<br />
Dehydration, Fungal <strong>and</strong> ABA treatment,<br />
respectively). rRNA is shown below as a control<br />
for equal loading.<br />
residues (Figure 5a). Secondary structure prediction<br />
suggested that the region is mainly composed <strong>of</strong><br />
R<strong>and</strong>om Coils (Figure 5b <strong>and</strong> Table 2). A<br />
phylogenetic tree (Figure 6) <strong>of</strong> drp nucleotide<br />
sequence from different Corchorus species was<br />
constructed using MEGA4 (Tamura et al. 2007).
A<br />
Corchorus_olitorius SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />
Corchorus_capsularis SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />
Corchorus_tridens SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />
Corchorus_pseudo-olitorius SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />
Corchorus_trilocularis SAPKARQRCVADGKLVNIPAPSYSAMGGRIAE<br />
Corchorus_aestuans SAPKARQRCVADGKQVNIPAPSYNAMGGRIAE<br />
************** ********.********<br />
B<br />
10 20 30<br />
| | |<br />
UNK_136050 SAPKARQRCVADGKQVNIPAPSYDAMGGRIAE<br />
DPM ctchhhhhhehtcccecccccccchhcchhcc<br />
DSC ccccceeeeecccccccccccccccccccccc<br />
GOR1 hhhhhheeeeettteeeeeeceeeehhhhhhh<br />
GOR3 cccchhheehhccceecccccccccccceehh<br />
HNNC cccccccccccccccccccccccccccccccc<br />
MLRC cccccceeeecccccecccccccccccccccc<br />
PHD ccccccchhhhccccccccccccccccccccc<br />
Predator ccchhhhhhhcccccccccccccccccccccc<br />
SOPM ccccccheeecttccccccccccchhtchhhh<br />
Sec.Cons. ccccc?heeecccccccccccccccccccccc<br />
Sequence length : 32<br />
Novel dehydration responsive transcript from jute 25<br />
Figure 5. A) Highly conserved segment <strong>of</strong> the translated protein sequence <strong>of</strong> drp gene from different<br />
Corchorus spp; B) Predicted secondary structure <strong>of</strong> the conserved segment. The last line shows consensus<br />
secondary structure from different methods <strong>of</strong> prediction.<br />
Table 2. Summary <strong>of</strong> predicted secondary structures from different prediction tools. The last row is for<br />
consensus secondary structure.<br />
S<strong>of</strong>tware R<strong>and</strong>om coil (c) Alpha helix (h) Extended str<strong>and</strong> (e)<br />
DPM (Deléage <strong>and</strong> Roux, 1987) 53.12 % 34.38% 6.25%<br />
DSC (King <strong>and</strong> Sternberg, 1996) 84.38% 0.00% 15.62%<br />
GOR1 (Garnier et al. 1978) 3.12% 40.62% 46.88%<br />
GOR3 (Gibrat et al. 1987) 59.38% 21.88% 18.75%<br />
HNNC (Guermeur, 1997) 100.00% 0.00% 0.00%<br />
MLRC (Guermeur et al. 1999) 84.38% 0.00% 15.62%<br />
PHD (Rost <strong>and</strong> S<strong>and</strong>er, 1993) 87.50% 12.50% 0.00%<br />
Predator (Frishman <strong>and</strong> Argos, 1996) 78.12% 21.88% 0.00%<br />
SOPM (Geourjon <strong>and</strong> Deléage, 1994) 59.38% 21.88% 9.38%<br />
Sec.Cons. (Consensus) 84.38% 3.12% 9.38%
26 Sazia SHARMIN et al.<br />
Figure 6. Evolutionary relationship <strong>of</strong> 6 Corchorus species, poplar <strong>and</strong> rice. The percentage <strong>of</strong> replicate trees<br />
in which the associated taxa clustered together in the bootstrap test (10000 replicates) is shown next to the<br />
branches. The rate variation among sites was modelled with a gamma distribution (shape parameter = 1).<br />
Discussion<br />
Acquisition <strong>of</strong> dehydration tolerance is one <strong>of</strong> the<br />
traits that enabled l<strong>and</strong>-plants to settle into<br />
terrestrial habitats (Richardt et al. 2007).<br />
Dehydration stress is a specific form <strong>of</strong> water<br />
deficit stress that results in alteration <strong>of</strong> plants at<br />
the cellular, morphological <strong>and</strong> developmental<br />
levels (Bray, 1993). At the molecular level, the<br />
pathway can be classified into two broad categories<br />
viz. ABA dependent <strong>and</strong> ABA independent<br />
pathway (Ramanjulu <strong>and</strong> Bartels, 2002). Individual<br />
pathways are discussed in detail elsewhere<br />
(Agarwal <strong>and</strong> Jha, 2010; Ingram <strong>and</strong> Bartels, 1996;<br />
Nakashima et al. 2009; Umezawa et al. 2006;<br />
Yamaguchi-Shinozaki <strong>and</strong> Shinozaki, 2006).<br />
The newly identified transcript, namely drp,<br />
was found to be expressed in all three tissues tested<br />
(root, stem <strong>and</strong> leaf) in normal condition (Figure 2).<br />
Analysis <strong>of</strong> the expression pattern after stress<br />
treatments suggests decreased expression in<br />
dehydration stress, but increased expression in<br />
ABA stress condition (Figures 3 <strong>and</strong> 4).<br />
Comparative analyses <strong>of</strong> water deficit stressed<br />
transcriptome <strong>of</strong> a number <strong>of</strong> plants identified plant<br />
genes showing altered expression in either<br />
dehydration stress alone or in combination with any<br />
other water deficit stress or ABA treatment (Bray,<br />
2004; Rabbani et al. 2003; Seki et al. 2002; Talame<br />
et al. 2007). Nevertheless, none <strong>of</strong> the studies<br />
identified single transcript showing opposite<br />
expression patterns in water deficit stress <strong>and</strong> ABA<br />
treatment as shown by drp. It is to be noted that the<br />
transcript also shows somewhat reduced expression<br />
in low temperature treated plants. Previous studies<br />
on dehydration stress responsive genes also found<br />
similar correlation with low temperature response<br />
pathways (Shinozaki <strong>and</strong> Yamaguchi-Shinozaki,<br />
2000).<br />
Comparative analysis <strong>of</strong> different experimental<br />
methods <strong>of</strong> water deficit stress treatment revealed<br />
that three transcripts (At2g06850, At1g72610 <strong>and</strong><br />
At5g20630) are down-regulated in Arabidopsis<br />
irrespective <strong>of</strong> the method (filter paper, mannitol or<br />
soil water deficit) applied (Bray, 2004).<br />
Interestingly all the three genes are either known or<br />
hypothesized to function in plant cell wall<br />
modification pathways that control growth (Bray,<br />
2004). Both semi-quantitative RT (reverse<br />
transcriptase) -PCR <strong>and</strong> northern blot suggests<br />
reduced expression <strong>of</strong> drp in fungus treated plants.<br />
Study by Schenk <strong>and</strong> co-workers (Schenk et al.<br />
2000) revealed that a significant portion <strong>of</strong> fungal<br />
inoculation responsive genes in Arabidopsis are<br />
associated with cell wall synthesis <strong>and</strong><br />
modification. Thus, drp might also play a role in<br />
defence pathways against fungal infection in jute<br />
by playing a role in cell wall synthesis <strong>and</strong>/or<br />
modification.<br />
Southern blot <strong>of</strong> the transcript suggests that C.<br />
olitorius genome has four copies <strong>of</strong> drp gene<br />
(Figure 1). Thus, it is also possible that different<br />
copies <strong>of</strong> the drp gene are under different<br />
regulatory mechanisms <strong>and</strong> the observed<br />
expression patterns are <strong>of</strong> different drp genes which
are indistinguishable in the region selected for<br />
analyses.<br />
The newly identified transcript failed to show<br />
significant similarity to any <strong>of</strong> the so far<br />
functionally characterized proteins. It is to be noted<br />
that plant specific nucleotide blast in NCBI<br />
database shows significant similarity to a<br />
hypothetical Poplus trichocarpa protein<br />
(XM_002337327.1) <strong>and</strong> other plant transcripts.<br />
Paralogues <strong>of</strong> the gene were found to be present in<br />
all tested Corchorus species. Phylogenetic analysis<br />
<strong>of</strong> drp gene <strong>and</strong> its homologues suggests that C.<br />
capsularis is the closest neighbour <strong>of</strong> C. olitorius in<br />
terms <strong>of</strong> drp. It is to be noted that all considered<br />
dicots grouped into same clade in the tree (Figure<br />
6).<br />
Multiple sequence alignment <strong>of</strong> protein<br />
sequences from different Corchorus spp. identified<br />
a highly conserved segment <strong>of</strong> 32 amino acid<br />
residues. Secondary structure prediction at NPS@<br />
webserver (Combet et al. 2000) suggested these<br />
amino acids are most likely to form r<strong>and</strong>om coils<br />
(Figure 5b <strong>and</strong> Table 2). R<strong>and</strong>om coils or more<br />
specifically coils add flexibility to the protein<br />
structure (Buxbaum, 2007). Our literature survey<br />
revealed an interesting relationship between<br />
r<strong>and</strong>om coils <strong>and</strong> their possible role in dehydration<br />
response. It has been long known that different<br />
organisms release osmolytes when subjected to<br />
water stresses (Yancey et al. 1982). Study by Qu<br />
<strong>and</strong> co-workers (1998) identified that osmolytes<br />
cause contraction <strong>of</strong> r<strong>and</strong>om coils leading to<br />
decrease <strong>of</strong> conformational entropy <strong>and</strong> subsequent<br />
stabilization <strong>of</strong> protein folding.<br />
The present study has identified a novel<br />
dehydration responsive transcript from different<br />
jute (Corchorus) species. Further studies are<br />
required to elucidate the detailed mechanism <strong>of</strong><br />
action <strong>of</strong> this transcript.<br />
Acknowledgement<br />
This research was supported by the United States<br />
Department <strong>of</strong> Agriculture (USDA). We are<br />
thankful to Bangladesh Jute Research Institute<br />
(BJRI) for providing seeds <strong>of</strong> different jute species.<br />
References<br />
Agarwal P <strong>and</strong> Jha B. Transcription factors in<br />
plants <strong>and</strong> ABA dependent <strong>and</strong> independent<br />
abiotic stress signalling. Biol Plant. 54:201-212,<br />
2010.<br />
Novel dehydration responsive transcript from jute 27<br />
Ahmed S, Nabi MZ, Alam MM, Islam MS, Samira<br />
R, Moosa MM <strong>and</strong> Khan H. A computational<br />
<strong>and</strong> experimental approach for developing jute<br />
ESTs from genomic clones. Aust J Crop Sci.<br />
3:322-328, 2009.<br />
Alam M, Sharmin S, Nabi Z, Mondal S, Islam M,<br />
Nayeem S, Shoyaib M <strong>and</strong> Khan H. A Putative<br />
Leucine-Rich Repeat Receptor-Like Kinase <strong>of</strong><br />
Jute Involved in Stress Response. Plant Mol<br />
Biol Rep. 28:394-402, 2010.<br />
Basu A, Ghosh M, Meyer R, Powell W, Basak SL<br />
<strong>and</strong> Sen SK. Analysis <strong>of</strong> genetic diversity in<br />
cultivated jute determined by means <strong>of</strong> SSR<br />
markers <strong>and</strong> AFLP pr<strong>of</strong>iling. Crop Science.<br />
44:678-685, 2004.<br />
Buxbaum E. Protein structure. Fundamentals <strong>of</strong><br />
protein structure <strong>and</strong> function. Springer<br />
ScienceBusiness Media, LLC, New York. 12-<br />
37, 2007.<br />
BBS. Statistical pocket book <strong>of</strong> Bangladesh<br />
statistics division, Bangladesh Bureau <strong>of</strong><br />
Statistics, Ministry <strong>of</strong> Planning, the People's<br />
Republic <strong>of</strong> Bangladesh. 2004.<br />
Bray EA. <strong>Molecular</strong> responses to water deficit.<br />
Plant Physiol. 103:1035-1040, 1993.<br />
Bray EA. Genes commonly regulated by waterdeficit<br />
stress in Arabidopsis thaliana. J Exp Bot.<br />
55:2331-2341, 2004.<br />
Combet C, Blanchet C, Geourjon C, <strong>and</strong> Deléage<br />
G. NPS@: Network Protein Sequence Analysis.<br />
Trends in Biochemical Science. 25:147-150,<br />
2000.<br />
Deléage G <strong>and</strong> Roux B. An algorithm for protein<br />
secondary structure prediction based on class<br />
prediction. Protein Eng. 1:289-294, 1987.<br />
Frishman D <strong>and</strong> Argos P. Incorporation <strong>of</strong> nonlocal<br />
interactions in protein secondary structure<br />
prediction from the amino acid sequence.<br />
Protein Eng. 9:133-142, 1996.<br />
Garnier J, Osguthorpe DJ <strong>and</strong> Robson B. Analysis<br />
<strong>of</strong> the accuracy <strong>and</strong> implications <strong>of</strong> simple<br />
methods for predicting the secondary structure<br />
<strong>of</strong> globular proteins. J Mol Biol. 120:97-120,<br />
1978.<br />
Geourjon C <strong>and</strong> Deléage G. SOPM: a selfoptimized<br />
method for protein secondary
28 Sazia SHARMIN et al.<br />
structure prediction. Protein Eng. 7:157-164,<br />
1994.<br />
Ghosh T. H<strong>and</strong> book on jute. Food <strong>and</strong> Agriculture<br />
Organization <strong>of</strong> the United Nations (FAO):115-<br />
116, 1983.<br />
Gibrat JF, Garnier J <strong>and</strong> Robson B. Further<br />
developments <strong>of</strong> protein secondary structure<br />
prediction using information theory: New<br />
parameters <strong>and</strong> consideration <strong>of</strong> residue pairs. J<br />
Mol Biol. 198:425-443, 1987.<br />
Guermeur Y. Combinaison de classifieurs<br />
statistiques, Application a la prediction de<br />
structure secondaire des proteines., p 169,<br />
Paris: University <strong>of</strong> Paris 06, 1997.<br />
Guermeur Y, Geourjon C, Gallinari P <strong>and</strong> Deléage<br />
G. Improved performance in protein secondary<br />
structure prediction by inhomogeneous score<br />
combination. Bioinformatics. 15:413-421, 1999.<br />
Hannah MA, Heyer AG <strong>and</strong> Hincha DK. A Global<br />
Survey <strong>of</strong> Gene Regulation during Cold<br />
Acclimation in Arabidopsis thaliana. PLoS<br />
Genetics. 1:e26, 2005.<br />
Holappa LD <strong>and</strong> Walker-Simmons MK. The Wheat<br />
Abscisic Acid-Responsive Protein Kinase<br />
mRNA, PKABA1, Is Up-Regulated by<br />
Dehydration, Cold Temperature, <strong>and</strong> Osmotic<br />
Stress. Plant Physiol. 108:1203-1210, 1995.<br />
Hossain MB, Awal A, Rahman MA, Haque S <strong>and</strong><br />
Khan H. Distinction between cold-sensitive <strong>and</strong><br />
-tolerant Jute by DNA polymorphism. <strong>Journal</strong><br />
<strong>of</strong> Biochemistry <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong>.<br />
36:427-432, 2003.<br />
Huang X <strong>and</strong> Madan A. CAP3: A DNA Sequence<br />
Assembly Program. Genome Research. 9:868-<br />
877, 1999.<br />
Ingram J <strong>and</strong> Bartels D. The molecular basis <strong>of</strong><br />
dehydration tolerance in plants. Annual Review<br />
<strong>of</strong> Plant Physiol <strong>and</strong> Plant <strong>Molecular</strong> <strong>Biology</strong>.<br />
47:377-403, 1996.<br />
Iseli C, Jongeneel CV <strong>and</strong> Bucher P. ESTScan: a<br />
program for detecting, evaluating, <strong>and</strong><br />
reconstructing potential coding regions in EST<br />
sequences. In: Proceedings / International<br />
Conference on Intelligent Systems for<br />
<strong>Molecular</strong> <strong>Biology</strong> pp 138-148, 1999.<br />
Islam AS, Taliaferro M, Lee CT, Ingram C,<br />
Montalvo RJ, Ende Gvd, Alam S, Siddiqui J<br />
<strong>and</strong> Sathasivan K. Preliminary progress in Jute,<br />
Corchorus species. genome analysis. Plant<br />
Tissue Cult Biotechnol. 15:145-156, 2005.<br />
Keka SI, Shamsuzzaman M, Pahloan MU, Pervin<br />
S, Rahman MM <strong>and</strong> Khan H. Identifying simple<br />
sequence repeat (SSR) marker linked to mite<br />
tolerance in jute species. Bangladesh <strong>Journal</strong> <strong>of</strong><br />
Botany. 37:161-171, 2008.<br />
King RD <strong>and</strong> Sternberg MJE. Identification <strong>and</strong><br />
application <strong>of</strong> the concepts important for<br />
accurate <strong>and</strong> reliable protein secondary structure<br />
prediction. Protein Sci. 5:2298-2310, 1996.<br />
Kulheim C, Agren J <strong>and</strong> Jansson S. Rapid<br />
Regulation <strong>of</strong> Light Harvesting <strong>and</strong> Plant<br />
Fitness in the Field. Science, 297:91-93, 2002.<br />
Kundu B. Jute — world’s foremost bast fibre, II.<br />
Technology, marketing, production <strong>and</strong><br />
utilization. Economic Botany. 10:203-240,<br />
1956.<br />
Larkin MA, Blackshields G, Brown NP, Chenna R,<br />
McGettigan PA, McWilliam H, Valentin F,<br />
Wallace IM, Wilm A, Lopez R, Thompson JD,<br />
Gibson TJ <strong>and</strong> Higgins DG. Clustal W <strong>and</strong><br />
Clustal X version 2.0. Bioinformatics. 23:2947-<br />
2948, 2007.<br />
Mahmood N, Azam MS, Islam MS, Sharmin S,<br />
Moosa MM, Hossain MA <strong>and</strong> Khan H.<br />
Differentially expressed transcripts <strong>of</strong> wild <strong>and</strong><br />
cultivated jute (Corchorus spp.) varieties upon<br />
fungal, Macrophomina phaseolina. infection.<br />
Annals <strong>of</strong> Biological Research. 1:120-127,<br />
2010.<br />
Murray MG <strong>and</strong> Thompson WF. Rapid isolation <strong>of</strong><br />
high molecular weight plant DNA. Nucleic<br />
Acids Res. 8:4321-4326, 1980.<br />
Nakashima K, Ito Y <strong>and</strong> Yamaguchi-Shinozaki K.<br />
Transcriptional Regulatory Networks in<br />
Response to Abiotic Stresses in Arabidopsis <strong>and</strong><br />
Grasses. Plant Physiol. 149:88-95, 2009.<br />
Perriere G, Combet C, Penel S, Blanchet C,<br />
Thioulouse J, Geourjon C, Grassot J, Charavay<br />
C, Gouy M, Duret L <strong>and</strong> Deleage G. Integrated<br />
databanks access <strong>and</strong> sequence/structure<br />
analysis services at the PBIL. Nucleic Acids<br />
Res. 31:3393-3399, 2003.<br />
Qu Y, Bolen CL, <strong>and</strong> Bolen DW. Osmolyte-driven<br />
contraction <strong>of</strong> a r<strong>and</strong>om coil protein.<br />
Proceedings <strong>of</strong> the National Academy <strong>of</strong><br />
Sciences <strong>of</strong> the United States <strong>of</strong> America.<br />
95:9268-9273,1998.
Rabbani MA, Maruyama K, Abe H, Khan MA,<br />
Katsura K, Ito Y, Yoshiwara K, Seki M,<br />
Shinozaki K <strong>and</strong> Yamaguchi-Shinozaki K.<br />
Monitoring Expression Pr<strong>of</strong>iles <strong>of</strong> Rice Genes<br />
under Cold, Drought, <strong>and</strong> High-Salinity<br />
Stresses <strong>and</strong> Abscisic Acid Application Using<br />
cDNA Microarray <strong>and</strong> RNA Gel-Blot Analyses.<br />
Plant Physiol. 133:1755-1767, 2003.<br />
Ramanjulu S <strong>and</strong> Bartels D. Drought- <strong>and</strong><br />
desiccation-induced modulation <strong>of</strong> gene<br />
expression in plants. Plant, <strong>Cell</strong> &<br />
Environment. 25:141-151, 2002.<br />
Richardt S, Timmerhaus G, Lang D, Qudeimat E,<br />
Corrêa L, Reski R, Rensing S <strong>and</strong> Frank W.<br />
Microarray analysis <strong>of</strong> the moss Physcomitrella<br />
patens reveals evolutionarily conserved<br />
transcriptional regulation <strong>of</strong> salt stress <strong>and</strong><br />
abscisic acid signalling. Plant <strong>Molecular</strong><br />
<strong>Biology</strong>. 72:27-45, 2007.<br />
Rost B <strong>and</strong> S<strong>and</strong>er C. Prediction <strong>of</strong> Protein<br />
Secondary Structure at Better than 70%<br />
Accuracy. J Mol Biol. 232:584-599, 1993.<br />
Samira R, Moosa MM, Alam MM, Keka SI <strong>and</strong><br />
Khan H. In silico analysis <strong>of</strong> jute SSR library<br />
<strong>and</strong> experimental verification <strong>of</strong> assembly.<br />
Plant Omics <strong>Journal</strong>. 3:57-65, 2010.<br />
Schenk PM, Kazan K, Wilson I, Anderson JP,<br />
Richmond T, Somerville SC <strong>and</strong> Manners JM.<br />
Coordinated plant defense responses in<br />
Arabidopsis revealed by microarray analysis.<br />
Proceedings <strong>of</strong> the National Academy Science<br />
<strong>of</strong> the United States <strong>of</strong> America. 97:11655-<br />
11660, 2000.<br />
Seki M, Ishida J, Narusaka M, Fujita M, Nanjo T,<br />
Umezawa T, Kamiya A, Nakajima M, Enju A,<br />
Sakurai T, Satou M, Akiyama K, Yamaguchi-<br />
Shinozaki K, Carninci P, Kawai J, Hayashizaki<br />
Y <strong>and</strong> Shinozaki K. Monitoring the expression<br />
pattern <strong>of</strong> around 7,000 Arabidopsis genes<br />
under ABA treatments using a full-length<br />
cDNA microarray. Functional & Integrative<br />
Genomics. 2:282-291, 2002.<br />
Shinozaki K <strong>and</strong> Yamaguchi-Shinozaki K.<br />
<strong>Molecular</strong> responses to dehydration <strong>and</strong> low<br />
temperature: differences <strong>and</strong> cross-talk between<br />
two stress signalling pathways. Current Opinion<br />
in Plant <strong>Biology</strong>. 3:217-223, 2000.<br />
Talame V, Ozturk NZ, Bohnert HJ <strong>and</strong> Tuberosa R.<br />
Barley transcript pr<strong>of</strong>iles under dehydration<br />
shock <strong>and</strong> drought stress treatments: a<br />
Novel dehydration responsive transcript from jute 29<br />
comparative analysis. J Exp Bot. 58:229-240,<br />
2007.<br />
Tamura K, Dudley J, Nei M <strong>and</strong> Kumar S.<br />
MEGA4: <strong>Molecular</strong> Evolutionary Genetics<br />
Analysis, MEGA. S<strong>of</strong>tware Version 4.0. Mol<br />
Biol Evol. 24:1596-1599, 2007.<br />
Umezawa T, Fujita M, Fujita Y, Yamaguchi-<br />
Shinozaki K <strong>and</strong> Shinozaki K. Engineering<br />
drought tolerance in plants: discovering <strong>and</strong><br />
tailoring genes to unlock the future. Curr Opin<br />
Biotechnol. 17:113-122, 2006.<br />
Untergasser A, Nijveen H, Rao X, Bisseling T,<br />
Geurts R <strong>and</strong> Leunissen JAM. Primer3Plus, an<br />
enhanced web interface to Primer3. Nucleic<br />
Acids Res. 35:W71-74, 2007.<br />
Wazni MW, Islam AS, Taliaferro JM, Anwar N<br />
<strong>and</strong> Sathasivan K. Novel ESTs from a Jute,<br />
Corchorus olitorius L). cDNA library. Plant<br />
Tissue Cult Biotechnol. 17:173-182, 2007.<br />
Yamaguchi-Shinozaki K <strong>and</strong> Shinozaki K.<br />
Transcriptional regulatory netwirks in cellular<br />
responses <strong>and</strong> tolerance to dehydration <strong>and</strong> cold<br />
stress. Annu Rev Plant Biol, 57:781-803, 2006.<br />
Yan S, Tang Z, Su W <strong>and</strong> Sun W. Proteomic<br />
analysis <strong>of</strong> salt stress-responsive proteins in rice<br />
root. Proteomics. 5:235-244, 2005.<br />
Yancey P, Clark M, H<strong>and</strong> S, Bowlus R <strong>and</strong> Somero<br />
G. Living with water stress: evolution <strong>of</strong><br />
osmolyte systems. Science. 217:1214-1222,<br />
1982.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 31-36, 2011 Research Article 31<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon<br />
toxicity in Swiss albino mice<br />
Preeti SINGH * , Priya MOGRA, V<strong>and</strong>ana SANKHLA <strong>and</strong> Kanchan DEORA<br />
Department <strong>of</strong> Zoology, College <strong>of</strong> Science, M.L.S. University, Udaipur-Rajasthan, 313001 India.<br />
(* author for correspondence; priti1960@yahoo.co.in )<br />
Received: 26 October 2010; Accepted: 29 April 2011<br />
Abstract<br />
Cadmium, an omnipresent, hazardous, heavy metal, is recognized to produce severe toxic effects in humans.<br />
The Agency for Toxic Substances <strong>and</strong> Disease Registry (ATSDR) in Atlanta, Georgia has listed cadmium as<br />
number 7 in its top 20 list <strong>of</strong> hazardous substances. In contrast to the toxic activity <strong>of</strong> cadmium chloride,<br />
curcumin derived from Curcuma longa (Turmeric) is attributed with numerous beneficial properties <strong>and</strong> is<br />
supposed to possess multifaceted healing properties. The purpose <strong>of</strong> the present study was to elucidate the<br />
protective efficacy <strong>of</strong> curcumin against cadmium chloride induced colon toxicity in Swiss albino mice. Four<br />
batches <strong>of</strong> Swiss-albino mice, each batch comprising six mice, were treated with cadmium chloride <strong>and</strong><br />
curcumin. Comparative observations <strong>of</strong> colon in cadmium-treated groups clearly showed induction <strong>of</strong><br />
histopathological damage as evidenced by emptied goblet cells, lacerated <strong>and</strong> suppressed mucosa, destruction<br />
<strong>of</strong> surface epithelium, marked decline in mucin production <strong>and</strong> hemorrhagic colon, which were not seen in<br />
control <strong>and</strong> curcumin treated group. In animals pretreated with curcumin <strong>and</strong> subsequently treated with<br />
cadmium chloride, the histopathology <strong>of</strong> colon clearly delineates the protection accorded by curcumin, as the<br />
induced damage by cadmium chloride was negligible <strong>and</strong> the number <strong>of</strong> empty goblet cells, hemorrhagic<br />
areas, suppression <strong>of</strong> mucosa was significantly reduced.<br />
Keywords: Curcumin, cadmium chloride, colon, goblet cells, mucosa<br />
Swiss albino farelerde zerdeçalın kadmiyum klorür ile indüklenmiş kolon<br />
toksisitesine koruyucu etkileri<br />
Özet<br />
Her yerde bulunan, tehlikeli bir ağır metal olan kadmiyumun ins<strong>and</strong>a şiddetli toksik etkiler yarattığı fark<br />
edilmiştir. Atlanta, Georgia’daki Toksik Maddeler ve Hastalık Kayıt Acentası (ATSDR) kadmiyumu ilk 20<br />
tehlikeli maddeler listesinde 7. sırada listelemiştir. Kadmiyum kloridin toksik aktivitesine karşın, Curcuma<br />
longa’dan (Turmeric) elde edilen zerdeçala çok sayıda yararlı özellikler atfedilmiş ve iyileştirici özelliklere<br />
sahip olduğu tahmin edilmiştir. Bu çalışmanın amacı Swiss albino farelerde zerdeçalın kadmiyum klorid ile<br />
indüklenmiş kolon toksisitesine karşı koruyucu etkisini açıklamaktır. Her birinde altı fare bulunan dört grup<br />
Swiss albino fare kadmiyum klorid ve zerdeçal ile muamele edilmiştir. Kadmiyum ile muamele edilmiş<br />
grupta kolonunun karşılaştırmalı gözlemi açıkça boşalmış goblet hücreleri, yırtılmış ve bastırılmış mukoza,<br />
yüzey epitelin yıkımı, müsin üretimindeki belirgin düşüş, kolon kanaması gibi durumlarla kanıtlanan<br />
histopatolojik hasar indüklenmesi göstermiştir. Öncelikle zerdeçal ve daha sonra kadmiyum klorid ile<br />
muamele edilmiş hayvanların kolon histopatolojisi, kadmiyum klorid ile indüklenen hasarın gözardı edilebilir<br />
olması ve boş goblet hücreleri ve kanama alanlarının sayısı ile mukoza baskılanmasının önemli derecede<br />
azalması ile zerdeçalın koruyucu rolünü anlaşılır bir biçimde açıklar.<br />
Anahtar Sözcükler: Curcumin, kadmiyum klorür, kolon, goblet hücreleri, mukoza
32 Preeti SINGH et al.<br />
Introduction<br />
Cadmium, an omnipresent, hazardous, heavy metal<br />
is recognized to produce severe toxic effects in<br />
humans (Lee et al., 1980; Jarup et al., 1998a;<br />
ATSDR, 1999 <strong>and</strong> Singh et al., 2007). The Agency<br />
for Toxic Substances <strong>and</strong> Disease Registry<br />
(ATSDR, 1989) in Atlanta, Georgia has listed<br />
cadmium as number 7 in its top 20 list <strong>of</strong> hazardous<br />
substances. Cadmium will invariably be present in<br />
our society, either in useful products in the form <strong>of</strong><br />
nickel-cadmium batteries, dyes, plastics,<br />
electrochemistry, paint pigments or in controlled<br />
wastes as a major source <strong>of</strong> pollution, in water <strong>and</strong><br />
as constituent <strong>of</strong> food material (Friberg et al., 1975;<br />
Goyer et al., 1984; Friberg et al., 1985a; Jarup et<br />
al., 1998 <strong>and</strong> Ikeda et al., 2000). In humans it has<br />
been found to produce wide range <strong>of</strong> biochemical<br />
<strong>and</strong> physiological dysfunctions as manifested in the<br />
forms <strong>of</strong> various diseases viz. Itai-itai, kidney<br />
malfunction, inflammation, Parkinsons disorder,<br />
liver malfunction etc. (Friberg et al., 1974; Nogawa<br />
et al.,1977; RAIS ,1991; Jarup et al., 1998; <strong>and</strong><br />
Ikeda et al.,2000).Various modes <strong>and</strong><br />
methodologies are being devised to combat<br />
cadmium-induced toxicity with a focus on herbal<br />
formulations. The use <strong>of</strong> herbal medicine increases<br />
every day <strong>and</strong> still finds a wide use worldwide.<br />
Traditional herbs have more acceptance than<br />
prescription drugs in many cultures. One <strong>of</strong> such<br />
drug is curcumin derived from Curcuma longa the<br />
dried powered form <strong>of</strong> which is known as Turmeric<br />
<strong>and</strong> is a m<strong>and</strong>atory condiment <strong>of</strong> every Indian<br />
kitchen. Turmeric extract containing the ingredient<br />
curcumin is marked widely in the western world as<br />
a dietary supplement for the treatment <strong>and</strong><br />
prevention <strong>of</strong> a variety <strong>of</strong> disorder, including<br />
inflammation, arthritis <strong>and</strong> other proposed uses <strong>of</strong><br />
curcumin is in Alzheimer's Disease, cancer<br />
prevention, cataract prevention, chronic, high<br />
cholesterol, liver protection, menstrual pain,<br />
multiple sclerosis, osteoarthritis, rheumatoid<br />
arthritis etc. (Deodhar et al., 1980; Chen et al.,<br />
1996; Eigner <strong>and</strong> Scholz, 1999). Curcumin is also<br />
reported to have antibacterial, antiamoebic,<br />
antifungal, antiviral <strong>and</strong> anti HIV activities<br />
(Ammon, 1992; Azuine, 1992; Ruby, 1995 <strong>and</strong><br />
Mortellini et al., 2000). In some experiments it has<br />
been shown to be 300 times more potent than<br />
vitamin E. However no concrete evidence in<br />
scientific field is available pertaining to the colonic<br />
protective effects <strong>of</strong> curcumin on cadmium chloride<br />
induced toxicity. Hence, the aim <strong>of</strong> the present<br />
research was to fulfill this lacuna <strong>and</strong> to determine<br />
the efficacy <strong>of</strong> curcumin in rendering protection<br />
against cadmium chloride induced colonic toxicity<br />
at the cellular level.<br />
Materials <strong>and</strong> methods<br />
In the present experiment the following chemical<br />
reagents were used. Cadmium chloride: CdCl2.<br />
H2O was procured from Glaxo company (India),<br />
with following features: <strong>Molecular</strong> Weight =<br />
201.32, Minimum assay (ex Cl) 95%. Curcumin<br />
Crystalline: C21H20O6 was procured from Loba<br />
Chem. Pvt. Ltd., with following features: <strong>Molecular</strong><br />
Weight = 368.39 Minimum assay (acidimetric)<br />
99%, Melting point= 170- 180°C.<br />
The present study was conducted after taking<br />
prior approval by Indian Animal Ethical Committee<br />
(No .CS\Res\07\759), on twenty four adult male<br />
Swiss albino mice 32-50 days old <strong>and</strong> weighing<br />
around to 30-40g were maintained in plastic cages<br />
under controlled lighting conditions (12:12 light:<br />
dark cycle) relative humidity (50 ± 5%) <strong>and</strong><br />
temperature (37 ± 2°C), fed with mice feed <strong>and</strong><br />
were given ad libitum access to water. A group <strong>of</strong> 6<br />
mice per experiment were taken <strong>and</strong> treated with<br />
CdCl2 <strong>and</strong> curcumin. The doses were prepared<br />
daily in distilled water <strong>and</strong> were administered by<br />
gastric gavage method.<br />
The dose protocol was as follows: Group-I<br />
Control group (a) were treated with only vehicle<br />
(water) for a day; Group-II Control groups (b) were<br />
treated with only curcumin 10mg/animal/day for 16<br />
days; Group-III Experimental batch were<br />
administered CdCl2 50mg/kg/animal for a single<br />
day; Group-IV Experimental batch with were pretreated<br />
with curcumin 10mg/animal/day for 15 days<br />
<strong>and</strong> on the 16 th day a single oral dose <strong>of</strong> CdCl2<br />
50mg/kg/day/animal was administered. After<br />
administration <strong>of</strong> the last dose, the control <strong>and</strong> the<br />
experimental animal were sacrificed. Their colon<br />
was excised <strong>and</strong> subsequently fixed in Bouins<br />
solutions. After fixation, wax block <strong>and</strong> paraffin<br />
sections <strong>of</strong> the colons were prepared, processed <strong>and</strong><br />
differentially stained in hematoxyline <strong>and</strong> eosin for<br />
general histopathological assessment. The sections<br />
were stained in bromophenol blue for assessment <strong>of</strong><br />
protein pr<strong>of</strong>ile, <strong>and</strong> in Schiff’s for the study <strong>of</strong><br />
glycoproteins. They were then observed under a<br />
light microscope <strong>and</strong> the gross histopathological<br />
pr<strong>of</strong>ile was assessed.
Results<br />
The colonic histopathological pr<strong>of</strong>ile <strong>of</strong> control<br />
group mice revealed no aberrations the colonic<br />
mucosa was distinct with no lacerations <strong>and</strong> the<br />
goblet cells present were filled. Mucin production<br />
was distinctly evident (Figure 1a <strong>and</strong> 1b).<br />
Similarly, no significant variations were observed<br />
in curcumin treated mice, which showed a similar<br />
structural pr<strong>of</strong>ile as that <strong>of</strong> control group mice<br />
(Figure 1c <strong>and</strong> 1d). The histopathology <strong>of</strong> colon in<br />
animals treated with CdCl2 was blunt <strong>and</strong><br />
suppressed, clearly delineating histopathological<br />
Protective effects <strong>of</strong> curcumin on colon toxicity 33<br />
damage. Emptied goblet cells, lacerated mucosa,<br />
destruction <strong>of</strong> surface epithelium, marked decline<br />
in mucin production <strong>and</strong> hemorrhagic areas in<br />
colon were also visible (Figure 1g <strong>and</strong> 1h). In<br />
animals pretreated with curcumin <strong>and</strong> subsequently<br />
treated with CdCl2 the histopathology <strong>of</strong> colon<br />
clearly delineates the protection accorded by<br />
curcumin as the induced damage by CdCl2 was<br />
negligible <strong>and</strong> the number <strong>of</strong> empty goblet cells,<br />
hemorrhagic areas, suppression <strong>of</strong> mucosa was<br />
significantly reduced (Figure 1e <strong>and</strong> 1f).<br />
Figure 1. (a) Photomicrograph showing the colonic surface <strong>of</strong> control group. Prominent mucosa <strong>and</strong> filled<br />
goblet cells is distinctly visible. (10X magnification), (b) Photomicrograph showing the colonic surface <strong>of</strong><br />
control group. Filled goblet cells are clearly visible. (40X magnification), (c) Photomicrograph <strong>of</strong> colon <strong>of</strong><br />
cur cumin treated group. Mucosa is similar to that <strong>of</strong> control group. (10X magnification), (d)<br />
Photomicrograph <strong>of</strong> colon <strong>of</strong> cur cumin treated group showing distinct goblet cells (40X magnification), (e)<br />
Photomicrograph <strong>of</strong> colon <strong>of</strong> group which was pretreated with cur cumin <strong>and</strong> subsequently treated with<br />
cadmium. Suppression <strong>of</strong> colonic mucosal surface is less as compared to mucosa <strong>of</strong> only cadmium chloride<br />
treated group. (10X magnification), (f) Photomicrograph <strong>of</strong> colon <strong>of</strong> group which was pretreated with cur<br />
cumin <strong>and</strong> subsequently treated with cadmium. Filled <strong>and</strong> empty goblet cells are clearly visible. (40X<br />
magnification), (g) Photomicrograph <strong>of</strong> colon <strong>of</strong> cadmium treated experimental group. Emptied goblet cells,<br />
suppressed mucosa, <strong>and</strong> destruction <strong>of</strong> surface epithelium are evident. (10X magnification), (h)<br />
Photomicrograph <strong>of</strong> colon <strong>of</strong> cadmium treated experimental group. Empty goblet cells are visible. (40X<br />
magnification).
34 Preeti SINGH et al.<br />
Discussion<br />
Cadmium is an omnipresent heavy metal which<br />
enters the biological systems from natural sources,<br />
such as volcanic emissions, weathering <strong>of</strong> rocks,<br />
mining processes as well as from industrial<br />
applications, agricultural practices <strong>and</strong> human<br />
usages. Cadmium emissions into the environment<br />
are normally continuous between the three main<br />
environmental compartments air, water <strong>and</strong> soil.<br />
The majority <strong>of</strong> cadmium exposure arises from<br />
ingestion <strong>of</strong> food substances due to uptake <strong>of</strong><br />
cadmium by plants from fertilizers, sewage sludge,<br />
manure <strong>and</strong> atmospheric deposition (Lee <strong>and</strong><br />
White, 1980; Anderson et al 1988; Hotz et al.,<br />
1989; Lauwerys et al., 1991; Iwata et al., 1992;<br />
Bernard et al 1992, Ikeda et al., 2000). Human<br />
uptake <strong>of</strong> cadmium is mainly through cigarette<br />
smoking <strong>and</strong> food intake. In vegetarian diet,<br />
mushrooms, cocoa powder, potatoes, fruits, wheat,<br />
grains, bran, sugerbeet fiber, carrot, dried seaweeds<br />
etc. are the source <strong>of</strong> cadmium intake. Similarly, in<br />
non-vegetarian diets shellfish, mussel, meat <strong>and</strong><br />
fish are rich in cadmium. These cadmium rich<br />
foods can greatly increase cadmium concentration<br />
in the human body (Friberg et al., 1985b; Vahter et<br />
al., 1996 <strong>and</strong> WHO, 2000). In humans cadmium<br />
has a long half life, which is reported to be <strong>of</strong> 10-30<br />
years in kidney, <strong>and</strong> 4.7-9.7 years in liver (Chen<br />
<strong>and</strong> Wang, 1990). On average, 5% <strong>of</strong> the total<br />
orally ingested cadmium is absorbed in the<br />
intestines, but individual values range from less<br />
than 1% to more than 20%.This reflects the fact<br />
that humans do not have effective pathways for<br />
cadmium elimination, hence cadmium shows the<br />
phenomenon <strong>of</strong> bioaccumulation. Once absorbed<br />
by an organism, it remains resident for many years.<br />
Where cadmium toxicity is concerned, colon is <strong>of</strong><br />
prime importance, for <strong>of</strong> the total cadmium that<br />
enters the gastrointestinal tract 90-95% is excreted<br />
out <strong>and</strong> hence colonic cells are exposed to cadmium<br />
in fecal matter as well as to cadmium present in the<br />
circulation. Hence in the present experiment we<br />
aimed to assess the toxic effects <strong>of</strong> cadmium<br />
chloride as well as to monitor the protective effects<br />
<strong>of</strong> curcumin in colon <strong>of</strong> Swiss albino mice on the<br />
basis <strong>of</strong> histopathological observations. The<br />
integrity <strong>of</strong> colon depends upon the balance<br />
between the hostile factors, one <strong>of</strong> them being<br />
cadmium, which damages the mucosa ,goblet cells<br />
etc. <strong>and</strong> the protective factors such as certain<br />
internal secretions like mucin <strong>and</strong> certain external<br />
agents like curcumin which render protection<br />
against cadmium toxicity. Pertaining to cadmium<br />
toxicity our results are similar to the results <strong>of</strong><br />
various studies where cadmium has been reported<br />
to cause variations in histoarctecture <strong>of</strong> colon.<br />
These reports revealed that oral exposure to<br />
cadmium caused severe necrosis, hemorrhage <strong>and</strong><br />
ulcers in the colonic epithelium as well induced<br />
decreased body weight <strong>and</strong> muscle atrophy (Barret<br />
et al., 1947; Stawe et al., 1972; Richardson et al.,<br />
1974 <strong>and</strong> ATSDR, 1999). These reports give<br />
validity to our experiment, where we have also<br />
discerned similar cadmium induced aberrations in<br />
colon. In contrast to the injurious activity <strong>of</strong><br />
cadmium, curcumin serves as protective agent<br />
where it has been shown to decrease congestion <strong>and</strong><br />
inflammation in stagnant mucus membranes <strong>and</strong> no<br />
negative side effects have been associated with<br />
curcumin supplementation (Mukhopadhyay et<br />
al.,1982; Rao et al., 1982; Dikshit et al., 1995;<br />
Shukla et al., 2002 <strong>and</strong> Egan et al., 2004).<br />
Curcumin has also been reported to have proposed<br />
uses in ulcerative colitis (Deodhar et al., 1980 <strong>and</strong><br />
Chen et al., 1996). Curcumin has been shown to<br />
protectively coat esophagus, stomach, intestinal<br />
mucus membrane <strong>and</strong> reduce acid secretion.<br />
However no information is available pertaining to<br />
protective effect <strong>of</strong> curcumin in relation to<br />
cadmium induced toxicity. Hence, this study clearly<br />
delineates the protective effect <strong>of</strong> curcumin against<br />
CdCl2 induced colonic toxicity.<br />
References<br />
Anderson O, Nielsen JB <strong>and</strong> Svendsen E. Oral<br />
cadmium chloride intoxication in mice: Effects<br />
<strong>of</strong> dose on tissue damage, intestinal absorption<br />
<strong>and</strong> relative organ distribution. Toxicology.<br />
48:225-236, 1988.<br />
ATSDR (Agency for Toxic Substances <strong>and</strong> Disease<br />
Registry). Toxicological pr<strong>of</strong>ile for cadmium.<br />
ATSDR/U.S. Public Health Service,<br />
Atlanta/TP-88/08, 1989.<br />
ATSDR (Agency for Toxic Substances <strong>and</strong> Disease<br />
Registry). Toxicological pr<strong>of</strong>ile for Cadmium.<br />
ATSDR / US department <strong>of</strong> Health <strong>and</strong> Human<br />
Services, Atlanta/, US, 1999.<br />
Ammon HPT, Anazodo M I, Safayhi H <strong>and</strong><br />
Dhawan BN. Curcumin a potent inhibitor <strong>of</strong><br />
leukotriene B4 formation in rat
polymorphonuclear neutrophils (PMNL).<br />
Planta Med. 67: 1-6, 1992.<br />
Azuine M <strong>and</strong> Bhide S. Chemo preventive effect <strong>of</strong><br />
turmeric against stomach <strong>and</strong> skin tumors<br />
induced by chemical carcinogens in Swiss mice.<br />
Nutr Cancer. 17: 77-83, 1992.<br />
Barret HM, Irwin DA <strong>and</strong> Semmons E. Studies on<br />
the toxicity <strong>of</strong> inhaled cadmium. The acute<br />
toxicity <strong>of</strong> cadmium oxide by inhalaltion. J Ing<br />
Hyg Toxicol. 29: 279, 1947.<br />
Bernard A, Lauwery R, <strong>and</strong> Amor AO. Loss <strong>of</strong><br />
glomerular polyanion correlated with<br />
albuminuria in experimental cadmium<br />
nephropathy. Arch Pathol. 66:272-278, 1992.<br />
Chen CJ <strong>and</strong> Wang CJ. Ecological correlation<br />
between arsenic level in well water <strong>and</strong> age<br />
adjusted mortality from malignant neoplasms.<br />
Cancer Res. 50: 5470 - 5474, 1990.<br />
Chen YC, Kuo TC, Lin-Shiau SY <strong>and</strong> Lin J K.<br />
Induction <strong>of</strong> HSP70 gene expression by<br />
modulation <strong>of</strong> Ca(+2) ion <strong>and</strong> cellular p53<br />
protein by curcumin in colorectal carcinoma<br />
cells. Mol Carcinogen. 17: 224-234, 1996.<br />
Deodhar SD, Sethi R <strong>and</strong> Srimal RC. Preliminary<br />
study on antirheumatic activity <strong>of</strong> curcumin<br />
(diferuloyl methane). Indian J Med Res. 71:632-<br />
634, 1980.<br />
Dikshit M, Rastogi L, Shukla R <strong>and</strong> Srimal RC.<br />
Prevention <strong>of</strong> ischaemia-induced biochemical<br />
changes by curcumin <strong>and</strong> quinidine in the cat<br />
heart. Indian J Med Res. 101: 31 - 35, 1995.<br />
Friberg L, Piscator MA, Nordberg G <strong>and</strong><br />
Kjellstrom T. Cadmium in the Environment,<br />
<strong>Vol</strong>. II: A Toxicological <strong>and</strong> Epidemiological<br />
Appraisal, Exposure, Dose <strong>and</strong> Metabolism,<br />
Clevel<strong>and</strong>, OH, CRC Press. 1974.<br />
Friberg L, Piscator MA, Nordberg G <strong>and</strong><br />
Kjellstrom T. Cadmium in Environment. 2nd.Ed<br />
CRC Press, Boca Raton, Florida, 1975.<br />
Friberg L, Kjellstrom T, Nordberg G <strong>and</strong> Piscator<br />
A. Cadmium <strong>and</strong> Health: Toxicological <strong>and</strong><br />
Epidemiological Appraisal, US Environment<br />
Protection Agency, Washington DC, 1985a.<br />
Protective effects <strong>of</strong> curcumin on colon toxicity 35<br />
Friberg L, Elinder CG, Kjellstrom T <strong>and</strong> Nordberg<br />
G. Cadmium <strong>and</strong> Health: A Toxicological <strong>and</strong><br />
Epidemiological Appraisal, CRC Press, Baca<br />
Raton, Florida. 23 – 63, 1985b.<br />
Eigner D <strong>and</strong> Scholz D. Ferula asafetida <strong>and</strong><br />
Curcuma longa in traditional medicinal<br />
treatment <strong>and</strong> diet in Nepal. J Ethnopharmacol.<br />
67: 1-6, 1999.<br />
Egan ME, Pearson M, Weiner SA, Rajendran V,<br />
Rubin D, Glockner-Pagel J, Canny S, Du K,<br />
Lukacs GL <strong>and</strong> Caplan MJ. Curcumin a major<br />
constituent <strong>of</strong> turmeric, corrects cystic fibrosis<br />
defects. Science. 23; 304 (5670): 600-2, 2004.<br />
Goyer R, Amdur MO, Doull JD <strong>and</strong> Klaassen CD.<br />
Toxicology: Toxic effects <strong>of</strong> metals. 4th ed. Eds.<br />
Casarett <strong>and</strong> Doull's. Progamone Press, New<br />
York. 623 -680, 1991.<br />
Hotz P, Buchet JP, Bernard A, Lison D <strong>and</strong><br />
Lauwerys R. Renal effects <strong>of</strong> low-level<br />
environmental cadmium exposure: 5-year<br />
follow-up <strong>of</strong> a subcohort from the Cadmibel<br />
Study, Lancet. 354:1508, 1989.<br />
Iwata K, Saito H, Moryiama M <strong>and</strong> Nakano A.<br />
Follow up study <strong>of</strong> renal tubular dysfunction<br />
<strong>and</strong> mortality in residents <strong>of</strong> an area polluted<br />
with cadmium. B r J Ind Med. 49: 736 - 737,<br />
1992.<br />
Ikeda M, Zang Z W, Moon C S, Shimbo S,<br />
Watanabe T, Nakatsuka H, MatsudaInoguchi N<br />
<strong>and</strong> Higashikawa K. Possible effects <strong>of</strong><br />
environmental cadmium exposure on kidney<br />
function in the Japanese general population. Int<br />
Arch Occup Environ Health. 73: 15 - 25, 2000.<br />
Jarup L, Alfven T, Persson B, Toss G <strong>and</strong> Elinder<br />
CG. Cadmium may be a risk factor for<br />
osteoporosis. Occup Environ Med. 55: 435-<br />
439, 1998a.<br />
Lee JS <strong>and</strong> White KL. A review <strong>of</strong> health effects <strong>of</strong><br />
cadmium. Am J Ind Med. 1: 307-317, 1980.<br />
Lauwerys R, Bernard A <strong>and</strong> Buchet JP. Does<br />
environmental exposure to cadmium represent a<br />
health risk? Conclusions from the Cadmibel<br />
Study. Acta Clin Belg. United States<br />
Environmental Protection Agency. 46: 219 -<br />
225, 1991.
36 Preeti SINGH et al.<br />
Mukhopadhyay A, Basu N <strong>and</strong> Ghatak N. Antiinflammatory<br />
<strong>and</strong> irritant activities <strong>of</strong> curcumin<br />
analogues in rats. Agents Actions. 12: 508 - 515,<br />
1982.<br />
Mortellini R, Foresti R, Bassi R <strong>and</strong> Green CJ.<br />
Curcumin, an antioxidant <strong>and</strong> anti-inflammatory<br />
agent, induces heme oxygenase-1 <strong>and</strong> protects<br />
endothelial cells against oxidative stress. Free<br />
Radic Biol Med. 28:1303-1312, 2000.<br />
Nogawa K, Ishizaki A <strong>and</strong> Evrin PE. Urinary<br />
beta2-microglobulin excretion among people<br />
exposed to cadmium in the general<br />
environment: An epidemiological study in<br />
cooperation between Japan <strong>and</strong> Sweden.<br />
Environ Res. 13(2):318-344, 1977.<br />
Richardson ME, Fox MRS, <strong>and</strong> Fry BE.<br />
Pathological changes produced in Japanese<br />
quail by ingestion <strong>of</strong> cadmium. J Nutr. 104:323,<br />
1974.<br />
Rao TS, Basu N <strong>and</strong> Siddiqui H. Antiinflammatory<br />
activity <strong>of</strong> curcumin analogues.<br />
Indian J Med Res. 75:574-8, 1982.<br />
Risk Assessment Information System (RAIS).<br />
Toxicity summary for cadmium. Chemical<br />
Hazard Evaluation <strong>and</strong> Communication Group,<br />
Biomedical <strong>and</strong> Environmental Information<br />
Analysis Section, Health <strong>and</strong> Safety Research<br />
Division. 1991.<br />
Ruby A J <strong>and</strong> Kuttan G. Anti-tumour <strong>and</strong><br />
antioxidant activity <strong>of</strong> natural curcuminoids.<br />
Cancer Lett .94: 79 - 80, 1995.<br />
Singh P, Chaudhary S, Patni A <strong>and</strong> Sankhla V.<br />
Effect <strong>of</strong> cadmium chloride induced<br />
genotoxicity in bone marrow chromosomes <strong>of</strong><br />
Swiss albino mice <strong>and</strong> subsequent protective<br />
effects <strong>of</strong> Emblica <strong>of</strong>ficinalis <strong>and</strong> vitamin C. J<br />
<strong>of</strong> Herbal Medicine <strong>and</strong> Toxicology. 1 (2): 67-<br />
71, 2007.<br />
Stawe H D, Wilson M <strong>and</strong> Goyer R A. Clinical <strong>and</strong><br />
morphological effects <strong>of</strong> oral cadmium toxicity<br />
in rabbits. Arch Pathol. 94: 389 - 405, 1972.<br />
Shukla Y, Arora A <strong>and</strong> Taneja P. Antimutagenic<br />
potential <strong>of</strong> curcumin on chromosomal<br />
aberrations in Wistar rats. Mutat Res. 515: 197-<br />
202, 2002.<br />
Vahter M, Bergl<strong>and</strong> M, Nermall B <strong>and</strong> Akesson A.<br />
Bioavailability <strong>of</strong> cadmium from shellfish <strong>and</strong><br />
mixed diet in women. Toxicol Appl Pharmacol.<br />
136: 332 -341, 1996.<br />
World Health Organization (WHO). Environmental<br />
Health Criteria 134. Cadmium International<br />
Programme on Chemical Safety (IPCS)<br />
Monograph, 2000.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 37-44, 2011 Research Article 37<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal<br />
herb<br />
Jeyaraj ANBURAJ *,1 , Chinnappan Ravinder SINGH 1 , Shenbagamoorthy SUNDARRAJ 2<br />
Soundarap<strong>and</strong>ian KANNAN 2<br />
1<br />
Ayya Nadar Janaki Ammal College, Department <strong>of</strong> Biotechnology, Sivakasi, India.<br />
2<br />
Bharathiar University, Proteomics <strong>and</strong> <strong>Molecular</strong> <strong>Cell</strong> Physiology Lab, Department <strong>of</strong> Zoology,<br />
Coimbatore, India.<br />
(* author for correspondence; geneanbu@yahoo.co.in)<br />
Received: 30 August 2010; Accepted: 26 May 2011<br />
Abstract<br />
Cleome viscosa is an important medicinal herb. Mass collection <strong>of</strong> the plant from natural habitats has led to<br />
its depletion. We have established a protocol for its mass propagation through in vitro organogenesis using<br />
leaf explants. For callus induction it was found that Indole-3acetic acid (2mg/l) has a significant effect on the<br />
callus induction, callus index <strong>and</strong> callus physical appearance. The moderate response was observed with<br />
Indole-3butyric acid (2mg/l), <strong>and</strong> a low response was observed with 2-Napthalene acetic acid (2mg/l). 2mg/l<br />
concentration <strong>of</strong> Benzyl aminopurine significantly influenced shoot proliferation. Optimum response was<br />
observed with Benzyl aminopurine + Kinetin (5+2.5mg/l), <strong>and</strong> low response was observed with Kinetin<br />
(1mg/l). About 91% <strong>of</strong> rooting response was observed with NAA (0.1mg/l). Moderate response was observed<br />
from Indole-3butyric acid (0.1mg/l) <strong>and</strong> low response observed from IAA (0.1mg/l). After two weeks <strong>of</strong><br />
acclimatization 90% <strong>of</strong> survival rate have been observed. The present study describes a well-documented <strong>and</strong><br />
reliable protocol for Cleome viscosa from leaf explants with a high rate <strong>of</strong> multiplication. This protocol could<br />
be used as a basic tool for commercial cultivation <strong>of</strong> this medicinally important plant Cleome viscosa.<br />
Keywords: Cleome viscosa, organogenesis, medicinal plants, in vitro regeneration, auxins<br />
Önemli bir tıbbi bitki olan Cleome viscosa’nın in vitro rejenerasyonu<br />
Özet<br />
Cleome viscosa önemli bir tıbbi bitkidir. Bitkinin doğal ortamından toplu halde toplanması tükenmesine<br />
sebep olmuştur. Yaprak eksplantları kullanarak in vitro organogenez ile toplu üretimini sağlayacak bir<br />
protokol oluşturduk. İndol- 3-asetik asitin (2mg/l) kallus oluşumunda, kallus indeksinde ve kallus fiziksel<br />
görünümünde önemli derecede etkili olduğu belirlenmiştir. İndol-3-butirik asitin (2mg/l) orta derecede, 2naptalen<br />
asetik asitin de (2mg/ml) düşük derecede etki gösterdiği belirlenmiştir. 2mg/ml konsantrasyonda<br />
benzil aminopürin ise filiz proliferasyonunu önemli derecede arttımıştır. Benzil aminopürin + Kinetin (5+2<br />
mg/l) ile optimum cevap, Kinetin (1mg/ml) ile de düşük dereceli cevap gözlemlenmiştir. İndol-3-bütirik<br />
asitin (0,1mg/l) orta derecede, İAA' nın ise düşük derecede cevaba sebep olduğu gözlemlenmiştir.<br />
İklimlendirmenin iki hafta sonrasında %90 hayatta kalma oranı gözlemlenmiştir. Bu çalışmada Cleome<br />
viscosa yaprak eksplantlarından yüksek or<strong>and</strong>a çoğaltım sağlayan güvenilir ve iyi belgelenmiş bir protokol<br />
tarif edilmektedir. Bu protokol tıbbi önemi olan bir bitki olan Cleome viscosa'nın ticari amaçlı kültürünün<br />
yapılabilmesi için temel bir araç olarak kullanılabilir.<br />
Anahtar Sözcükler: Cleome viscosa ,organogenez, tıbbi bitkiler, in vitro rejenerasyon, oksinler.
38 Jeyaraj ANBURAJ et al.<br />
Introduction<br />
Cleome viscosa Linn. (Capparidaceae) is<br />
commonly known as Tickweed, wild mustard or<br />
Spider plant (English), Hurhur (Hindi) <strong>and</strong><br />
Hurhuria (Bengali). It occurs in woodl<strong>and</strong> <strong>and</strong><br />
grassl<strong>and</strong>, <strong>and</strong> is a weed <strong>of</strong> fallow l<strong>and</strong>, fields,<br />
roadsides <strong>and</strong> wastel<strong>and</strong>, <strong>of</strong>ten occurring on s<strong>and</strong>y<br />
soils, but sometimes on calcareous <strong>and</strong> rocky soils.<br />
It is a widely distributed herb with yellow flowers<br />
<strong>and</strong> long slender pods containing seeds. The whole<br />
plant is sticky in nature <strong>and</strong> has a strong odour<br />
resembling asafoetida. It is found in both seasonal<br />
dry <strong>and</strong> humid conditions, from mean sea level up<br />
to an altitude <strong>of</strong> 1000 m. The seeds have no<br />
dormancy <strong>and</strong> germinate readily after shedding.<br />
Plants start flowering 3–4 weeks after germination<br />
<strong>and</strong> the lifecycle is about 3 months. Cleome viscosa<br />
Linn (Capparidaceae), also called “Dog mustard”,<br />
is a herb that grow up to 1m height in India<br />
(Parimala et al., 2004). Cleome is a large genus<br />
included in the Capparaceae family, which<br />
comprises 427 species occurring in tropical <strong>and</strong><br />
subtropical regions <strong>of</strong> the world (Brummit, 1992).<br />
In Asia <strong>and</strong> Africa the leaves <strong>and</strong> seeds are used<br />
as a rubefacient <strong>and</strong> vesicant <strong>and</strong> to treat infections,<br />
fever, rheumatism <strong>and</strong> headache. The whole herb is<br />
used in the treatment <strong>of</strong> ringworm, flatulence, colic,<br />
dyspepsia, constipation, cough, bronchitis, cardiac<br />
disorders (Kirtikar <strong>and</strong> Basu, 1975; Saxena et al.,<br />
2000). Leaves are used as the external application<br />
to inflammation <strong>of</strong> the middle ear <strong>and</strong> applied on<br />
wounds <strong>and</strong> ulcers (Chopra et al., 1986),<br />
hepatoprotective activity (Gupta <strong>and</strong> Dixit, 2009).<br />
Traditionally, this plant is used in various disorders<br />
such as diarrhoea, fever, inflammation, liver<br />
diseases, bronchitis, skin diseases, <strong>and</strong> malarial<br />
fever. Its juice is useful in piles, lumbago <strong>and</strong><br />
earache (Rukmini, 1978). The analgesic, antipyretic<br />
<strong>and</strong> anti-diarrhoeal activities <strong>of</strong> the extract have<br />
been reported by researchers. A decoction is used<br />
as an expectorant <strong>and</strong> digestive stimulant <strong>and</strong> the<br />
vapour from a steaming decoction <strong>of</strong> the whole<br />
plant is inhaled to treat headache (CSIR, 1950). The<br />
seeds <strong>and</strong> its oil have anti-helminthic properties but<br />
they are ineffective in treating roundworm<br />
infections (Saxena et al., 2000). They also have<br />
anti-convulsant effect in Swiss albino mice (Mishra<br />
et al., 2010). The root is a remedy for scurvy <strong>and</strong><br />
rheumatism (Rukmini, 1978). An aqueous seed<br />
extract displayed significant analgesic activity in<br />
mice <strong>and</strong> local anaesthetic activity in guinea pigs<br />
(Singh <strong>and</strong> West, 1991; Parimaladevi et al., 2003).<br />
In tests with rats, the anti-diarrhoeal (Devi et al.,<br />
2002) <strong>and</strong> anti-pyretic (Devi et al., 2003) activities<br />
<strong>of</strong> the extracts have been confirmed. Leaves <strong>and</strong><br />
young shoots are cooked as a vegetable<br />
(Man<strong>and</strong>har, 2002). It has a sharp mustard like<br />
flavor (Facciola, 1990). The pungent seed can be<br />
pickled or used as a mustard substitute in curries<br />
(Man<strong>and</strong>har, 2002; Facciola, 1990). The juice <strong>of</strong><br />
the plant is used as a condiment (Facciola, 1990).<br />
Oil obtained from the seeds is used for cooking<br />
(Man<strong>and</strong>har, 2002). All parts <strong>of</strong> the plant are used<br />
in liver diseases, chronic painful joints <strong>and</strong> mental<br />
disorders (Chatterjee <strong>and</strong> Pakrashi, 1991).<br />
The induction <strong>of</strong> callus growth <strong>and</strong> subsequent<br />
differentiation <strong>and</strong> organogenesis is accomplished<br />
by the differential application <strong>of</strong> growth regulators<br />
<strong>and</strong> the control conditions in the culture medium.<br />
With the stimulus <strong>of</strong> endogenous growth substances<br />
or by addition <strong>of</strong> exogenous growth regulators to<br />
the nutrient medium cell division, cell growth <strong>and</strong><br />
tissue differentiation are induced (Tripathi <strong>and</strong><br />
Tripathi 2003). Organogenesis permits the<br />
manipulation <strong>of</strong> large numbers <strong>of</strong> high quality plant<br />
material within a short period <strong>of</strong> time. The vast<br />
usage <strong>of</strong> the Cleome viscosa in medicinal purpose,<br />
based on the above reason, it is increasing<br />
commercial dem<strong>and</strong> <strong>of</strong> Cleome viscosa. The<br />
present study was undertaken to develop a more<br />
efficient protocol for rapid in vitro multiplication <strong>of</strong><br />
Cleome viscosa using leaf explants as an initial<br />
plant material.<br />
Materials <strong>and</strong> methods<br />
The plants were collected from in <strong>and</strong> around<br />
Virudhunagar district, Tamil Nadu, India (Figure<br />
1). Small young leaves were collected from healthy<br />
plants <strong>of</strong> Cleome viscosa L defoliated <strong>and</strong> sectioned<br />
into many segments. They were washed under<br />
continuous flashing <strong>of</strong> running tap water for 30<br />
minutes <strong>and</strong> then with distilled water three times.<br />
Leaves were treated with 0.1% mercury chloride<br />
for 1.5 minutes <strong>and</strong> washed with sterilized double<br />
distilled water for 3 times. The small washed<br />
explants were treated with 3% hydrogen peroxide<br />
for 1.5 minutes <strong>and</strong> then washed with sterilized<br />
double distilled water for 3 times. At final the<br />
explants were treated with 70% ethanol for 0.5<br />
minutes <strong>and</strong> then washed with sterilized double<br />
distilled water for 3 times in laminar air flow<br />
cabinet.
Figure 1. Natural habitat <strong>of</strong> Cleome<br />
(Linn.).<br />
Culture media <strong>and</strong> growth condition<br />
viscosa<br />
The medium comprised <strong>of</strong> macro <strong>and</strong><br />
micro<br />
elements according to Murashige <strong>and</strong> Skoog (1962)<br />
with myoinositol (100mg/l), thamine<br />
HCl<br />
(0.1mg/l), pyridoxine (0.5mg/l), nicotinic acid<br />
(0.5mg/l) <strong>and</strong> sucrose (30g/l), solidified with 0.8%<br />
agar. The plant growth regulators used were<br />
Kinetin (Kn), Indole-3butyric acid (IBA), Indole-<br />
3acetic acid (IAA), 2-Napthalene acetic acid<br />
(NAA) <strong>and</strong> Benzyl aminopurine (BAP). All<br />
experiments were carried out in culture tubes<br />
(25×150mm) containing 10ml <strong>of</strong> culture medium.<br />
The pH <strong>of</strong> the medium was adjusted to 5.8 prior to<br />
autoclaving at 121ºC for 20 minutes. Cultures were<br />
incubated under 16 hours/8 hours light/dark cycles.<br />
Callus induction <strong>and</strong> shoot regeneration<br />
The small segments <strong>of</strong> leaf explants were cultured<br />
on MS medium fortified with different<br />
concentration <strong>of</strong> auxins such as, IAA, NAA <strong>and</strong><br />
IBA ranging from 0.5 – 4.0mg/l for callus<br />
initiation. Explants were found to give pr<strong>of</strong>use<br />
callusing <strong>and</strong> when callusing was observed in entire<br />
explant, the callus was transferred to MS medium<br />
supplemented with various concentrations <strong>of</strong> BAP<br />
(0.5-4.0mg/l), Kinetin (0.5-4.0mg/l) <strong>and</strong> BAP (1.0-<br />
5.0mg/l) in combinations with Kinetin (0.5-<br />
2.5mg/l). All the cultures were maintained at 25 ± 2<br />
ºC for a photoperiod <strong>of</strong> 16h light per day. A total <strong>of</strong><br />
40 explants was used for each experiment <strong>and</strong> was<br />
repeated 5 times. Data on percent <strong>of</strong> response,<br />
number <strong>of</strong> shoots <strong>and</strong> shoot length formation per<br />
explant was recorded after 30 days <strong>of</strong> culture.<br />
Callus Growth Measurement<br />
In order to minimize the differences in growth that<br />
may have been the result <strong>of</strong> variation in inoculum<br />
Regeneration <strong>of</strong> Cleome viscosa 39<br />
size, a growth index was used to evaluate the callus<br />
growth after 30 days <strong>of</strong> culture. Dry weight <strong>of</strong> calli<br />
was evaluated by drying fresh calli in an air forced<br />
oven at 60ºC for 36 hrs. The growth index was<br />
determined according to the formula:<br />
Regeneration <strong>of</strong> roots <strong>and</strong> development <strong>of</strong> complete<br />
plantlets<br />
For rooting individual microshoots (1.5-2.5mm<br />
length) were isolated from callus clumps <strong>and</strong><br />
cultured on MS medium containing 0.1-1.0mg/l <strong>of</strong><br />
different auxins such as, IBA, IAA <strong>and</strong> NAA to<br />
induce <strong>of</strong> root formation. A total <strong>of</strong> 40 plantlets<br />
were taken for each experiment <strong>and</strong> were repeated<br />
5 times. Percent <strong>of</strong> rooting, number <strong>of</strong> root<br />
formations <strong>and</strong> root length was recorded 40 days<br />
after root initiation. All the rooted plants were<br />
carefully removed from culture tubes <strong>and</strong> washed<br />
in tap water to remove agar gels <strong>and</strong> transferred to<br />
plastic pots containing soil mixture (sterile soil,<br />
vermicompost <strong>and</strong> s<strong>and</strong>) in the ratio <strong>of</strong> 1:2:1. In<br />
vitro regenerated plants covered with polythene<br />
bags to maintain high humidity. These were<br />
acclimatized at 25 ± 3ºC less than 16/8 hours<br />
photoperiod <strong>and</strong> watered regularly. After 3 – 4<br />
weeks, the polythene bags were removed <strong>and</strong><br />
established plantlets were transplanted to earthen<br />
pots in a greenhouse.<br />
Statistical analysis<br />
All results reported are the means <strong>of</strong> five replicate.<br />
The result are expressed as mean values ± st<strong>and</strong>ard<br />
deviation (n=5). Data were statistically analyzed at<br />
P≤0.05 levels using one way analysis <strong>of</strong> variance<br />
(ANOVA). Mean comparisons were carried out by<br />
Duncan's multiple ran test was used as a post hoc<br />
analysis (SPSS package, Version 17).<br />
Results<br />
The fresh smaller size <strong>of</strong> explants provide less<br />
chance <strong>of</strong> contamination, as well as, longer leaves<br />
showed, total loss <strong>of</strong> morphogenic potential. 3%<br />
hydrogen peroxide, 0.1% mercuric chloride <strong>and</strong><br />
70% ethanol was used to sterilize the leaves.
40 Jeyaraj ANBURAJ et al.<br />
Surface <strong>of</strong> the leaves were sterilized with 0.1%<br />
mercuric chloride for 1.5minutes, 3% hydrogen<br />
peroxide for 1.5minutes <strong>and</strong> 70% ethanol for<br />
0.5minutes reported the maximum growth without<br />
contamination.<br />
Interactive effects <strong>of</strong> culture medium <strong>and</strong><br />
explant type were statistically significant (P≤0.05)<br />
for calli fresh weight, <strong>and</strong> calli growth index (Table<br />
1). Calli were initiated from leaf explants <strong>of</strong><br />
Cleome viscosa (Figure 2A&B). After two weeks<br />
<strong>of</strong> culture on MS medium fortified with different<br />
concentrations <strong>of</strong> auxins IBA (0.5-4 mg/l), NAA<br />
(0.5-4 mg/l) <strong>and</strong> IAA (0.5-4 mg/l). The highest<br />
mean for calli growth index, <strong>and</strong> calli fresh weight<br />
<strong>of</strong> leaf explant belonged to the MS culture medium,<br />
supplemented with 2mg/L IAA. Leaf explant was<br />
superior to the nodal explants regarding the growth<br />
index, <strong>and</strong> calli fresh weight. About 81% callusing<br />
response with maximum <strong>of</strong> 178±0.71mg (P≤0.05)<br />
fresh mass <strong>and</strong> calli growth index 2.3±0.07<br />
(P≤0.05) was observed. The optimum concentration<br />
<strong>of</strong> IBA (2mg/l) showed 70% callusing response<br />
with 122±0.54mg fresh mass was observed in leaf<br />
explants. Here IBA (2mg/l) was more effective<br />
callusing response <strong>and</strong> callus growth index<br />
compare with IBA (1mg/l) (P=0.526). Low<br />
callusing response (55%) with 107±0.57mg fresh<br />
mass was observed in leaf explants cultured on<br />
NAA (2mg/l) fortified medium (Figure 2C, D & E).<br />
The callus cultured on MS medium with 3.0%<br />
sucrose <strong>and</strong> 0.8% agar medium supplemented with<br />
hormones such as, BAP, KN <strong>and</strong> BAP+KN<br />
produced microshoots. High frequency (95%)<br />
multiple shoot induction with 7.6±0.54 (P≤0.05)<br />
number <strong>of</strong> shoots <strong>and</strong> an average length <strong>of</strong><br />
4.10±0.18cm shoots in MS medium supplemented<br />
with 2.0mg/l BAP. On the other h<strong>and</strong>, the callus<br />
cultured on cytokinin combination BAP <strong>and</strong> KN<br />
(5+2.5mg/l) containing medium promoted the<br />
microshoots. About 85% moderate shooting<br />
response with 7.2±0.83 number <strong>of</strong> shoots <strong>and</strong> an<br />
average length <strong>of</strong> 3.62±0.15cm shoots from leaf<br />
callus. Low frequency (69%) multiple shoot<br />
induction with 5.6±0.55 (P=0.149) number <strong>of</strong><br />
shoots <strong>and</strong> an average length <strong>of</strong> 3.15±0.28cm<br />
shoots in MS medium supplemented with 1.0mg/l<br />
Kn (Table 2, Figure 2F, G & H).<br />
The healthy shoots with two to three leaves<br />
were isolated from shoot clumps <strong>and</strong> cultured on<br />
root induction medium to induce adventitious<br />
rooting. MS medium fortified with different<br />
concentration <strong>of</strong> auxins IBA (0.1-1.0mg/l), NAA<br />
(0.1-1.0mg/l) <strong>and</strong> IAA (0.1-1.0mg/l). The<br />
individual plantlets cultured on MS medium<br />
supplemented with NAA (0.1mg/l) fortified<br />
medium induced high frequency (91%) rooting<br />
with 3.4±0.89 (P≤0.05) number <strong>of</strong> microroots <strong>and</strong><br />
an average length <strong>of</strong> 3.00±0.25cm roots. There is<br />
no significant compared with concentration <strong>of</strong><br />
0.2mg/l NAA (P=0.6). When cultured on the MS<br />
medium containing other hormones such as IBA<br />
(0.1mg/l) <strong>and</strong> IAA (0.1mg/l) both explants showed<br />
low response than 0.1mg/l <strong>of</strong> NAA (Table 3, Figure<br />
2 I). The healthy rooted plants were carefully<br />
removed from the culture tubes <strong>and</strong> washed in<br />
running tap water to remove agar gels <strong>and</strong><br />
transferred to plastic pots containing soil mixture.<br />
Finally, the regenerated plants were successfully<br />
transferred to earthen pot containing soils. Almost<br />
all (90%) the in vitro regenerated plants<br />
successfully survived in green house condition<br />
(Figure 2J, K, L & M).<br />
Figure 2. A) Callus initiation in Cleome viscosa<br />
from leaf explants in MS media containing 2mg/l<br />
IBA. B) Callus initiation in Cleome viscosa from<br />
leaf explants in MS media containing 2mg/l NAA.<br />
C) Callus induction in Cleome viscosa from leaf<br />
explants in MS media containing 2mg/l IAA. D)<br />
Kinetin MS media. H) Shoot regeneration from<br />
callus on BAP + KN (4+2mg/l) MS media. I)<br />
Rooting generation on 0.5mg/l IAA & NAA. J) In<br />
vitro regeneration <strong>of</strong> complete plantlets <strong>of</strong> Cleome<br />
viscosa from leaf explants. K) Plants growing in<br />
Callus induction in Cleome viscosa from leaf<br />
explants in MS media containing 2mg/l NAA. E)<br />
Callus induction in Cleome viscosa from leaf<br />
explants in MS media containing 2mg/l IBA. F)<br />
Shoot regeneration from callus on 2mg/l BAP MS<br />
media. G) Shoot regeneration from callus on 2mg/l<br />
earthen pots containing soil under green house<br />
condition.
Regeneration <strong>of</strong> Cleome viscosa 41<br />
Table 1. Effects <strong>of</strong> different concentration <strong>of</strong> auxins on callus growth index from leaf <strong>of</strong> Cleome viscosa after<br />
30days.<br />
Growth regulators Callusing Callus growth Callus growth<br />
Callus<br />
(mg/l)<br />
IAA<br />
response % (mg fresh mass) index (Mean ±SE) morphology<br />
0.5 60 129±0.83a 1.2±0.09ac Green nodular calli<br />
1 65 140±0.89a 1.4±0.09b Green nodular calli<br />
2 81 178±0.71a 2.3±0.07abc Green nodular calli<br />
3 80 156±0.55a 1.8±0.07ab Green nodular calli<br />
4<br />
IBA<br />
75 147±0.45a 1.6±0.09c Green nodular calli<br />
0.5 65 114±0.84ab 1.3±0.05a White green compact calli<br />
1 60 109±0.71b 1.2±0.03b White green compact calli<br />
2 70 122±0.54a 1.6±0.04c White green compact calli<br />
3 60 110±0.57ab 1.2±0.04abc White green compact calli<br />
4<br />
NAA<br />
60 80±0.99ab 1.0±0.03abc White green compact calli<br />
0.5 45 100±0.45a 1.4±0.02a White yellow friable calli<br />
1 50 103±0.83a 1.8±0.11ab White yellow friable calli<br />
2 55 107±0.57a 2.1±0.12ab White yellow friable calli<br />
3 40 84±0.55a 1.4±0.05b White yellow friable calli<br />
4 15 39±0.89a 1.0±0.06ab White yellow friable calli<br />
Values followed by the same letter within each column are not significantly different.<br />
Table 2. Effects <strong>of</strong> different concentration <strong>of</strong> cytokinins <strong>and</strong> cytokinins combinations on multiple shoot<br />
induction from leaf <strong>of</strong> Cleome viscosa.<br />
Growth regulators Callusing<br />
Number <strong>of</strong><br />
Shoot length<br />
(mg/l)<br />
Bap<br />
response % total shoots)<br />
(cm)<br />
0.5 60<br />
5.4±0.54ac<br />
3.50±0.24a<br />
1 80<br />
6.2±0.83bd<br />
3.60±0.16b<br />
2 95<br />
7.6±0.54ac<br />
4.10±0.18abc<br />
3 55<br />
2.6±0.89ab<br />
3.20±0.25c<br />
4 50<br />
2.2±0.45cd<br />
3.10±0.18b<br />
Kn<br />
Bap+Kn<br />
0.5<br />
1<br />
2<br />
3<br />
4<br />
60<br />
69<br />
54<br />
45<br />
40<br />
5.2±0.45a<br />
5.6±0.55b<br />
5.1±0.84c<br />
4.8±0.95d<br />
4.2±0.84e<br />
2.85±0.21a<br />
3.15±0.28b<br />
3.08±0.15c<br />
3.20±0.25d<br />
3.00±0.13e<br />
0.5<br />
1<br />
2<br />
3<br />
4<br />
60<br />
45<br />
75<br />
80<br />
85<br />
5.4±0.89a<br />
4.2±0.84bc<br />
6.0±0.71c<br />
4.4±0.89d<br />
7.2±0.83abd<br />
2.95±0.31a<br />
2.63±0.18b<br />
3.25±0.15bc<br />
2.80±0.14c<br />
3.62±0.15abc<br />
Values followed by the same letter within each column are not significantly different.
42 Jeyaraj ANBURAJ et al.<br />
Table 3. Effects <strong>of</strong> different concentration <strong>of</strong> auxins on efficient rooting from shooted callus <strong>of</strong> Cleome<br />
viscosa.<br />
Growth regulators<br />
(mg/l)<br />
NAA<br />
0.1<br />
0.2<br />
0.5<br />
1<br />
IBA<br />
IAA<br />
0.1<br />
0.2<br />
0.5<br />
1<br />
0.1<br />
0.2<br />
0.5<br />
1<br />
Callusing<br />
response %<br />
91<br />
80<br />
55<br />
40<br />
85<br />
70<br />
40<br />
35<br />
65<br />
40<br />
35<br />
25<br />
Number <strong>of</strong><br />
total shoots)<br />
3.4±0.89ac<br />
3.2±0.45bd<br />
2.6±0.89ab<br />
2.4±0.54cd<br />
3.2±0.83a<br />
3.0±0.71b<br />
2.2±0.84ab<br />
1.6±0.54ab<br />
2.8±0.84ab<br />
1.6±0.89a<br />
1.4±0.55b<br />
1.2±0.44a<br />
Values followed by the same letter within each column are not significantly different<br />
Discussion<br />
The fresh smaller size <strong>of</strong> explants provide less<br />
chance <strong>of</strong> contamination, longer leaves showed a<br />
total loss <strong>of</strong> morphogenic potential as well. A<br />
similar report has been published in Rauvolfia<br />
serpentine by Singh et al. (2009) who reported that<br />
shoot regeneration from small leaf explants <strong>of</strong><br />
Rauvolfia serpentine L. The surface sterilization <strong>of</strong><br />
explants is very essential for establishment, as well<br />
as for optimum induction <strong>of</strong> callus <strong>and</strong> plantlet<br />
regeneration in vitro condition (Yeoman <strong>and</strong><br />
Macleod, 1977). In the present study 3% hydrogen<br />
peroxide, 0.1% mercuric chloride <strong>and</strong> 70% ethanol<br />
was used to sterilize the leaves, resulted the<br />
maximum growth without contamination.<br />
Similarly, Sairkar et al. (2009) reported that the<br />
cultured explants showed more than 80%<br />
contamination free cultures when treated with 0.1%<br />
HgCl2 for surface sterilization.<br />
The MS medium was the most effective for<br />
callusing <strong>of</strong> leaf explants. The explants cultured on<br />
MS medium supplemented with different auxins <strong>of</strong><br />
IBA, NAA <strong>and</strong> IAA showed varied response for<br />
callusing. Among three types <strong>of</strong> auxins, IBA <strong>and</strong><br />
IAA were previously found to be very effective<br />
(Singh et al., 2009). However, in the present<br />
Shoot length<br />
(cm)<br />
3.00±0.25abc<br />
2.50±0.28a<br />
2.45±0.23b<br />
2.30±0.23c<br />
2.10±0.23ac<br />
1.85±0.41b<br />
1.80±0.19a<br />
1.53±0.18bc<br />
2.00±0.18ac<br />
1.85±0.12b<br />
1.65±0.16a<br />
1.50±0.20bc<br />
investigation calli were initiated from leaf explants<br />
<strong>of</strong> Cleome after two weeks <strong>of</strong> culture on MS<br />
medium fortified with different auxins IBA (0.5-4<br />
mg/l), NAA (0.5-4 mg/l) <strong>and</strong> IAA (0.5-4 mg/l).<br />
About 81% callusing response with maximum <strong>of</strong><br />
178mg fresh mass was observed in leaf explants<br />
cultured on MS medium supplemented with IAA<br />
(2mg/l).<br />
In this present research that the callus cultured<br />
on MS medium, hormones such as BAP, KN <strong>and</strong><br />
BAP+KN produced microshoots. High frequency<br />
(95%) multiple shoot induction with 7.6±0.54<br />
number <strong>of</strong> shoots <strong>and</strong> an average length <strong>of</strong><br />
4.10±0.18 shoots in MS medium supplemented<br />
with 2.0mg/l BAP, was observed. Similarly, the<br />
two cytokinins used BAP induced significantly<br />
higher percentage <strong>of</strong> shoot initiation <strong>and</strong> mean<br />
number <strong>of</strong> shoot, whereas higher mean shoot length<br />
was obtained in the shoots obtained on media<br />
supplement with KN (Gokhale <strong>and</strong> Bansal 2009).<br />
The healthy shoots were isolated from shoot<br />
clumps <strong>and</strong> cultured on root induction medium to<br />
induce adventitious rooting. MS medium was<br />
fortified with different concentrations <strong>of</strong> auxins<br />
IBA (0.1-1.0mg/l), NAA (0.1-1.0mg/l) <strong>and</strong> IAA
(0.1-1.0mg/l). The individual plantlets cultured on<br />
MS medium supplemented with NAA (0.1mg/l)<br />
fortified medium induced high frequency (91%)<br />
rooting with 3.4±0.89 number <strong>of</strong> microroots <strong>and</strong> an<br />
average length <strong>of</strong> 3.00±0.25 roots. When cultured<br />
on the MS medium containing other hormones such<br />
as IBA (0.1mg/l) <strong>and</strong> IAA (0.1mg/l), both explants<br />
showed lower response than that <strong>of</strong> 0.1mg/l <strong>of</strong><br />
NAA. A similar report has been published by Amin<br />
et al, (2003), who reported the root formation was<br />
induced in in vitro regenerated shoots by culturing<br />
them on half strength <strong>of</strong> MS medium with 0.1-<br />
1.0mg/l either <strong>of</strong> NAA, IBA <strong>and</strong> IAA. Among three<br />
types <strong>of</strong> auxins, NAA was found to be most<br />
effective at different concentrations tested for root<br />
production. The findings are in agreement with<br />
those observed in other plant species. Although<br />
Gokhale <strong>and</strong> Bansal (2009) reported that the three<br />
auxins (IAA, IBA, NAA) induced roots in in vitro<br />
raised shoots <strong>of</strong> O. indicum, yet NAA responded<br />
best for all parameters <strong>of</strong> rooting. For shoots with<br />
highest percentage <strong>of</strong> root induction, maximum<br />
number <strong>of</strong> elongated roots was developed on MS<br />
medium containing NAA. Long, branched healthy<br />
roots were produced in this rooting media.<br />
The in vitro derived plants acclimated better<br />
under ex vitro conditions when they were<br />
transferred on specially made plastic trays<br />
containing coco-peat as potting mix <strong>and</strong> moistened<br />
uniformly at periodic intervals taking special care<br />
not to damage the roots. The rest <strong>of</strong> the procedure,<br />
followed from this stage up to their establishment<br />
in soil was as usual (Amin et al., 2003). In the<br />
present investigation the healthy rooted plants were<br />
carefully removed from the culture tubes <strong>and</strong><br />
washed in running tap water to remove agar gels<br />
<strong>and</strong> transferred to plastic pots containing soil<br />
mixture. Finally, the regenerated plants were<br />
successfully transferred to earthen pot containing<br />
soils. Almost all (90%) the in vitro regenerated<br />
plants successfully survived at green house<br />
conditions. Similarly, the success <strong>of</strong> transplantation<br />
was 85% when plantlets were sufficiently healthy<br />
with new growth.They were subsequently<br />
transferred to larger pots <strong>and</strong> gradually acclimated<br />
to outdoor conditions. The protocol reported here is<br />
reproducible, it has a potential for being utilized to<br />
conserve the germplasm <strong>and</strong> allowing at the same<br />
time, a large scale micropropagation <strong>of</strong> this<br />
important medicinal plants (Jeyakumar <strong>and</strong><br />
Jayabalan, 2002).<br />
In conclusion, a significant progress has been<br />
made in the in vitro regeneration system <strong>of</strong> this<br />
Regeneration <strong>of</strong> Cleome viscosa 43<br />
medicinally important Cleome viscosa. Using this<br />
technique, it is possible to produce healthy <strong>and</strong><br />
disease free clones which could be released to their<br />
natural habitat in large scale. It may also be useful<br />
for gene manipulation for this important medicinal<br />
species.<br />
Acknowledgements<br />
I am extremely grateful to Dr. M. Vimala Devi, the<br />
head at Department <strong>of</strong> Biotechnology, Ayya Nadar<br />
Janaki Ammal College, Sivakasi, India for his<br />
stimulating guidance, invaluable suggestions <strong>and</strong><br />
critical <strong>and</strong> persistent encouragement. I wish to<br />
thank Mr. Ga. Bakavathiappan <strong>and</strong> Mr. M. Pavaraj,<br />
for helping me to carry out my project work in<br />
Ayya Nadar Janaki Ammal College, Sivakasi,<br />
India.<br />
References<br />
Amin MN, Rahman MM, Manik MS. In vitro<br />
clonal propagation <strong>of</strong> Paederia foetida L.- A<br />
medicinal plant <strong>of</strong> Bangaladesh. Plant tissue<br />
Cult. 13:117-123, 2003.<br />
Brummit RK. Vascular plants families <strong>and</strong> genera.<br />
Kew: Royal Botanic Gardens; 1992.<br />
Chatterjee A, Pakrashi SC. The Treatise on Indian<br />
Medicinal Plants. <strong>Vol</strong>.1, PID, CSIR, New<br />
Delhi, P.215, 1991.<br />
Chopra RN, Nayar SL, Chopra IC. Glossary <strong>of</strong><br />
Indian Medicinal Plants. Council <strong>of</strong> Scientific<br />
<strong>and</strong> Industrial Research, New Delhi, 1986.<br />
CSIR, The wealth <strong>of</strong> India: A dictionary <strong>of</strong> Indian<br />
raw materials <strong>and</strong> industrial products raw<br />
materials. Council <strong>of</strong> Scientific <strong>and</strong> Industrial<br />
Research, New Delhi, India, <strong>Vol</strong>. 2, pp 427,<br />
1950.<br />
Devi BP, Boominathan R, M<strong>and</strong>al SC. Evaluation<br />
<strong>of</strong> anti-diarrheal activity <strong>of</strong> Cleome viscosa L.<br />
extract in rats. Phytomedicine. 9: 739–742,<br />
2002.<br />
Devi BP, Boominathan R, M<strong>and</strong>al SC. Evaluation<br />
<strong>of</strong> antipyretic potential <strong>of</strong> Cleome viscosa<br />
Linn. (Capparidaceae) extract in rats. <strong>Journal</strong><br />
<strong>of</strong> Ethnopharmacology. 87: 11–13, 2003.<br />
Facciola S. Cornucopia- A source Book <strong>of</strong> Edible<br />
Plants. Kampong Publications, ISBN 0-<br />
9628087-0-9, 1990.
44 Jeyaraj ANBURAJ et al.<br />
Gokhale M, Bansal YK. Direct In vitro<br />
regeneration <strong>of</strong> a medicinal tree Oroxylum<br />
indicum (L.) Vent. through tissue culture.<br />
African <strong>Journal</strong> <strong>of</strong> Biotechnology. 8: 3777-<br />
3781, 2009.<br />
Gupta NK, Dixit VK. Evaluation <strong>of</strong><br />
hepatoprotective activity <strong>of</strong> Cleome viscose<br />
Linn. extract. Indian J Pharmacol. 41: 36-40,<br />
2009<br />
Jeyakumar M, Jeyabalan N. In vitro plant<br />
regeneration from cotyledonary node <strong>of</strong><br />
Psoralea corylifolia L. Plant Tissue Cult.<br />
12:125-129, 2002.<br />
Kirtikar KR, Basu BD. Indian medicinal plants. 2nd<br />
ed. <strong>Vol</strong>. 1. Periodical Experts, New Delhi: p.<br />
183-5, 1975.<br />
Man<strong>and</strong>har NP. Plants <strong>and</strong> people <strong>of</strong> Nepal.<br />
Timber Press. Oregon. ISBN 0-88192-527-6,<br />
2002.<br />
Mishra A, Mishra AK, Jain SK. Anticonvulsant<br />
activity <strong>of</strong> cleome viscosa seed extracts in<br />
Swiss albino mice. International <strong>Journal</strong> <strong>of</strong><br />
Pharmacy <strong>and</strong> Pharmaceutical Sciences. 2:<br />
177-181, 2010.<br />
Murashige T, Skoog F. A revised medium for rapid<br />
growth <strong>and</strong> bioassays with tobacco tissue<br />
cultures. Plant Physiol. 15:473-497, 1962.<br />
Parimala DB, Boominathan R, M<strong>and</strong>al SC. Studies<br />
on psychopharmacological effects <strong>of</strong> Cleome<br />
viscosa Linn. Extracts in rats <strong>and</strong> mice.<br />
Phytotherapy Research. 18:169-172, 2004.<br />
Parimaladevi B, Boominathan R, M<strong>and</strong>al SC.<br />
Studies on analgesic activity <strong>of</strong> Cleome<br />
viscosa in mice. Fitoterapia. 74: 262–266,<br />
2003.<br />
Rukmini C. Chemical, nutritional <strong>and</strong> toxicological<br />
evaluation <strong>of</strong> the seed oil <strong>of</strong> Cleome viscose.<br />
Indian <strong>Journal</strong> <strong>of</strong> Medical Research. 67: 604–<br />
607, 1978.<br />
Sairkar P, Ch<strong>and</strong>ravanshi MK, Shukla NP,<br />
Mehrotra NN. Mass production <strong>of</strong> an<br />
economically important medicinal plant<br />
Stevia rebaudiana using in vitro propagation<br />
techniques. <strong>Journal</strong> <strong>of</strong> Medicinal Plant<br />
Research. 3:266-270, 2009.<br />
Saxena BR, Koli MC, Saxena RC. Preliminary<br />
ethnomedical <strong>and</strong> phytochemical study <strong>of</strong><br />
Cleome viscosa L. Ethnobotany. 12: 47–50,<br />
2000.<br />
Singh P, Singh A, Shukla AK, Singh L, P<strong>and</strong>e V,<br />
Nailwal TK. Somatic embryogenesis <strong>and</strong> in<br />
vitro regeneration <strong>of</strong> an endangered medicinal<br />
plant Sarpag<strong>and</strong>ha(Rauvolfia serpentiana L.).<br />
Life Science <strong>Journal</strong>. 6:57-62, 2009.<br />
Singh PDA, West ME. Pharmacological<br />
investigations <strong>of</strong> sticky viscome extract<br />
(Cleome viscosa L.) in rats, mice <strong>and</strong> guineapigs.<br />
Phytotherapy Research. 5: 82–84, 1991.<br />
Tripathi L, Tripathi JN. Role <strong>of</strong> biotechnology in<br />
medicinal plants. Tropical <strong>Journal</strong> <strong>of</strong><br />
Pharmaceutical Research. 2:243-253, 2003.<br />
Yeoman MM, Macleod AJ. Tissue (callus) culture<br />
technique. Plant tissue <strong>and</strong> cell culture. 1:31-<br />
59, 1977.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 45-52, 2011 Research Article 45<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Bio-database compression using enhanced suffix array for pairwise<br />
sequence alignment<br />
Arumugam KUNTHAVAI *1 <strong>and</strong> Somasundaram VASANTHA RATHNA 2<br />
1 Department <strong>of</strong> CSE/IT, Coimbatore Institute <strong>of</strong> Technology, Coimbatore, Tamilnadu, India<br />
2 Department <strong>of</strong> EEE, Coimbatore Institute <strong>of</strong> Technology, Coimbatore, Tamilnadu, India<br />
(* author for correspondence; kunthavai@cit.edu.in)<br />
Received: 19 February 2011; Accepted: 10 June 2011<br />
Abstract<br />
Sequence alignment is a bioinformatics application that determines the degree <strong>of</strong> similarity between<br />
nucleotide or amino acid sequences which is assumed to have same ancestral relationships. This sequence<br />
alignment method reads query sequence from the user <strong>and</strong> makes an alignment against large <strong>and</strong> genomic<br />
sequence data sets <strong>and</strong> locate targets that are similar to an input query sequence. Traditional accurate<br />
algorithm, such as Smith-Waterman <strong>and</strong> FASTA are computationally very expensive, which limits their use<br />
in practice. The current set <strong>of</strong> popular search tools, such as BLAST <strong>and</strong> WU-BLAST, employ heuristics to<br />
improve the speed <strong>of</strong> such searches. However, such heuristics can sometimes miss targets, in which many<br />
cases are undesirable. This paper provides BioDB Compression Tool using enhanced suffix array, to perform<br />
accurate <strong>and</strong> faster biological sequence analysis as an improvement on the computation time <strong>of</strong> existing tools<br />
in this area using data base compression. The main idea is to pick matched patterns <strong>of</strong> the query sequence <strong>and</strong><br />
identify sequences in the database which share a large number <strong>of</strong> these matched patterns, thereby<br />
compressing the size <strong>of</strong> the database to very few sequences. Experiment results are cross validated using data<br />
mining technique. This shows that a new BioDB Compression developed effectively compresses the database<br />
<strong>and</strong> obtains very similar results compared to that traditional algorithm in approximately half the time taken<br />
by them.<br />
Keywords: Sequence alignment, enhanced suffix array, compression, local alignment, data mining<br />
Çiftli dizi sıralaması için kuvvetlendirilmiş sonek dizilişi kullanarak biyo-veritabanı<br />
sıkıştırması<br />
Özet<br />
Dizi sıralaması aynı atasal ilişkiye sahip olduğu tahmin edilen nükleotid ve amino asit dizisi arasında<br />
benzerlik derecesini tayin eden bir biyoenformatik uygulamadır. Dizi sıralama metodu kullanıcıdan sorgu<br />
dizisini okur, büyük ve genomik dizi veri setlerine karşı sıralama yapar ve giriş sorgu dizisine benzer olan<br />
hedefleri yerleştirir. Smith-Waterman ve FASTA gibi geleneksel güvenilir algoritmaların çok pahalı olması<br />
pratik olarak kullanımlarını kısıtlar. BLAST ve WU-BLAST gibi güncel popüler araştırma araç setleri bu tür<br />
araştırmaların hızını geliştirmek için buluşsal yöntemler kullanırlar. Ancak, bu tür buluşsal yöntemlerin çoğu<br />
istenmeyen durumlarda bazen hedefleri kaçırabilir. Bu yayın bu al<strong>and</strong>a var olan araçların hesaplama<br />
zamanını geliştirmek amaçlı kesin ve daha hızlı biyolojik dizi analizi yapmak üzere kuvvetlendirilmiş sonek<br />
dizilişi kullanarak BioDB Sıkıştırma Aracını sunar. Ana fikir sorgu dizisinin eşleşen paternlerini seçmek ve<br />
veri tabanında büyük sayıda eşleşen paterni paylaşan dizileri tayin ederek veri tabanı büyüklüğünü çok az<br />
sayıda diziye sıkıştırmaktır. Deneysel sonuçlar veri madenciliği tekniği kullanılarak çapraz onaylanmıştır. Bu<br />
da yeni geliştirilen BioDB Sıkıştırmanın veritabanını efektif olarak sıkıştırdığını ve klasik algoritmalarla<br />
karşılaştırıldığında yarı zam<strong>and</strong>a çok benzer sonuçlar elde edildiğini gösterir.<br />
Anahtar Sözcükler: Dizi sıralaması, kuvvetlendirilmiş sonek dizilişi, sıkıştırma, veri madenciliği
46 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />
Introduction<br />
Bioinformatics is the field <strong>of</strong> analyzing the<br />
biological information using computers <strong>and</strong><br />
statistical techniques; the science <strong>of</strong> developing <strong>and</strong><br />
utilizing computer databases <strong>and</strong> algorithms to<br />
accelerate <strong>and</strong> enhance biological research. The<br />
primary goal <strong>of</strong> bioinformatics is to increase the<br />
underst<strong>and</strong>ing <strong>of</strong> biological processes. Common<br />
activities <strong>of</strong> bioinformatics include mapping <strong>and</strong><br />
analyzing DNA <strong>and</strong> protein sequences, aligning<br />
different DNA <strong>and</strong> protein sequences to compare<br />
them <strong>and</strong> creating <strong>and</strong> viewing 3-D models <strong>of</strong><br />
protein structures. It has been successfully applied to<br />
predict the function, structure <strong>and</strong> evolution <strong>of</strong><br />
biological sequences. It can reveal biological<br />
relationship among organisms, for example, finding<br />
evolutionary information, determining causes <strong>and</strong><br />
cures <strong>of</strong> diseases.<br />
Sequence comparison is a basic operation <strong>of</strong> the<br />
sequencing problem. Sequences can be aligned<br />
across their entire length (global alignment) or only<br />
in certain regions (local alignment). Local sequence<br />
alignment plays a major role in the analysis <strong>of</strong> DNA<br />
<strong>and</strong> protein sequences (GusFeild, 1997). This paper<br />
describes the pair wise local alignment, which is the<br />
basic step for many other applications like detecting<br />
homology, finding protein structure <strong>and</strong> function,<br />
deciphering evolutionary relationships, etc. Smith<br />
Waterman developed a dynamic programming<br />
approach to sequence alignment problem that is<br />
widely used (Smith <strong>and</strong> Waterman, 1999). BLAST<br />
(Altschul et al., 1990), FASTA (Pearson, 2000), WU-<br />
BLAST (blast.wustl.edu) <strong>and</strong> (Matthew et al., 2003)<br />
is two commonly used programs for similarity<br />
searching on biological sequences. The methods<br />
widely used are based on heuristic paradigms <strong>and</strong><br />
have relatively a fast execution time, they do not<br />
produce optimal alignments sought by entirely<br />
sequenced. This reality presents the need for<br />
comparing long DNA or protein sequences, which is<br />
a challenging task due to its high dem<strong>and</strong>s for<br />
computational requirements (power <strong>and</strong> memory).<br />
One important feature <strong>of</strong> BLAST is its ability to<br />
compare a query with a database <strong>of</strong> sequences.<br />
Considering the rapid growth <strong>of</strong> database sizes, this<br />
problem dem<strong>and</strong>s ever-growing computation<br />
resources, <strong>and</strong> remains as a computational challenge.<br />
Divya in Sequence Comparison Tool - SCT (Divya<br />
et al., 2006) developed sequence similarity in a<br />
database instead <strong>of</strong> pair wise sequence alignment.<br />
This tool preprocesses the database to create a<br />
special generalized suffix tree from the sequences in<br />
the database. The suffix tree (Divya et al., 2006) is<br />
one <strong>of</strong> the most important data structures in string<br />
processing <strong>and</strong> comparative genomic. The space<br />
consumption <strong>of</strong> the suffix tree is a bottleneck in<br />
large-scale applications such as genome analysis. To<br />
overcome this bottleneck, in this paper suffix tree is<br />
replaced with suffix arrays enhanced with the Lcptable.<br />
Every algorithm that uses a suffix tree as data<br />
structure can systematically be replaced with an<br />
algorithm that uses an enhanced suffix array<br />
(Abouelhoda et al., 2004) <strong>and</strong> solves the same<br />
problem in the same time complexity but with<br />
improved space complexity. The generic name<br />
enhanced suffix array (Manber <strong>and</strong> Myers, 1993)<br />
st<strong>and</strong>s for data structures consisting <strong>of</strong> the basic<br />
suffix array enhanced with additional tables.<br />
Generalized suffix array (GSArray) is formed for<br />
the query sequence <strong>and</strong> longest common<br />
subsequence (LCS) is obtained <strong>and</strong> is compared<br />
against the database; sequences, which consist <strong>of</strong><br />
LCS, are identified from the database. Sequences are<br />
ranked with respect to the number <strong>of</strong> significant<br />
patterns they share with the query sequence. Finally<br />
database is compressed by selecting only a given<br />
number <strong>of</strong> sequences with topmost ranks.<br />
Materials <strong>and</strong> methods<br />
Let S be a string <strong>of</strong> length ‘n’ over an ordered<br />
alphabet ∑. It is assumed that the size <strong>of</strong> the alphabet<br />
is a constant, <strong>and</strong> i.e. n < 232.The latter implies that<br />
an integer in the range [0: n] can be stored in 4 bytes<br />
<strong>and</strong> also assumed that the special symbol $ is an<br />
element <strong>of</strong> ∑ (which is larger than all other<br />
elements) but does not occur in S. S[i] denotes the<br />
character at position i in S, for 0 ≤ i < n. For i ≤ j, S<br />
[i...j] denotes the substring <strong>of</strong> S starting with the<br />
character at position i <strong>and</strong> ending with the character<br />
at position j. The substring S [i...j] is also denoted by<br />
the pair <strong>of</strong> positions (i, j).<br />
Suffix Tree: A suffix tree for the string S is a<br />
rooted directed tree with exactly n+1 leaves<br />
numbered 0 to n. Each internal node, other than the<br />
root, has at least two children <strong>and</strong> each edge is<br />
labeled with a nonempty sub string <strong>of</strong> S$. No two<br />
edges out <strong>of</strong> a node can have edge-labels beginning<br />
with the same character. The key feature <strong>of</strong> the suffix<br />
tree is that for any leaf i, the concatenation <strong>of</strong> the<br />
edge-labels on the path from the root to leaf i exactly<br />
spells out the string Si, where Si = S [i...n – 1]
denotes the ith nonempty suffix <strong>of</strong> the string S$, 0 ≤ i<br />
< n. The space <strong>and</strong> time complexity <strong>of</strong> this suffix<br />
tree is O (n). Consider the suffix tree as an example<br />
shown in Figure 1 for the string S = acaaacatat.<br />
Using the suffix tree <strong>of</strong> S1 # S2, MUMs(Maximum<br />
Unique Match) (Delcher et al., 1999) can be<br />
computed in O (n) time <strong>and</strong> space, where n = [S1 #<br />
S2] <strong>and</strong> # is a symbol neither occurring in S1 nor in<br />
S2.<br />
However, the space consumption <strong>of</strong> the suffix tree<br />
is a major problem when comparing large genomes.<br />
Figure 1. The suffix tree for S = acaaacatat.<br />
Suffix array<br />
Suffix array is designed for efficient searching <strong>of</strong> a<br />
large text. It requires only 4n bytes (4 bytes per<br />
input character) in its basic form. Searching a text<br />
can be performed by binary search using the suffix<br />
array. Suffix trees can be constructed in O (n) time<br />
in the worst case, versus O (nlogn) time for suffix<br />
arrays. Suffix arrays will prove to be better than<br />
suffix trees for many applications. The suffix array<br />
(denoted by suftab) <strong>of</strong> the string S is an array <strong>of</strong><br />
integers in the range 0 to n, specifying the<br />
lexicographic ordering <strong>of</strong> the n + 1 suffixes <strong>of</strong> the<br />
string S$. That is, S (suftab [0]), S (suftab [1] … S<br />
(suftab[n]) is the sequence <strong>of</strong> suffixes <strong>of</strong> S$ in<br />
ascending lexicographic order as shown in Table 1.<br />
Suffix array generation<br />
Creating suffix array requires time O (nlogn) <strong>and</strong><br />
searching for a pattern in it requires time O<br />
(nlogm), where n is the length <strong>of</strong> the pattern <strong>and</strong> m<br />
is the length <strong>of</strong> the string. In (Abouelhoda et al.,<br />
2002), the authors provides a systematic way <strong>of</strong><br />
replacing string processing algorithm based on a<br />
bottom-up traversal <strong>of</strong> a suffix tree by a<br />
corresponding algorithm that is based on an<br />
enhanced suffix array. The advantages <strong>of</strong> this<br />
approach are better search, more space efficient<br />
Bio-database compression using enhanced suffix array 47<br />
than suffix tree since the implementation <strong>of</strong> the<br />
enhanced suffix array requires only 5n bytes <strong>and</strong><br />
the running times <strong>of</strong> the algorithms are much better<br />
than those based on the suffix tree <strong>and</strong> the<br />
algorithm is easier to implement on enhanced suffix<br />
arrays than on suffix trees.<br />
Table 1. The Lcp-interval table <strong>of</strong> S = acaaacatat$<br />
s.no Suftab Lcptab S(suftab[i])<br />
0 2 0 aaacatat$<br />
1 3 2 aacatat$<br />
2 0 1 acaaacatat$<br />
3 4 3 acatat$<br />
4 6 1 atat$<br />
5 8 2 at$<br />
6 1 0 caaacatat$<br />
7 5 2 catat$<br />
8 7 0 tat$<br />
9 9 1 t$<br />
10 10 0 $<br />
A pair <strong>of</strong> substrings R = ((i1, j1); (i2, j2)) is a<br />
repeated pair if <strong>and</strong> only if = ((i1, j1) ≠ (i2, j2)) <strong>and</strong><br />
S [(i1… j1)] = S [(i2 …j2)]. The length <strong>of</strong> R is j1 -<br />
i1+1. A repeated ((i1, j1); (i2, j2)) is called left<br />
maximal if S[i1 ─ 1] ≠ S[i2 ─ 1] <strong>and</strong> right maximal<br />
if S[j1 ─ 1] ≠ S[j2 ─ 1]. A repeated pair is called<br />
maximal if it is left <strong>and</strong> right maximal. A substring<br />
ω <strong>of</strong> S is a (maximal) repeat if there is a (maximal)<br />
repeated pair ((i1, j1); (i2, j2)) such that ω = S<br />
[i1...j1]. A super maximal repeat is a maximal<br />
repeat that never occurs as a substring <strong>of</strong> any other<br />
maximal<br />
repeat.<br />
The suffix array suftab is an array <strong>of</strong> integers in<br />
the range 0 to n, specifying the lexicographic<br />
ordering <strong>of</strong> the n+1 suffixes <strong>of</strong> the string S$. That<br />
is, Ssuftab [0]; Ssuftab [1] … Ssuftab[n] is the sequence<br />
<strong>of</strong> suffixes <strong>of</strong> S$ in ascending lexicographic order,<br />
where Si = S [i ... n -1 $ denotes the ith nonempty<br />
suffix <strong>of</strong> the string S$ , 0 ≤ i ≤ n. The suffix array<br />
requires<br />
4n bytes.<br />
The Lcp-interval table Lcptab is an array <strong>of</strong><br />
integers in the range 0 to n <strong>and</strong> Lcptab [0] = 0<br />
shown table 1. Lcptab[i] is the length <strong>of</strong> the longest<br />
common prefix <strong>of</strong> Ssuftab [i−1] <strong>and</strong> Ssuftab[i], for 1 ≤<br />
i ≤ n. Since Ssuftab[n] = $, it is always have<br />
Lcptab[n] = 0. The Lcp-table can be computed as a<br />
by-product during the construction <strong>of</strong> the suffix
48 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />
array. The lcp-interval tree <strong>of</strong> S = acaaacatat$ is<br />
shown in Figure 2.<br />
Figure 2. The Lcp-interval tree <strong>of</strong> S = acaaacatat$<br />
An interval [i...j], where 0 ≤ i ≤ j ─ n, in an Lcparray<br />
is called an Lcp-interval<br />
<strong>of</strong> Lcp-value ℓ<br />
(denoted by ℓ-[i...j]) if<br />
Lcptab[i] < ℓ<br />
Lcptab[k] ≤ ℓ for all k with i+1 ≤ k ≤ j<br />
Lcptab[k] = ℓ for at least one k with<br />
i+1 ≤ k ≤ j<br />
Lcptab [j + 1] < ℓ<br />
Every index k, i+1 ≤ k ≤ j, with Lcptab[k] = Ssuftab<br />
is called ℓ index. The set <strong>of</strong> all ℓ indices <strong>of</strong> an ℓ<br />
interval [i...j] will be denoted by ℓ Indices (i...j). If<br />
[i...j] is an ℓ-interval such that ω =<br />
S[suftab[i]..Suftab[i]+ ℓ -1] is the longest common<br />
prefix <strong>of</strong> the suffixes Ssuftab[i]; Ssuftab[i+1]; … ;<br />
Suftab[j], then [i...j] is also called ω-interval. Based<br />
on the analogy between the suffix array <strong>and</strong> the<br />
suffix tree, it is desirable to enhance the suffix array<br />
with additional information to determine, for any ℓ-<br />
interval [i..j], all its child intervals in constant time<br />
using enhancing the suffix array with two tables.<br />
Enhanced Suffix array<br />
The new data structure consists <strong>of</strong> the suffix array,<br />
the Lcp-interval table, <strong>and</strong> an additional<br />
table: the<br />
child-table cldtab shown in Table 2.<br />
The child-table is a table <strong>of</strong> size n+1 indexed<br />
from 0 to n <strong>and</strong> each entry contains three values:<br />
up, down, <strong>and</strong> nextℓIndex. Each <strong>of</strong> these three<br />
values requires 4 bytes in the worst case. The<br />
values <strong>of</strong> each cldtab-entry are defined as follows<br />
(it is assumed that min Φ = max Φ = 1):<br />
1. cldtab[i].up =<br />
Min {q Є [0..i - 1] | Lcptab[q] > Lcptab[i]<br />
<strong>and</strong> for all k Є [q + 1..i - 1] :<br />
Lcptab[k] ≥ Lcptab[q]}<br />
2. cldtab[i].down<br />
=<br />
Max {q Є [i + 1.. n] | Lcptab[q] > Lcptab[i]<br />
<strong>and</strong> for all k Є [i + 1..q - 1] : Lcptab[k] ≥<br />
Lcptab[q]}<br />
3. cldtab[i].next ℓ Index =<br />
Min {q Є [i + 1.. n] | Lcptab[q] = Lcptab[ i]<br />
<strong>and</strong> for all k Є [i + 1..q - 1] : Lcptab[k] ><br />
Lcptab[i]}<br />
The child-table stores the parent-child<br />
relationship <strong>of</strong> Lcp-intervals. For an ℓ -interval<br />
[i...j] whose ℓ -indices are i1 < i2
with a highly conserved region. It is calculated<br />
based on the length <strong>of</strong> the pattern <strong>and</strong> frequency<br />
i.e., number <strong>of</strong> occurrences in the database. The<br />
given pattern p is classified as significant if it<br />
satisfies the following constraints:<br />
The length <strong>of</strong> p ≥ a given length-threshold: a<br />
significant pattern must be sufficiently long<br />
to carry important biological information.<br />
The score <strong>of</strong> p ≥ a given score-threshold: a<br />
significant pattern<br />
must have a sufficiently<br />
high score.<br />
GSArray is constructed for the entire sequences<br />
in the database. While constructing GSArray, at<br />
each node i, the length <strong>and</strong> the<br />
frequency ) (i.e. the number <strong>of</strong> occurrences <strong>of</strong><br />
pi in the database) is stored for the corresponding<br />
pattern pi this frequency is incremented for every<br />
new node. Then the score function<br />
is<br />
calculated using the equation (1)<br />
(1)<br />
Where = Function value <strong>of</strong> the pattern,<br />
= frequency <strong>of</strong> the node,<br />
= length <strong>of</strong> the label <strong>of</strong> prefix,<br />
i = node number,<br />
|DB| = Database size.<br />
The score function is used as a measure<br />
to determine whether a particular pattern is<br />
significant to be included in the post-processing for<br />
evaluation <strong>of</strong> sequences, to determine the closest<br />
set <strong>of</strong> sequences. Then the query sequence Q <strong>and</strong><br />
number <strong>of</strong> sequences to be selected from the<br />
database is read from the user, temporarily added<br />
onto GSArray. This enables to determine which<br />
suffixes <strong>of</strong> the query are shared by the sequence in<br />
the database. The query sequence is only<br />
temporarily added to the tree so that GSAlign is not<br />
affected for future sequence searches. Initially all<br />
the nodes in the GSArray are 0. When the query<br />
sequence Q is added as a suffix, the nodes visited is<br />
set to 1. This expedites the search for common<br />
patterns within the GSArray because only those<br />
paths in the tree for patterns that contain substrings<br />
<strong>of</strong> the query sequence are examined. In depth-first<br />
manner, starting at the root all the nodes are visited<br />
to check the value 1. If the current node has no<br />
child whose value is 1, then the search backtrack to<br />
its parent node. During this traversal all the<br />
significant patterns are collected. The sequence<br />
may have other common patterns that are not<br />
significant. An optimal alignment between these<br />
two sequences in an ideal case contains all<br />
significant patterns. After this process the query<br />
Bio-database compression using enhanced suffix array 49<br />
sequence from GSArray is deleted. Top ten<br />
significant patterns are selected <strong>and</strong> stored. The<br />
sequence that contains significant patterns is<br />
extracted <strong>and</strong> stored. Reverse check is made to<br />
obtain the accuracy <strong>of</strong> the results; it computes how<br />
many chosen patterns are being shared by each <strong>of</strong><br />
the sequences extracted already. Higher the number<br />
(weight), greater will be the similarity <strong>of</strong> the<br />
corresponding sequence to the query. Based on this<br />
weight<br />
the sequences are ranked.<br />
A top n sequences are transferred to new<br />
database. Algorithm for<br />
BioDB Compression Tool<br />
is shown in Figure 3.<br />
//Input: Set <strong>of</strong> DNA <strong>and</strong> Protein Sequences<br />
// Output: Compressed set <strong>of</strong> DNA <strong>and</strong> Protein sequences<br />
S1: Read DNA or Protein database;<br />
S2: Construct GSArray for the input sequences, Set node visit<br />
=0;<br />
S3: While constructing the suffix array, store the information <strong>of</strong><br />
label length, frequency at nodes <strong>and</strong> sequences traversing<br />
through the branches;<br />
S4: Use the equation (1) to calculate the degree <strong>of</strong> similarity <strong>of</strong><br />
patterns in the form <strong>of</strong> prefixes;<br />
S5: Read query sequence Q <strong>and</strong> the number <strong>of</strong> sequences n to<br />
select from the user;<br />
S6: Temporarily add the suffixes <strong>of</strong> query to the generalized<br />
GSArray;<br />
S7: While adding the suffixes highlight nodes <strong>of</strong> the paths which<br />
are traversed by the query sequence;<br />
S8: Post process the GSArray to extract patterns shared by the<br />
query Sequence, which lies above a defined threshold on<br />
the<br />
function-value;<br />
S9: Pick the top ten <strong>of</strong> these patterns <strong>and</strong> store;<br />
S8: Do a reverse check to compute the weight <strong>of</strong> each sequence<br />
in the subset;<br />
S9: Rank the sequences according to these weights;<br />
S11: Pick top n sequences from the subset <strong>and</strong> write to a new<br />
database;<br />
Figure 3. Algorithm for BioDB Compression Tool<br />
Cross validation<br />
The real world DNA (GSS, EST) <strong>and</strong> Protein<br />
sequence (Protein C, S) databases from Oryza<br />
sativa group is extracted from NCBI website <strong>and</strong><br />
enhanced suffix array is formed for all the<br />
sequences in the database. Based on the user given<br />
query sequence, the significant patterns are<br />
generated. The sequences in the DNA or Protein<br />
database are given weights according to the number<br />
<strong>of</strong> patterns they contain. The compressed database<br />
is formed by selecting top ‘n’ sequences with<br />
highest<br />
ranks <strong>and</strong> written into a new database.<br />
The latest data mining technique, 7-fold cross<br />
validation is used to validate the results obtained<br />
from BioDB Compression Tool <strong>and</strong> WU-BLAST.
50 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />
The main idea <strong>of</strong> 7-fold cross validation approach<br />
is ‘train on 6 folds, test on 1 fold. The data set is<br />
divided into 7 parts. Among the 7 parts 6/7 <strong>of</strong> the<br />
data are used for training data set <strong>and</strong> the remaining<br />
1/7 is used for testing data set. BioDB Compression<br />
Tool is applied on training data set <strong>and</strong> then on<br />
WU_BLAST for single user given query sequence.<br />
For the same query sequence WU-BLAST alone is<br />
applied on the testing data set. The average <strong>of</strong> this<br />
seven runs is computed for analysis. In this paper<br />
such seven queries are taken <strong>and</strong> analyzed. 49<br />
sequences from Oryza sativa GSS gi: 288881557 to<br />
gi: 288881606 are taken as a database set, 42<br />
sequences are used for training data set <strong>and</strong> 7<br />
sequences are used for test data set. Single query<br />
sequence is applied first on BioDB Compression<br />
Tool, data base is compressed. WU-BLAST is<br />
performed on the new data base <strong>and</strong> the same query<br />
sequence. Then for same sequence WU-BLAST<br />
alone is applied. The sequences in the training <strong>and</strong><br />
test data set are interchanged <strong>and</strong> the above steps<br />
are repeated until every fold is used for training.<br />
Average <strong>of</strong> the result from 7 runs are calculated <strong>and</strong><br />
stored. This is experimented for 7 different queries.<br />
The objective is to test whether the results are<br />
consistent for all the queries on a particular<br />
database in terms <strong>of</strong> computational time.<br />
Results<br />
Compressed database from BioDB Compression<br />
Tool is cross validated using 7-fold cross validation<br />
approach. The cross validation results <strong>of</strong> seven<br />
different queries for DNA database set GSS gi:<br />
288881557 to gi: 288881606 are shown in Figure 4<br />
<strong>and</strong> EST gi: 288886142 to gi: 288886191 are<br />
shown in Figure 5 <strong>and</strong> the results <strong>of</strong> seven different<br />
queries Protein C &S are shown in Figures 6 <strong>and</strong> 7.<br />
Figure 4.<br />
Results <strong>of</strong> cross validation for GSS DNA<br />
dataset<br />
Figure 5. Results <strong>of</strong> cross validation for EST DNA<br />
dataset<br />
The idea is to test whether the results are<br />
consistent for all queries on a particular database in<br />
terms <strong>of</strong> computation time. From the figures 4-6 it<br />
is inferred that the developed BioDB Compression<br />
Tool performs much better than WU-BLAST.<br />
Computational complexity <strong>of</strong> using developed<br />
BioDB Compression Tool is reduced compared to<br />
WU-BLAST because; compression takes place<br />
along sequence alignment. The Enhanced suffix<br />
array algorithm used in BioDB Compression Tool<br />
requires 5n bytes character where SCT requires 20n<br />
bytes which uses suffix tree.<br />
Figure 6. Results <strong>of</strong> cross validation for Protein C<br />
Hence it is proved that space complexity is<br />
approximately five times less than SCT.<br />
Implementation results show that the running time<br />
<strong>of</strong> developed algorithm BioDB Compression Tool<br />
using enhanced suffix array is much better than<br />
SCT which uses suffix tree.
Figure 7. Results <strong>of</strong> cross validation for Protein S<br />
Discussion<br />
In this paper the BioDB Compression Tool using<br />
enhanced suffix array has been developed. BioDB<br />
Compression Tool pre-processes the database to<br />
create a generalized enhanced suffix array <strong>and</strong><br />
extended by adding frequency <strong>and</strong> length<br />
information for the patterns. BioDB Compression<br />
Tool distinguishes patterns by computing<br />
significance-scores. A pattern is regarded as<br />
significant if it is long enough, <strong>and</strong> it appears<br />
frequently enough in the database. The scoring<br />
function takes into account a pattern's length <strong>and</strong><br />
frequency, the given threshold values, <strong>and</strong><br />
determines if a pattern is significant. Using these,<br />
for a given query sequence BioDB Compression<br />
Tool compresses the database to only a few<br />
sequences that share the most significant patterns<br />
with the query. This compression in database size<br />
speeds-up the local alignment <strong>of</strong> the query<br />
sequence against the database. Experimental results<br />
have shown that BioDB Compression Tool<br />
provides a speed-up over WU-BLAST. It is able to<br />
reduce the time <strong>of</strong> a database search to nearly five<br />
times originally taken by WU-BLAST. Results<br />
from WU-BLAST have shown that this method is<br />
experimentally effective, as the results obtained by<br />
BioDB Compression Tool produces accurate<br />
alignment. Combined with the extended suffix<br />
array, BioDB Compression Tool has the advantage<br />
<strong>of</strong> using WU-BLAST to do the local sequence<br />
alignment. Latest Data Mining technique, 7-fold<br />
cross validation is applied to attain a greater<br />
accuracy in the results <strong>and</strong> the results are<br />
satisfactory. The Enhanced suffix array algorithm<br />
used in BioDB Compression Tool requires 5n bytes<br />
/character where SCT requires 20n bytes which<br />
uses suffix tree. So, space complexity is<br />
approximately five times more than SCT.<br />
Experimental results show that the running time <strong>of</strong><br />
Bio-database compression using enhanced suffix array 51<br />
BioDB Compression Tool is much better than SCT<br />
which uses suffix tree.<br />
In this paper, a small domain <strong>of</strong> sequences have<br />
been selected from the DNA <strong>and</strong> Protein database<br />
<strong>and</strong> experimentally proved that, enhanced suffix<br />
array reduces space complexity by five times.<br />
BioDB Compression Tool can also be applied to<br />
Global Sequence Alignment <strong>and</strong> Multiple Sequence<br />
Alignment. This work can also be applied on<br />
databases <strong>of</strong> protein sequences for alignment.<br />
References<br />
Abouelhoda MI, Kurtz S <strong>and</strong> Ohlebusch E. The<br />
enhanced suffix array <strong>and</strong> its applications to<br />
genome analysis. Proc. Workshop on<br />
Algorithms in Bioinformatics. Springer- Verlag,<br />
Berlin. 2452: 449- 463, 2002.<br />
Abouelhoda MI, Stefan Kurtz <strong>and</strong> Enno Ohlebusch.<br />
Replacing suffix trees with enhanced suffix<br />
arrays. <strong>Journal</strong> <strong>of</strong> Discrete Algorithms. 2:53-86,<br />
2004.<br />
Altschul SF, Gish W, Miller W, Myers E <strong>and</strong><br />
Lipmann D. Basic Local Alignment Search<br />
Tool. <strong>Journal</strong> <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong>. 215:403 -<br />
410, 1990.<br />
Delcher AL, Kasif S, Fleischmann RD, Peterson J,<br />
White O <strong>and</strong> Salzberg SL. Alignment <strong>of</strong> Whole<br />
Genomes. Nucleic Acids Res. 27:2369-2376,<br />
1999.<br />
Divya RS, Abdullah NA <strong>and</strong> Xindong Wu. Using<br />
an extended suffix Treeto speed-up sequence<br />
alignment. IADIS International Conference<br />
Applied Computing. 655-660, 2006.<br />
Gus Field D. Algorithms on Strings, Trees <strong>and</strong><br />
Sequences. Cambridge University Press. 1997.<br />
Basic Local Sequence Alignment Tool. Retrieved<br />
May 4, 2009, from http://blast.wustl.edu/<br />
Manber U <strong>and</strong> Myers EW. Suffix Arrays: A New<br />
Method for On-Line String Searches. SIAM<br />
<strong>Journal</strong> on Computing. 22(5):935-948, 1993.<br />
Matthew Bellgard, Thomas Gamble, Mark<br />
Reynolds, Adam Hunter, Ed Trifonov, <strong>and</strong> Ross<br />
Taplin. Gap apping: a paradigm for aligning two<br />
sequences. Applied Bioinformatics. 2(3 Suppl):<br />
31-35, 2003.<br />
Pearson WR. Flexible sequence similarity<br />
searching with the FASTA3 program package.<br />
Methods in <strong>Molecular</strong> <strong>Biology</strong>.132: 185-219,
52 Arumugam KUNTHAVAI <strong>and</strong> Somasundaram VASANTHA RATHNA<br />
2000.<br />
Smith TF <strong>and</strong> Waterman MS. Identification <strong>of</strong><br />
common molecular subsequences. <strong>Journal</strong> <strong>of</strong><br />
<strong>Molecular</strong> <strong>Biology</strong>. 147:195-197, 1981
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 53-61, 2011 Research Article 53<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene<br />
in E. coli <strong>and</strong> characterization <strong>of</strong> the recombinant enzyme<br />
Sabira TAIPAKOVA 1 , Bauyrzhan SMAILOV 1 , Gulshan STANBEKOVA 2 <strong>and</strong><br />
Amangeldy BISSENBAEV 1, *<br />
1<br />
Department <strong>of</strong> Genetics <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong>, Faculty <strong>of</strong> <strong>Biology</strong>, al-Farabi Kazakh National University,<br />
050038, Almaty,al-Farabi 71, Kazakhstan<br />
2<br />
Institute <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Biochemistry, Dosmukhamedov 86, 480012, Almaty, Kazakhstan<br />
(* author for correspondence; Amangeldy.Bisenbaev@kaznu.kz)<br />
Received: 11 March 2011; Accepted: 10 June 2011<br />
Abstract<br />
A gene encoding cellobiohydrolase CEL7A was successfully isolated from the L. edodes mushroom strain<br />
N127 using RT-PCR. The deduced amino acid sequence encoded by cel7A showed high homology with the<br />
sequence <strong>of</strong> glycoside hydrolase family 7. To confirm the gene sequence encoding the CEL7A the cloned<br />
gene was expressed in E. coli. For the first time the cel7A gene from the L. edodes was expressed in E. coli<br />
<strong>and</strong> characterized. The recombinant CEL7A has the ability to hydrolyze Avicel, Filter paper, p-Nitrophenyl<br />
β-D-lactopyranoside (pNP-Lac) <strong>and</strong> p-Nitrophenyl β-D-cellobioside (pNP-Cel). The activity <strong>of</strong> the cloned<br />
enzyme towards carboxymethylcellulose (CMC) is much lower. It showed an optimal working condition at<br />
50 0 C <strong>and</strong> pH 7.<br />
Keywords: <strong>Cell</strong>ulose, cellobiohydrolase, Lentinula edodes, gene expression, enzyme activity<br />
Lentinula edodes selobiyohidrolaz geninin E. coli’de klonlanması, ekspresyonu ve<br />
recombinant enzimin karakterizasyonu<br />
Özet<br />
L. edodes mantarı N127 suşundan selobiyohidrolaz CEL7A’yı kodlayan bir gen RT-PCR kullanarak<br />
başarıyla izole edilmişti. Cel7A tarafından kodlanan tahmini aminoasit dizisi gilikosid hidrolaz ailesi 7 dizisi<br />
ile yüksek homoloji göstermiştir. CEL7A’yı kodlayan gen dizisini doğrulamak için klonlanan gen E. coli’de<br />
eksprese edilmiştir. L. edodes’den izole edilen cel7A ilk kez E. coli’de ifade edilip karakterize edilmiştir.<br />
Rekombinant CEL7A, Avisel’i, Filtre kağıdını, p-Nitr<strong>of</strong>enil β-D-laktopiranosidi (pNP-Lac) ve p-Nitr<strong>of</strong>enil β-<br />
D-selobiosidi (pNP-Cel) hidrolize etme yeteneğine sahiptir. Klonlanan enzimin karboksimetilselüloza (CMC)<br />
aktivitesi daha azdır. 50 0 C ve pH 7’nin optimal çalışma şartları olduğu gösterilmiştir.<br />
Anahtar Sözcükler: Selüloz, selobiyohidrolaz, Lentinula edodes, gen ifadesi, enzim aktivitesi<br />
Introduction<br />
<strong>Cell</strong>ulose, consisting <strong>of</strong> glucose units linked<br />
together by β-1,4-glycosidic bonds, is the most<br />
abundant carbohydrate in the biosphere. An<br />
estimated rate <strong>of</strong> cellulose synthesis is<br />
approximately 4 x 10 7 tons per year. For a longrange<br />
solution for problems <strong>of</strong> energy, chemicals,<br />
<strong>and</strong> food, cellulose is the most promising renewable<br />
carbon source that is available in large quantities<br />
(Murai et al., 1998).<br />
Full hydrolysis <strong>of</strong> cellulose requires synergistic<br />
action <strong>of</strong> three major types <strong>of</strong> enzymatic activity:<br />
1,4-β-D-endoglucanases (EC 3.1.2.4), 1,4-β-Dcellobiohydrolases<br />
(CBH; EC 3.1.2.91) <strong>and</strong> βglucosidases<br />
(EC 3.2.1.21). CBHs hydrolyze
54 Sabira TAIPAKOVA et al.<br />
crystalline cellulose by initiating their action from<br />
the ends <strong>of</strong> the cellulose chains <strong>and</strong> producing<br />
primarily cellobiose. Endoglucanases catalyze<br />
hydrolysis internally in the cellulose chain <strong>and</strong><br />
attack the amorphous regions in cellulose,<br />
providing new chain ends for CBHs. β-<br />
glucosidases hydrolyze cellobiose to glucose. These<br />
enzymes are collectively known as cellulases <strong>and</strong><br />
act in a synergistic manner to facilitate complete<br />
cleavage <strong>of</strong> the cellulose β -1,4-glycosidic bonds<br />
(Teeri, 1997)<br />
CBHs are key components in the multi-enzyme<br />
cellulose complexes. Most <strong>of</strong> them belong to<br />
glycosyl hydrolase families 6 or 7. <strong>Cell</strong>ulolytic<br />
fungus generally produces two different CBHs,<br />
CBHI <strong>and</strong> CBHII. These two types <strong>of</strong> enzymes<br />
which are classified based on sequence identity <strong>and</strong><br />
can achieve complete, although slow, solubilization<br />
<strong>of</strong> cellulose crystals even without help <strong>of</strong><br />
endoglucanases (Teeri, 1997).<br />
Lentinula edodes, commonly referred to as the<br />
Shiitake mushroom, is the most popular <strong>and</strong><br />
economically important edible mushroom in the<br />
world because <strong>of</strong> its taste, nutritional <strong>and</strong> medicinal<br />
properties (Mizuno, 1995). L. edodes has<br />
traditionally been grown on freshly cut logs<br />
(Leatham, 1985). It is a white rot fungus that<br />
decays for nutrients all the major polymers<br />
(cellulose, hemicelluloses, <strong>and</strong> lignin) found in<br />
wood lignocelluloses (Lee et al., 2001). Thus, L.<br />
edodes produces a wide variety <strong>of</strong> enzymes that<br />
may have high activities against cellulosic biomass.<br />
Several papers reported that L. edodes has a<br />
strong ability to produce thermostable cellulases,<br />
including CBH (Leatham, 1985; Lee et al., 2001;<br />
Pereira Júnior et al., 2003). L. edodes produces at<br />
least two forms <strong>of</strong> cellobiohydrolase (CEL7A <strong>and</strong><br />
CEL6B). Genes encoding each <strong>of</strong> these enzymes<br />
were cloned from L. edodes grown on a wood<br />
substrate using a PCR based strategy with<br />
degenerate primers directed at the cellulose-binding<br />
domain (Lee et al., 2001). On the basis <strong>of</strong><br />
nucleotide sequence analysis it was shown that<br />
cel7A encodes a 516-amino acid (aa) protein that<br />
belongs to glycosyl hydrolase family 7 <strong>and</strong> has<br />
sequence similarities to CBHI genes from other<br />
fungi. Whereas cel6B gene encodes a 444 aa<br />
protein that belongs to glycosyl hydrolase family 6<br />
<strong>and</strong> has sequence similarities to CBHII genes from<br />
other fungi. However, both fungal CBHs genes<br />
have not been previously expressed <strong>and</strong><br />
characterized.<br />
In this paper we report the cloning <strong>of</strong> a L.<br />
edodes cel7A gene <strong>and</strong> its successful expression in<br />
a heterologous host, E. coli.<br />
Materials <strong>and</strong> methods<br />
Materials<br />
Restriction enzymes, T4 DNA ligase <strong>and</strong> Taq DNA<br />
polymerase were purchased from Fermentas Life<br />
Sciences (St. Leon-Rot, Germany). Plasmid DNA<br />
was isolated using High Pure Plasmid Isolation Kit<br />
<strong>and</strong> DNA fragments were purified using Agarose<br />
Gel DNA Extraction Kit (Roche Diagnostics<br />
GmbH. Mannheim, Germany). All other chemicals<br />
<strong>and</strong> reagents were analytical grade <strong>and</strong> were<br />
supplied by Sigma-Aldrich Corp (St. Louis, MO<br />
USA). The expression vector pET11d was from<br />
Invitrogen, USA.<br />
Strains <strong>and</strong> culture conditions<br />
L. edodes strain N127 was obtained from collection<br />
<strong>of</strong> Kazakh National Agrarian University (Almaty,<br />
Kazakhstan). L. edodes strain N127 was cultured at<br />
room temperature on poplar sawdust blocks. From<br />
sawdust blocks the mycelium was harvested with a<br />
scalpel. The mycelium samples were pooled <strong>and</strong><br />
frozen in liquid nitrogen <strong>and</strong> stored at -80 0 C until<br />
further processing. Escherichia coli DH5a were<br />
used as a host for plasmid propagation. E.coli<br />
Rosetta (DE3) (Invitrogen, USA) was used as a<br />
host for expression <strong>of</strong> the recombinant CEL7A.<br />
Total RNA extraction <strong>and</strong> RT-PCR<br />
Total RNA extraction <strong>of</strong> L.edodes <strong>and</strong> RT-PCR<br />
was performed as described (Sambrook et al.,<br />
1989). Total RNA isolated as described above was<br />
used as a template for RT reactions. Using the<br />
sequence <strong>of</strong> the L. edodes cel7A cDNA available in<br />
the GenBank database (GenBank accession number<br />
AF411250), the forward primer, сel7A Dir: 5’-<br />
GATCACCATGGTCCGAACAGCAGCTCTCCT<br />
CT-<strong>and</strong> the reverse primer, сel7А Rev: 5’-<br />
CTAGGATCCCTACAAACATTGACTGTAGTA<br />
AGG-3’ were designed <strong>and</strong> used for RT-PCR. The<br />
underlined bases in primers are the sites <strong>of</strong><br />
restriction enzymes NcoI <strong>and</strong> BamHI, respectively.
Construction <strong>of</strong> expression vector <strong>and</strong> protein<br />
expression<br />
The PCR product <strong>and</strong> pET11d vector were doubledigested<br />
by NcoI <strong>and</strong> BamHI at 37 0 C according to<br />
the protocol. The digested products were ligated by<br />
T4 ligase at 4 0 C for overnight. The recombinant<br />
vector pET-11d/cel7A was transformed into E.coli<br />
Rosetta (DE3) competent cells <strong>and</strong> the<br />
transformants were selected on LB plates with<br />
ampicillin. The different resistant transformants<br />
were picked <strong>and</strong> inoculated into 20 mL LB medium<br />
with 200 μg/ml ampicillin <strong>and</strong> grown at 37°C in a<br />
shaking incubator (150 rpm) for 12 to 16 h. Then,<br />
the incubation was continued in 1L LB medium.<br />
When the culture grown at 30°C reached an<br />
OD600=0.4–0.6, isopropyl-D-thiogalactopyranoside<br />
(IPTG) was added to a final concentration <strong>of</strong> 0.2<br />
mM to induce expression. After incubation cells<br />
were harvested by centrifugation at 6000 rpm for 5<br />
min at 4°C. <strong>Cell</strong>s were resuspended in storage<br />
buffer containing 20 mM HEPES-KOH pH 7.6, 40<br />
mM NaCl. The cells were lysed by successive<br />
cycles <strong>of</strong> freezing (liquid nitrogen) <strong>and</strong> thawing by<br />
sonication for 20 s at half power (14 mA) until a<br />
clear cell lysate was obtained. This mix was used as<br />
crude protein extracts or alternatively the sonicated<br />
mixture was centrifuged at 14 000 g for 10 min to<br />
remove cell debris, <strong>and</strong> this cleared supernatant<br />
fluid was used as crude proteins extracts. The crude<br />
protein extracts <strong>and</strong> cellular fractions regarded as<br />
crude enzyme extracts were used for identifying<br />
CEL7A expression by SDS-PAGE, Western<br />
blotting <strong>and</strong> enzyme analysis.<br />
Preparation <strong>of</strong> anti-CEL7A antibodies <strong>and</strong> Western<br />
blotting<br />
The enzyme sample (preincubated with Complete<br />
EDTA-free Protease Inhibitor Cocktail) was<br />
electrophoresed on a 10% (w/v) polyacrylamide gel<br />
contaning 0.1% (w/v) SDS. The gel was stained<br />
with Coomassie Brillant Blue R-250 <strong>and</strong> the major<br />
protein b<strong>and</strong> was excised from the gel <strong>and</strong> used as<br />
antigen. The gel piece was homogenized with<br />
liquid nitrogen <strong>and</strong> emulsified in Freund’s complete<br />
adjuvant (Sigma) <strong>and</strong> injected subcutaneously into<br />
a rabbit. The same amount <strong>of</strong> booster injections<br />
was given every two weeks using incomplete<br />
Freund’s adjuvant. The rabbit was bled before the<br />
first injection (preimmune serum) <strong>and</strong> then one<br />
week after the last booster to obtain immune serum<br />
(anti-CEL7A antibodies). Western blots were<br />
Expression <strong>of</strong> L. edodes cel7A gene in E.coli 55<br />
performed by st<strong>and</strong>ard protocols using 1:400 anti-<br />
CEL7A polyclonal antibody diluted in blocking<br />
buffer <strong>and</strong> 1:10000 horseradish peroxidaseconjugated<br />
secondary antibody.<br />
Mass spectrometry<br />
The target b<strong>and</strong>s on SDS-PAGE gels were excised<br />
<strong>and</strong> subjected to in-gel digestion with trypsin<br />
followed by peptide mass fingerprinting by matrix<br />
assisted laser desorption ionization time-<strong>of</strong>-flight<br />
mass spectrometry (MALDI-TOF) using a<br />
MALDI-TOF-TOF spectrometer, Ultraflex II<br />
(Bruker). Spectra from all experiments were<br />
converted to DTA files <strong>and</strong> merged to facilitate<br />
database searching using the Mascot search<br />
algorithm v2.1 (Matrix Science, Boston, MA)<br />
against the non-redundant protein sequences <strong>of</strong><br />
GenBank (National Center for Biotechnology<br />
Information).<br />
Protein <strong>and</strong> enzyme assays<br />
The protein content was determined by Bradford<br />
method (Bradford, 1976) Enzyme activity was<br />
assayed with Avicel, filter paper,<br />
carboxymethylcellulose (CMC) as a substrate by<br />
measuring the amount <strong>of</strong> reducing sugar according<br />
to the Nelson-Somogyi method (Somogyi, 1952;<br />
Nelson, 1944). The reaction mixture consisted <strong>of</strong><br />
50 mM sodium phosphate buffer (pH 7.0), 1%<br />
(w/v) <strong>of</strong> CMC or Avicel or 50 mg <strong>of</strong> filter paper<br />
(1x 6 cm) <strong>and</strong> an appropriate amount <strong>of</strong> enzyme.<br />
The generated reducing sugar was quantified at 540<br />
nm <strong>and</strong> using D-glucose as a st<strong>and</strong>ard for<br />
spectrophotometric estimation. One unit <strong>of</strong><br />
cellobiohydrolase activity was defined as the<br />
amount <strong>of</strong> enzyme that releases 1 μM <strong>of</strong> reducing<br />
sugar per minute per mg <strong>of</strong> total protein under the<br />
assay conditions.<br />
When p-Nitrophenyl β-D-lactopyranoside<br />
(pNP-Lac) <strong>and</strong> p-Nitrophenyl β-D-cellobioside<br />
(pNP-Cel) were used as a substrate, assays were<br />
performed in 500 μl reaction volume in 50 mM<br />
sodium phosphate buffer (pH 7.0) containing 8 mM<br />
<strong>of</strong> pNP-Cel or pNP-Lac with appropriate amounts<br />
<strong>of</strong> enzyme. The reaction was terminated by the<br />
addition <strong>of</strong> 2 ml <strong>of</strong> 1 M Na2CO3 after 1 h<br />
incubation. One unit <strong>of</strong> enzyme activity was<br />
defined as the amount <strong>of</strong> the enzyme that produced<br />
the equivalence <strong>of</strong> 1 μM pNP at the optimal<br />
conditions in 1 min per 1 mg <strong>of</strong> total protein.
56 Sabira TAIPAKOVA et al.<br />
Results<br />
To isolate a gene coding CEL7A, we designed two<br />
oligonucleotide primers based on the previously<br />
published sequence (Lee et al., 2001). First, PCR<br />
was done using genomic DNA <strong>of</strong> L. edodes N127<br />
as a template. PCR product showed a clear b<strong>and</strong><br />
about 2000 bp (Figure 1B).<br />
In the following experiments we amplified<br />
cel7A cDNA by reverse transcriptase (RT) PCR<br />
starting from total RNA. High quality RNA was<br />
isolated from mycelium <strong>of</strong> L. edodes grown on the<br />
poplar sawdust using the CTAB-based extraction<br />
method. RNA examined by electrophoresis on<br />
0.8% agarose gel showed two b<strong>and</strong>s corresponding<br />
to 18S <strong>and</strong> 25S rRNA (Figure 1A), that little or no<br />
RNA degradation occurred during the isolation.<br />
The A260/A280 <strong>and</strong> A260/A230 absorbance ratios<br />
were 1.9 <strong>and</strong> 2.0, respectively. This indicates low<br />
contamination by protein substances <strong>and</strong> secondary<br />
metabolites in the isolated RNA samples. In<br />
general, the RNA obtained was <strong>of</strong> high quality <strong>and</strong><br />
integrity. Total RNA prepared as above was<br />
subjected to RT-PCR with the same primers. A<br />
single DNA b<strong>and</strong> about 1551 bp in size was<br />
amplified (Figure 1B). The 1551 bp DNA fragment<br />
was ligated into pET11d vector <strong>and</strong> propagated in<br />
E.coli. The clones were sequenced from both<br />
directions.<br />
Figure 1. A) Extraction <strong>of</strong> total RNA from L. edodes N127, B) PCR amplification <strong>of</strong> cel7A gene. M: marker<br />
(bp), Lane1: Genomic DNA as template, Lane2: total RNA as template.<br />
Determination <strong>of</strong> the nucleotide sequence<br />
revealed complete coincidence with the nucleotide<br />
sequence <strong>of</strong> the cel7A gene L. edodes strain<br />
Stamets CS-2, that was published earlier (Lee et al.,<br />
2001).<br />
The blastp results in Table 1 showed that the<br />
deduced amino acid sequence <strong>of</strong> 516 amino acids is<br />
identical with L. edodes cellobiohydrolase I amino<br />
acid sequence <strong>and</strong> showed high homology to other<br />
fungal CBHI enzymes belonging to glycosyl<br />
hydrolases family 7: 99% identity to cellulase <strong>of</strong><br />
Irpex lacteus, 96% to cellobiohydrolase I <strong>of</strong><br />
Schizophyllum commune <strong>and</strong> 95% to<br />
cellobiohydrolase I–II <strong>of</strong> <strong>Vol</strong>variella volvacea.<br />
Results in this study show that amino acid<br />
sequence deduced from the nucleotide sequence <strong>of</strong><br />
cel7A is homologous to other CBHs. However,<br />
until now the cel7A gene <strong>of</strong> L. edodes<br />
cellobiohydrolase has not been expressed in<br />
bacterial <strong>and</strong> yeast systems. Therefore, it was<br />
needed to be determined if it really codes a CBH.<br />
In order to confirm that the cel7A gene encodes<br />
a cellobiohydrolase we used E. coli Rosetta (DE3)<br />
expression system. The synthesized by RT-PCR<br />
1551bp fragment was digested with restriction<br />
endonucleases NcoI <strong>and</strong> BamHI <strong>and</strong> cloned in the<br />
pET11d plasmid with retention <strong>of</strong> the reading<br />
frame. The inserted fragment was tested for the<br />
absence <strong>of</strong> mutations by sequencing. The resulting
plasmid pET11d/cel7A was then used to transform<br />
E. coli Rosetta (DE3).<br />
Table 1. The significant matches <strong>of</strong> blastp analysis for cDNA <strong>of</strong> L.edodes N127<br />
Expression <strong>of</strong> L. edodes cel7A gene in E.coli 57<br />
Genbank accession Organism <strong>and</strong> gene Score E value Identity<br />
AAK95563.1<br />
Lentinula edodes cellulase CEL7A<br />
mRNA<br />
1043 1043 100%<br />
BAA76365.1 Irpex lacteus cellulase mRNA 639 639 99%<br />
AAX55505.1<br />
Schizophyllum commune H4-8<br />
glycoside hydrolase family 7 protein<br />
586 625 96%<br />
AAT64007.1<br />
<strong>Vol</strong>variella volvacea<br />
cellobiohydrolase I-II mRNA<br />
The transformation <strong>of</strong> competent E.coli cells<br />
with the ligation products <strong>of</strong> the pET11d vector <strong>and</strong><br />
the L. edodes cel7A gene amplicon yielded over 47<br />
colonies, among which 4 individual clones were<br />
selected. All the selected colonies were assayed by<br />
PCR <strong>and</strong> restriction analysis for the presence <strong>of</strong> the<br />
recombinant plasmids carrying the cel7A gene.<br />
Plasmid DNAs were isolated <strong>and</strong> purified<br />
according to the protocol <strong>of</strong> High Pure Plasmid<br />
Isolation Kit. Plasmid DNAs were digested by NcoI<br />
<strong>and</strong> BamHI, followed by agarose gel<br />
electrophoresis. From Figure 2 we can see that<br />
plasmid DNAs was cut into two fragments, one<br />
Figure 2. Verification <strong>of</strong> the recombinant plasmid<br />
pET11d/cel7A digested by Nco I <strong>and</strong> BamHI M -<br />
Marker (bp); 1-4 Clones<br />
647 681 95%<br />
about 1551 bp corresponding to cel7A gene, <strong>and</strong> the<br />
other about 5674 bp corresponding to the vector.<br />
We amplified the cel7A gene by PCR, using<br />
transformant plasmid DNA as a template <strong>and</strong> gene<br />
specific primers. The fragment detected by agarose<br />
gel electrophoresis corresponded in length to the<br />
cloned cel7A gene (Figure 3). Detection <strong>of</strong> the PCR<br />
product corresponding in length to the cloned cel7A<br />
gene sequence indicated that the analyzed colonies<br />
contained plasmids carrying the relevant gene. As a<br />
result <strong>of</strong> screening, we identified four colonies<br />
carrying the recombinant plasmids.<br />
Figure 3. Verification <strong>of</strong> the recombinant plasmid<br />
pET11d/cel7A M - Marker (bp); 1- 4 Clones
58 Sabira TAIPAKOVA et al.<br />
Synthesis <strong>of</strong> CEL7A protein was assessed in<br />
recombinant E. coli. <strong>Cell</strong> lysate <strong>of</strong> an E. coli<br />
expressing the cel7A gene was analyzed by SDS-<br />
PAGE <strong>and</strong> Western blotting using polyclonal anti-<br />
CEL7A antibodies.<br />
After induction with IPTG for 4-12 hours the<br />
cells were lysed <strong>and</strong> the protein samples were<br />
prepared for SDS-PAGE by boiling in 2x sample<br />
buffer. 53,5kDa <strong>and</strong> 49 kDa protein b<strong>and</strong>s from<br />
crude extracts <strong>of</strong> cells harboring the plasmid<br />
pET11b/cel7A were shown on SDS-PAGE (Figure<br />
4A), whereas no similar protein b<strong>and</strong>s from crude<br />
extracts <strong>of</strong> cells harboring the plasmid pET11d<br />
were detected (Figure 4A). In Figure 4B, the SDS-<br />
PAGE gel was transferred to a PVDF membrane<br />
<strong>and</strong> probed with anti-CEL7A polyclonal antibody.<br />
Western blot analysis revealed a major protein<br />
b<strong>and</strong> <strong>of</strong> 53,5-kDa specific to CEL7A in the crude<br />
extracts <strong>of</strong> the cells harboring the plasmid<br />
pET11d/cel7A, but not pET11d (Figure 4B). To<br />
validate the identity <strong>of</strong> these proteins to CEL7A,<br />
the polypeptides were excised from the gel,<br />
subjected to trypsin digestion <strong>and</strong> MALDI-TOF-<br />
MS analysis. MASCOT search results revealed a<br />
top score <strong>of</strong> 659 for CBHI, where probability based<br />
mowse score > 44 are significant <strong>and</strong> indicate<br />
identity or extensive homology (p
Expression <strong>of</strong> L. edodes cel7A gene in E.coli 59<br />
Figure 5. Effects <strong>of</strong> pH <strong>and</strong> temperature on the activities <strong>of</strong> recombinant CEL7A. A) pH pr<strong>of</strong>ile was<br />
determined by incubating the enzyme at 50 0 C for 1 h at varying pHs (sodium acetate buffer pH 4-6, sodium<br />
phosphate buffer pH 6-7 <strong>and</strong> glycine buffer pH 9). B) Temperature pr<strong>of</strong>ile was determined by incubating the<br />
enzyme in 0.05M sodium phosphate buffer pH 7 for 1 h at different temperatures.<br />
Crude extract <strong>of</strong> an E. coli expressing the cel7A<br />
gene was examined for its ability to hydrolyze<br />
various cellulosic substrates at pH 7 <strong>and</strong> 50 0 C<br />
(Table 2). It could hydrolyze Avicel, Filter paper,<br />
pNP-Lac <strong>and</strong> pNP-<strong>Cell</strong>, but activity towards<br />
carboxymethylcellulose (CMC) was much lower<br />
compared to Avicel <strong>and</strong> Filter paper. These results<br />
strongly indicate that CEL7A has cellobiohydrolase<br />
activity.<br />
Table 2. Activities <strong>of</strong> the recombinant enzyme toward different cellulosic substrates at pH 7.0 <strong>and</strong> 50 0 C<br />
Substrate<br />
Activity<br />
(U/mg total protein)<br />
Avicel 21.4 ± 1.4<br />
Filter paper 23.2 ± 0.3<br />
CMC 2.9 ± 0.5<br />
pNP-Lac 4.1 ± 0.08<br />
pNP-<strong>Cell</strong> 3.8 ± 0.1
60 Sabira TAIPAKOVA et al.<br />
Discussion<br />
CBH enzymes are key components in fungal<br />
cellulase systems, <strong>and</strong> their functional activity is<br />
critical for consolidated bioprocessing for<br />
bioethanol production. For example, CBHs make<br />
up to 80% <strong>of</strong> the total mass for the T. reesei system,<br />
<strong>and</strong> CBH plays a particularly important role,<br />
making up 60% <strong>of</strong> the total mass (van Zyl et al.,<br />
2007). A number <strong>of</strong> cellulase genes from bacteria<br />
<strong>and</strong> fungus have been cloned <strong>and</strong> expressed in yeast<br />
or E. coli (Qiao et al., 2004; Hong et al., 2001,<br />
Hong et al., 2003). However fungal <strong>and</strong> bacterial<br />
endoglucanase (EG) production in recombinant<br />
strains was more successful than CBH production<br />
(van Zyl et al., 2007). This is not surprising<br />
considering that EG enzymes usually have specific<br />
activities <strong>of</strong> 2 to 3 orders higher in magnitude on<br />
synthetic <strong>and</strong> amorphous cellulose substrates, such<br />
as carboxymethylcellulose (CMC), in comparison<br />
to CBHs. Thus it is easier to measure the presence<br />
<strong>of</strong> even small amounts <strong>of</strong> heterologous EG<br />
compared to CBHs.<br />
Expression <strong>of</strong> fungal cellulases in E. coli as<br />
non-glycosylated forms has been attempted with<br />
limited success. Only a few cellulose genes, such as<br />
cbhI <strong>and</strong> egl3 <strong>of</strong> the well-studied fungus T. reesei,<br />
were expressed in E. coli, but the productivity <strong>of</strong><br />
cellulases was very low (Ekino et al., 1999).<br />
In this study, we have successfully expressed the<br />
cel7A gene <strong>of</strong> L. edodes in E. coli under the control<br />
<strong>of</strong> the T7 promoter. SDS–PAGE <strong>and</strong> Western<br />
blotting analysis showed that CEL7A constitutes a<br />
major protein produced in E. coli with a molecular<br />
weight <strong>of</strong> 53,5 kDa, which agrees with the<br />
predicted size from the deduced amino acid<br />
sequence. Amino acid sequencing <strong>of</strong> the putative<br />
recombinant protein by MALDI-TOF <strong>and</strong> its<br />
analysis using NCBI BLAST indicated that the<br />
enzyme contained putative conserved domains <strong>of</strong><br />
glycosyl hydrolase family 7.<br />
As shown in Figure 4A plasmid vector<br />
pET11d/cel7A expresses two additional b<strong>and</strong>s<br />
which in SDS-PAGE migrate as 53 kDa <strong>and</strong> 49<br />
kDa proteins. Since the difference in molecular<br />
weight between these two proteins is approximately<br />
5 kDa we may suggest that the CEL7A protein was<br />
partially degraded possibly during cell lysis. The<br />
cel7A enzyme contains 430 aa catalytic domain <strong>and</strong><br />
57 aa C-terminal cellulose-binding domain (CBD)<br />
<strong>and</strong> serine/threonine-rich linker sequence (Lee et<br />
al., 2001). We may speculate that the proteolytic<br />
degradation <strong>of</strong> 57 aa C-terminal CBD <strong>and</strong> linker<br />
sequence results in truncated 49 kDa protein.<br />
Indeed, western blot analysis confirms the presence<br />
<strong>of</strong> low molecular weight CEL7A proteins which<br />
migrate below the full-length recombinant protein<br />
in SDS-PAGE suggesting proteolytic degradation<br />
<strong>of</strong> CEL7A during expression <strong>and</strong>/or cell lysis.<br />
Furthermore we hypothesize that the linker region<br />
<strong>of</strong> E. coli-expressed CEL7A might be more<br />
susceptible to proteolysis as compared to<br />
glycosylated form <strong>of</strong> this protein expressed in yeast<br />
cells (unpublished observation). It seems likely that<br />
glycosylated linker region in native CEL7A <strong>of</strong> L.<br />
edodes protects the enzyme from proteolytic<br />
degradation nevertheless further investigations are<br />
required.<br />
The substrate specificities indicated that CEL7A<br />
contains cellobiohydrolase activity since it could<br />
hydrolyze crystalline cellulose (Avicel, Filter<br />
paper). Activity <strong>of</strong> cloned enzyme toward CMC<br />
was much lower than to Avicel <strong>and</strong> filter paper.<br />
These data are consistent with the established<br />
results that fungal CBH proteins have very limited<br />
action on substituted cellulose such as CMC or<br />
hydroxyethylcellulose (Basiria <strong>and</strong> Mishra, 1989;<br />
Kanokratana et al., 2002). Since most <strong>of</strong> the fungal<br />
cellulases are glycoproteins, the modification <strong>of</strong> the<br />
native protein by glycosylation has been reported to<br />
play an important role in synthesis, secretion, <strong>and</strong><br />
stability <strong>of</strong> extracellular cellulases (Basiria <strong>and</strong><br />
Mishra, 1989). Here we have demonstrated that<br />
CEL7A synthesized in E. coli without<br />
glycosylation has an enzymatical activity. This<br />
indicates that glycosylation is not necessary for<br />
enzymatic activity <strong>of</strong> CEL7A.<br />
In summary, a gene encoding CEL7A was<br />
successfully isolated from L. edodes strain N127<br />
using RT-PCR technique. The determined<br />
nucleotide sequence is completely corresponded to<br />
the nucleotide sequence <strong>of</strong> the cel7A gene <strong>of</strong> L.<br />
edodes strain Stamets CS-2 which was described<br />
previously (Lee et al., 2001). The enzyme was<br />
successfully expressed in E. coli in an active form.<br />
Enzymatic properties <strong>of</strong> CEL7A were also<br />
determined. The optimal temperature for enzyme<br />
activity was 50 0 C <strong>and</strong> the optimal pH was 7.0.<br />
Acknowledgement<br />
This work was supported by grant from National<br />
Centre for Biotechnology <strong>of</strong> the Republic <strong>of</strong><br />
Kazakhstan.
References<br />
Basiria VS <strong>and</strong> Mishra S. Regulation aspects <strong>of</strong><br />
cellulose biosynthesis <strong>and</strong> secretion. CRC Crit<br />
Rev Biotechnol. 9: 61-162, 1989.<br />
Bradford MM. A rapid <strong>and</strong> sensitive method for the<br />
quantitation <strong>of</strong> microgram quantities <strong>of</strong> protein<br />
using the principle <strong>of</strong> protein–dye binding.<br />
Anal Biochem. 72: 248-252, 1976.<br />
Ekino KK, Goto M <strong>and</strong> Furukawa K. Heterologous<br />
expression <strong>and</strong> characterization <strong>of</strong><br />
endoglucanase I (EGI) from Trichoderma<br />
viride HK-75. Biosci Biotechnol Biochem. 63<br />
(10): 1714-1720, 1999.<br />
Hong J, Tamaki H, Akiba S, Yamamoto K <strong>and</strong><br />
Kumagai H. Cloning <strong>of</strong> a gene encoding a<br />
highly stable endo-b-1,4-β-glucanase from<br />
Aspergillus niger <strong>and</strong> its expression in yeast. J<br />
Biosci Bioeng. 92: 434-441, 2001.<br />
Hong J, Tamaki H, Yamamoto K <strong>and</strong> Kumagai H.<br />
Cloning <strong>of</strong> a gene encoding thermo-stable<br />
endo-b-1,4-glucanase from Thermoascus<br />
aurantiacus <strong>and</strong> its expression in yeast.<br />
Biotechnol Lett 25: 657–661, 2003.<br />
Kanokratana P, Chantasingh D, Champreda V,<br />
Tanapongpipat S, Pootanakit K <strong>and</strong><br />
Eurwilaichitr L. Identification <strong>and</strong> expression<br />
<strong>of</strong> cellobiohydrolase (CBHI) gene from an<br />
endophytic fungus, Fusicoccum sp.<br />
(BCC4124) in Pichia pastoris. Protein Expr<br />
Purif. 58: 148-153, 2008.<br />
Leatham GF. Extracellular enzymes produced by<br />
the cultivated mushroom Lentinus edodes<br />
during degradation <strong>of</strong> a lignocellulosic<br />
medium. Appl Environ Microbiol. 50: 859-867,<br />
1985.<br />
Lee CC, Wong DWS <strong>and</strong> Robertson GH. Cloning<br />
<strong>and</strong> characterization <strong>of</strong> two cellulase genes<br />
from Lentinula edodes. FEMS Microbiology<br />
Letters. 205: 355-360, 2001.<br />
Expression <strong>of</strong> L. edodes cel7A gene in E.coli 61<br />
Mizuno T. Shiitake, Lentinus edodes: functional<br />
properties for medicinal <strong>and</strong> food purposes.<br />
Food Rev Int. 11: 111-128, 1995.<br />
Murai T, Ueda M, Kawaguchi T, Arai M <strong>and</strong><br />
Tanaka A. Assimilation <strong>of</strong><br />
cellooligosaccharides by a cell surfaceengineered<br />
yeast expressing beta -glucosidase<br />
<strong>and</strong> carboxymethylcellulase from Aspergillus<br />
aculeatus. Appl Environ Microbiol. 64: 4857-<br />
4861, 1998.<br />
Nelson NJ. A photometric adaptation <strong>of</strong> the<br />
Somogyi method for the determination <strong>of</strong><br />
glucose. J Biol Chem. 153: 375-380, 1944.<br />
Pereira Júnior JA, Correia MJ <strong>and</strong> Oliveira NT.<br />
<strong>Cell</strong>ulase activity <strong>of</strong> a Lentinula edodes (Berk.)<br />
Pegl. strain grown in media containing<br />
carboximethylcellulose or microcrystalline<br />
cellulose. Brazilian Archives <strong>of</strong> <strong>Biology</strong> <strong>and</strong><br />
Technology. 46: 333-337, 2003<br />
Qiao Y, Mao AJ, He YZ, Liu WF <strong>and</strong> Dong ZY.<br />
Secreted expression <strong>of</strong> Trichoderma reesei<br />
endo-glucanase II gene in Pichia pastoris <strong>and</strong><br />
analysis <strong>of</strong> enzymatic properties. Mycosystema.<br />
23(3): 388–396, 2004.<br />
Sambrook et al. <strong>Molecular</strong> Cloning: a Laboratory<br />
Manual (2 nd ed.). Cold Spring Harbor<br />
Laboratory Press. 1989.<br />
Somogyi M. Notes on sugar determination. J Biol<br />
Chem. 195: 19-23, 1952.<br />
Teeri TT. Crystalline cellulose degradation: new<br />
insight into the function <strong>of</strong> cellobiohydrolases.<br />
Trends in Biotechnology. 15: 160-167, 1997.<br />
van Zyl WH, Lynd LR, den Haan R <strong>and</strong> McBride<br />
JE. Consolidated bioprocessing for bioethanol<br />
production using Saccharomyces cerevisiae in<br />
bi<strong>of</strong>uels. Adv Biochem Eng Biotechnol. 108:<br />
205-235, 2007.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 63-68, 2011 Research Article 63<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in<br />
temporom<strong>and</strong>ibular joint disorder<br />
Necati TASKIN 1 , Korkut ULUCAN 2,* , Guhan DEGIN 3 , Arzu AKCAY 4 , Berfin<br />
KARATAS 3 <strong>and</strong> Teoman AKCAY 5<br />
1<br />
Istanbul Education <strong>and</strong> Research Hospital, Department <strong>of</strong> Pediatrics, Istanbul, Turkey.<br />
2<br />
Marmara University, Faculty <strong>of</strong> Dentistry, Department <strong>of</strong> Medical <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul, Turkey.<br />
3<br />
Marmara University, Faculty <strong>of</strong> Dentistry, Department Of Oral And Maxill<strong>of</strong>acial Surgery, Istanbul,<br />
Turkey.<br />
4<br />
Bakirkoy Maternity <strong>and</strong> Child Education <strong>and</strong> Research Hospital, Pediatric Hematology, Istanbul, Turkey.<br />
5<br />
Sisli Etfal, Education <strong>and</strong> Research Hospital, Istanbul, Turkey.<br />
(* author for correspondence; korkutulucan@hotmail.com)<br />
Received: 24 May 2011; Accepted: 16 June 2011<br />
Abstract<br />
Matrix metalloproteinases 1 <strong>and</strong> 3 (MMP1 <strong>and</strong> MMP3) are metal dependent endopeptidases responsible for<br />
hydrolyzing extracellular matrix molecules, <strong>and</strong> also have important roles during the matrix destruction in<br />
temporom<strong>and</strong>ibular joint (TMJ) degeneration. In the present study, we aimed to investigate the relation<br />
between characterized promotor polymorphisms <strong>of</strong> MMP1 <strong>and</strong> MMP3 genes <strong>and</strong> TMJ in a Turkish<br />
population. 35 TMJ patients <strong>and</strong> 50 healthy controls were recruited to the study. MMP1 <strong>and</strong> MMP3 promotor<br />
polymorphisms were examined by PCR-RFLP methodology. For MMP1 polymorphism; 8, 14 <strong>and</strong> 13 <strong>of</strong> 35<br />
patients were 1G/1G, 1G/2G <strong>and</strong> 2G/2G, respectively. For the same polymorphism; 11, 28, 11 <strong>of</strong> 50 controls<br />
were 1G/1G, 1G/2G <strong>and</strong> 2G/2G, respectively. 6, 14, 15 <strong>of</strong> 35 patients were 5A/5A, 5A/6A <strong>and</strong> 6A/6A,<br />
respectively, for MMP3 genotype. Of the 50 controls, 8, 23, 19 were 5A/5A, 5A/6A <strong>and</strong> 6A/6A, respectively.<br />
Comparison <strong>of</strong> the polymorphism between healthy subjects <strong>and</strong> patients yielded no statistically significant<br />
difference (p0,05). The examined polymorphisms didn’t have major effects on the TMJ formation. With the<br />
increasing number <strong>of</strong> the both groups <strong>and</strong> classification <strong>of</strong> the patients with their pain level <strong>and</strong> disease<br />
severity will give us more informative data about the polymorphism <strong>of</strong> the genes <strong>and</strong> TMJ formation.<br />
Keywords: Temporom<strong>and</strong>ibular joint disorder, matrix metalloproteinase, MMP1 promotor polymorphism,<br />
MMP3 promotor polymorphism, or<strong>of</strong>acial pain.<br />
Temporom<strong>and</strong>ibular bağlantı bozukluklarında MMP1 ve MMP3 promotor polimorfizmlerinin<br />
incelenmesi<br />
Özet<br />
Matriks metaloproteinaz 1 ve 3 (MMP1 ve MMP3) ektraselüler matriks moleküllerini parçalayan metal<br />
iyonlarına bağımlı endopeptidazlardır ve temporom<strong>and</strong>ibular bağlantı bozukluklarında (TBB) hücrelerarası<br />
matriks yıkımında önemli rolleri bulunmaktadır. Bu çalışmada 35 TBB hastasında, hastalığın oluşumunda rol<br />
oynayan MMP1 ve MMP3 genlerindeki promotor polimorfizmlerinin ilişkisini saptamayı amaçladık. Bu<br />
nedenle 35 hasta ve 50 sağlıklı kontrolü çalışmaya dahil ettik. Polimorfizm analizleri st<strong>and</strong>art PCR-RFLP<br />
metodu ile gerçekleştirildi. MMP1 polimorfizm sonuçlarına göre 35 hastanın 8’i 1G/1G, 14’ü 1G/2G ve 13’ü<br />
ise 2G/2G, 50 kontrolün ise 11’i 1G/1G ve 2G/2G, 28’i ise 1G/2G genotiplerinde bulunmuştur. MMP3<br />
polimorfizm sonuçları ise hasta grubunda 6’sı 5A/5A, 14’ü 5A/6A ve 15’I 6A/6A, kontrol grubunun ise 8’i<br />
5A/5A, 23’ü 5A/6A ve 19’u ise 6A/6A genotipinde bulunmuştur. Kontrol grubu ve hasta gruplarının<br />
istatistiksel olarak karşılaştırıldıklarında anlamlı bir fark bulunamamıştur. Bu sonuçlara dayanarak analiz<br />
edilen polimorfizmler ve TBB arasında çalışılan populasyonda bir ilişki saptanamamıştır. Hasta ve kontrol<br />
sayısının artırılması ve TBB’li hastaların ağrı ve hastalığın ilerleme durumlarına göre sınıfl<strong>and</strong>ırmalarının<br />
yapılması ile daha anlamlı sonuçların alınacağına inanmaktayız.
64 Necati TASKIN et al.<br />
Anahtar Sözcükler: Temporom<strong>and</strong>ibular bağlantı bozuklukları, matriks metaloproteinaz, MMP1 promotor<br />
polimorfizmi, MMP3 promotor polimorfizmi, or<strong>of</strong>asyal ağrı<br />
Introduction<br />
Temporom<strong>and</strong>ibular joint disorders (TMJD) are the<br />
or<strong>of</strong>acial problems involving masticatory<br />
musculature, the temporom<strong>and</strong>ibular joint (TMJ),<br />
<strong>and</strong> related structures. This disorder frequently<br />
causes chronic pain in the or<strong>of</strong>acial region<br />
(Dworkin et al., 2002). Degeneration <strong>of</strong> articular<br />
cartilage, capsule, ligaments <strong>and</strong> synovial<br />
membrane are the major clinical outcomes <strong>of</strong> TMJ.<br />
These degenerative changes in the tissues are slow<br />
at the beginning but with the progression <strong>of</strong> the<br />
disease, irreversible changes occur in the joint<br />
(Stegenga, 2001).<br />
The main characteristic change in TMJ is the<br />
alteration <strong>of</strong> the equilibrium between synthesis <strong>and</strong><br />
degradation <strong>of</strong> extracellular matrix (ECM)<br />
collagens, especially by proteolysis (Planello et al.,<br />
2011). Accumulation <strong>of</strong> the hydrolyzed proteins,<br />
catabolites formed by proteolytic activities,<br />
inflammatory modulators like cytokines <strong>and</strong> nitric<br />
oxide, matrix metalloproteinases (MMPs) found in<br />
the synovial fluid are the reason <strong>of</strong> inflammatory<br />
process <strong>of</strong> TMJ (Dijkgraaf et al,1995; Srinivas et<br />
al., 2001; Kubota et al., 1998). On the other h<strong>and</strong>,<br />
MMPs are considered to be the key proteolytic<br />
enzymes for the destruction <strong>of</strong> ECM in TMJ<br />
(Wadhwa <strong>and</strong> Kapila, 2008).<br />
MMPs are metal dependent endopeptidases that<br />
are capable <strong>of</strong> cleaving most, if not all <strong>of</strong> the<br />
constituents <strong>of</strong> the extracellular matrix including<br />
collagen, fibronectin, <strong>and</strong> proteoglycans (Astolfi et<br />
al., 2006; Plenello et al., 2011). They are secreted<br />
as pro-enzymes, inactive state <strong>of</strong> the enzyme, <strong>and</strong><br />
activated after the cleavage <strong>of</strong> N- terminal domain<br />
(Visse <strong>and</strong> Negasse, 2003) by other proteinases.<br />
Also several promotor polymorphisms were<br />
reported to regulate transcription activity <strong>and</strong> these<br />
have been associated with degenerative diseases<br />
like periodontitis <strong>and</strong> arthritis (Barlas et al., 2009;<br />
Astolfi et al., 2006). These promotor variations can<br />
influence the basal <strong>and</strong> inducible levels <strong>of</strong> MMP<br />
expression. An insertion/ deletion variation <strong>of</strong><br />
MMP1 promotor at position -1607 creates two<br />
alleles, 1G having one guanin <strong>and</strong> 2G, having two<br />
guanines at this position (Rutter et al., 1998).<br />
MMP3 also has a functional variation at -1612<br />
which give rise to 5A <strong>and</strong> 6A alleles, according to<br />
repeat number (de Maat, 1999). MMP3 degrades a<br />
wide range <strong>of</strong> extracellular matrix proteins <strong>and</strong><br />
should be regarded as a potential interest in DNA<br />
polymorphism- TMJ studies.<br />
Of the big family <strong>of</strong> MMPs, MMP1 <strong>and</strong> MMP3<br />
are synthesized <strong>and</strong> exocytosed in fibroblasts <strong>and</strong><br />
chondrocytes, increasing the possibility <strong>of</strong> their<br />
probable role in TMJ. In this study, we aimed to<br />
identify the effect <strong>of</strong> 1G/2G MMP1 <strong>and</strong> 5A/6A<br />
MMP3 polymorphisms in TMJ formation.<br />
Materials <strong>and</strong> methods<br />
Study Group<br />
35 TMJ patients <strong>and</strong> 50 healthy subjects with no<br />
history <strong>of</strong> any genetically based disease were<br />
enrolled to the study. All the participants were<br />
informed in detail about the study. The participants<br />
were unrelated Turkish people from the eastern<br />
region <strong>of</strong> Turkey. The TMJ degeneration group<br />
included 30 individuals <strong>of</strong> both genders <strong>and</strong><br />
undergone MRI scans in Marmara University,<br />
Faculty <strong>of</strong> Dentistry, Department <strong>of</strong> Oral <strong>and</strong><br />
Maxill<strong>of</strong>acial Surgery. The individuals who have<br />
shown at least one sign <strong>of</strong> degenerative process in<br />
any <strong>of</strong> the m<strong>and</strong>ibular condyles were included to<br />
the TMJ group, according to their MRI scans.<br />
Amplification <strong>and</strong> Genotyping <strong>of</strong> SNPs<br />
Genomic DNA isolated from peripheral blood by<br />
using a commercial kit (Roche, Germany) by<br />
following the instruction guide. For MMP1<br />
analysis, PCR reactions were carried out in a<br />
volume <strong>of</strong> 50 µl containing 50–100 ng DNA<br />
template in 10 mM Tris–HCl (pH 8.0), 50 mM<br />
KCl, 1.5 mM MgCl2, 1 mM each <strong>of</strong> dNTPs, 1.0 U<br />
Taq DNA polymerase (Fermentas, Germany) <strong>and</strong><br />
1.0 mM <strong>of</strong> each primer previously described<br />
(Rutter 98). The conditions <strong>of</strong> PCR amplification<br />
were as follows: a denaturation step at 95˚C for 5<br />
min followed by 38 cycles at 95˚C for 1 min, 55˚C<br />
for 1 min, 72˚C for 1 min, a final extension at 72˚C<br />
for 10 min <strong>and</strong> stop at 4˚C. For MMP3 analysis,<br />
PCR reactions were carried out in a volume <strong>of</strong> 50
µl containing 50–100 ng DNA template in 10 mM<br />
Tris–HCl (pH 8.0), 50 mM KCl, 1.5 mM MgCl2, 1<br />
mM each <strong>of</strong> dNTPs, 1.0 U Taq DNA polymerase<br />
(Fermentas, Germany) <strong>and</strong> 1.0 mM <strong>of</strong> each primer<br />
previously described (Ye et al., 1996) The<br />
conditions <strong>of</strong> PCR amplification were as follows:<br />
denaturation step at 94˚C for 5 min followed by 35<br />
cycles at 94˚C for 1 min, 65˚C for 45 s, 72˚C for 1<br />
min, a final extension at 72˚C for 7 min <strong>and</strong> stop at<br />
4˚C.<br />
In order to complete genotype analyses, amplicons<br />
MMP1 <strong>and</strong> MMP3 promotor polymorphisms in TMJ disorder 65<br />
<strong>of</strong> MMP1 <strong>and</strong> MMP3 were digested by XmnI (New<br />
Engl<strong>and</strong> Biolabs) <strong>and</strong> Tth111I (New Engl<strong>and</strong><br />
Biolabs) restriction enzymes, respectively, as<br />
previously described (Planello et al., 2011). 1G<br />
allele <strong>of</strong> MMP1 was digested to 89 <strong>and</strong> 29 bp<br />
whereas 2G allele was not digested <strong>and</strong> remained in<br />
its original amplicon length, 118 bp. 5A allele <strong>of</strong><br />
MMP3 yielded 97 <strong>and</strong> 33 bp products by digestion,<br />
6A allele was not digested <strong>and</strong> maintained the<br />
original length <strong>of</strong> 130 bp. All the visualization<br />
processes were carried out by 12% polyacrylamide<br />
gel stained with etidium bromide (Figure 1)<br />
Figure 1. RFLP analyses <strong>of</strong> MMP1 <strong>and</strong> MMP3 genes, M: <strong>Molecular</strong> marker (Fermentas, Germany), 2G/2G:<br />
Homozygous genotype <strong>of</strong> 2G allele for MMP1, 1G/2G: Heterozygous genotype for MMP1, 1G/1G:<br />
Homozygous <strong>of</strong> 1G allele for MMP1, 5A/5A: Homozygous genotype <strong>of</strong> 5A allele for MMP3, 5A/6A:<br />
Heterozygous genotype for MMP3, 6A/6A: Homozygous genotype <strong>of</strong> 6A allele for MMP3.<br />
Statistical analysis<br />
Statistical analysis for identifying the differences<br />
between TMJ <strong>and</strong> control groups was performed<br />
with Chi-square test by using SPSS 18.0. p0,05<br />
was accepted as statistically significant whereas<br />
values higher than 0,05 was not.<br />
Results<br />
For the MMP1 genotypes, 8 <strong>of</strong> the 35 patients <strong>and</strong><br />
11 <strong>of</strong> the 50 controls were 1G/1G, 14 patients <strong>and</strong><br />
28 were 1G/2G <strong>and</strong> 13 patients <strong>and</strong> 11 controls<br />
were 2G/2G, respectively. Genotypes <strong>of</strong> MMP1<br />
polymorphisms <strong>and</strong> p- values were summarized in<br />
Table 1. When we compare two groups for MMP1<br />
genotypes, we could not find any statistically<br />
significant association, all <strong>of</strong> the p- values are <br />
0,5%.<br />
For the MMP3 genotypes, <strong>of</strong> the 50 controls, 8<br />
were 5A/5A, 23 were 5A/6A <strong>and</strong> 19 were 6A/6A,<br />
respectively. 6 <strong>of</strong> the 35 patients were 5A/5A, 14<br />
were 5A/6A <strong>and</strong> 15 were 6A/6A. Genotypes <strong>of</strong><br />
MMP1 polymorphisms were summarized in Table<br />
2. Like in MMP1 genotypes, we could not find any<br />
statistically significant association in patient <strong>and</strong><br />
control group, the p- values are 0,5%.
66 Necati TASKIN et al.<br />
Discussion<br />
Table 1. Genotype distribution <strong>and</strong> OR <strong>of</strong> MMP1 polymorphism in control <strong>and</strong> TMJ groups<br />
Genotypes<br />
Control Group<br />
(n=50)<br />
TMJ Group<br />
(n=35)<br />
p- value<br />
OR (95% CI)<br />
Control/TMJ Group<br />
1G/1G 11 8 0,56 0,952 (0,338-2,678)<br />
1G/2G 28 14 0,14 1,909 (0,794-4,589)<br />
2G/2G 11 13 0,1 0,541 (0,206-1,422)<br />
Table 2. Genotype distribution <strong>and</strong> OR <strong>of</strong> MMP3 polymorphism in control <strong>and</strong> TMJ groups<br />
Genotypes<br />
Control Group<br />
(n=50)<br />
TMJ Group<br />
(n=35)<br />
p- value<br />
OR (95% CI)<br />
Control/TMJ Group<br />
5A/5A 8 6 0,889 0,921 (0,289-2,935)<br />
5A/6A 23 14 0,659 1,278 (0,532-3,067)<br />
6A/6A 19 15 0,653 0,817 (0,339-1,970)<br />
MMPs are secreted by pro- enzymes <strong>and</strong> activated<br />
after the removal <strong>of</strong> their N- terminal domain<br />
(Visse <strong>and</strong> Negase, 2003). For MMP1 <strong>and</strong> MMP3<br />
enzymes, there is an additional activation process,<br />
transcriptional regulation. Promoter 1G/2G<br />
polymorphism at the -1607 position <strong>of</strong> MMP1 gene<br />
<strong>and</strong> 5A/6A promoter polymorphism <strong>of</strong> MMP3 were<br />
reported to influence gene expression levels <strong>of</strong><br />
related MMPs, <strong>and</strong> associate these SNPs with<br />
degenerative diseases (Ye et al., 1996; Barlas et al.,<br />
2009; Astolfi et al., 2006).<br />
Rutter et al. reported that 2G allele <strong>of</strong><br />
MMP1gene increases the gene expression <strong>and</strong><br />
mRNA levels <strong>of</strong> MMP1 gene (Rutter et al., 1998).<br />
This allele creates a binding site for Ets<br />
transcription factor family, which promotes 37-<br />
fold in vitro increase <strong>of</strong> transcription activity. Also<br />
another study, in transgenic mice, showed the in<br />
vivo effect <strong>of</strong> 2G allele on transcription activity<br />
(Coon et al., 2009).<br />
We could not observe a significant difference in<br />
1G/2G SNP <strong>of</strong> MMP1 gene between TMJ patients<br />
<strong>and</strong> control group. Our findings are in accordance<br />
with the study reporting no association between<br />
MMP1 -1607 polymorphism <strong>and</strong> rheumatoid<br />
arthritis progression, degenerative disease including<br />
systemic joints. Although there are some reports<br />
indicating the molecular difference <strong>of</strong> systemic<br />
joints <strong>and</strong> TMJ, the exact mechanism <strong>of</strong><br />
degenerative effect, in which MMP1 is in charge, is<br />
still unclear (Wadhwa <strong>and</strong> Capila, 2008). There are<br />
also other studies that our findings are not in<br />
agreement. These studies reported the association<br />
<strong>of</strong> 2G allele <strong>and</strong> certain types <strong>of</strong> cancer (Peng et al.,<br />
2010), periodontitis (de Souza et al., 2003) <strong>and</strong><br />
TMJ (Planello et al., 2011). The latter associated<br />
the 2G allele <strong>and</strong> TMJ degeneration <strong>and</strong> showed<br />
that 2G/2G individuals have a 2,47 time higher<br />
probability <strong>of</strong> developing TMJ when compared to<br />
1G/1G <strong>and</strong> 1G/2G individuals. At the same study,<br />
authors couldn’t find any allelic association,<br />
claiming only 2G/2G individuals are in risk <strong>of</strong><br />
developing TMJ, individuals without 2G allele are<br />
protected from the disease. Small sample size,<br />
heterogenetic nature <strong>of</strong> genetic diseases <strong>and</strong><br />
probable multifactorial background <strong>of</strong> TMJ may be<br />
the reasons <strong>of</strong> our results that are not in agreement<br />
with previous mentioned studies.<br />
Like MMP1, MMP3 has an SNP at position -<br />
1612 which shows variation in enzyme activity. 5A<br />
allele in this position <strong>of</strong> the gene has a greater<br />
activity to 6A allele, in vitro (Ye at al., 1996).<br />
Allele 5A is associated to increase the risk <strong>of</strong> acute<br />
myocardial infarction (Terashima et al., 1999) <strong>and</strong><br />
in another study, 5A allele has been suspected to<br />
atherosclerosis (Ye, 2000). MMP3 has an<br />
accumulative activity during the initial phase <strong>of</strong><br />
TMJ, degrades various types <strong>of</strong> matrix proteins <strong>and</strong><br />
activates other MMPs like MMP1, MMP8 <strong>and</strong><br />
MMP13, leading to an increase in tissue<br />
degradation (Planello et al., 2011; Fujita et al.,<br />
2009). We couldn’t find any association with the<br />
polymorphism <strong>and</strong> TMJ, like Planello et al (2011).<br />
The exact activity <strong>of</strong> MMP3 in tissue degradation is<br />
not clear <strong>and</strong> may be the SNP examined has a<br />
limited influence on the enzyme activity.
There are number <strong>of</strong> factors which affect<br />
unexpected results on polymorphism- disease<br />
association studies. Ethnicities <strong>of</strong> the races,<br />
different allele frequencies between populations,<br />
classifications <strong>of</strong> patient groups are only some <strong>of</strong><br />
them. Also the metabolism or the activity processes<br />
<strong>of</strong> the examined molecules are important. In our<br />
study, MMP1 <strong>and</strong> MMP3, they are regulated not<br />
only by transcription, but also activation <strong>of</strong> the pro-<br />
enzyme <strong>and</strong> inhibitions <strong>of</strong> enzymes by their tissue<br />
inhibitors (TIMPs) (Astolfi et al., 2006). There are<br />
other factors that influence secretion, cell surface<br />
localization <strong>and</strong> clearance <strong>of</strong> the degraded MMPs.<br />
These regulation factors may help us to explain<br />
why our results didn’t support the information on<br />
the literature. Astolfi et al. (2006) also supported<br />
the idea that increase in mRNA levels may not<br />
necessarily lead to increased levels <strong>of</strong> MMPS.<br />
References<br />
Astolfi CM, Shinohara AL, da Silva RA, Santos<br />
MC, Line SR, de Souza AP. Genetic<br />
polymorphisms in the MMP-1 <strong>and</strong> MMP-3 gene<br />
may contribute to chronic periodontitis in a<br />
Brazilian population. J Clin Periodontol. 33:<br />
699–703, 2006.<br />
Barlas IO, Sezgin M, Erdal ME, Sahin G, Ankarali<br />
HC, Altintas ZM, Turkmen E. Association <strong>of</strong> (-<br />
1,607) 1G/2G polymorphism <strong>of</strong> matrix<br />
metalloproteinase-1 gene with knee<br />
osteoarthritis in the Turkish population (knee<br />
osteoarthritis <strong>and</strong> MMPs gene polymorphisms).<br />
Rheumatol Int. 29: 383– 388, 2009.<br />
Coon CI, Fiering S, Gaudet J, Wyatt CA,<br />
Brinckerh<strong>of</strong>f CE. Site controlled transgenic<br />
mice validating increased expression from<br />
human matrix metalloproteinase (MMP-1)<br />
promoter due to a naturally occurring SNP.<br />
Matrix Biol. 28: 425–431, 2009.<br />
De Maat MP, Jukema J, Ye S. Effect <strong>of</strong><br />
stromelysin-1 promotor on efficacy <strong>of</strong><br />
pravastatin in coronary atherosclerosis <strong>and</strong><br />
restenosis. Am. J. <strong>of</strong> Cardiology. 83:852-856,<br />
1999.<br />
de Souza AP, Trevilatto PC, Scarel-Caminaga RM,<br />
Brito RB, Line SR. MMP-1 promoter<br />
polymorphism: association with chronic<br />
periodontitis severity in a Brazilian population.<br />
J Clin Periodontol. 30: 154–158, 2003.<br />
MMP1 <strong>and</strong> MMP3 promotor polymorphisms in TMJ disorder 67<br />
Dijkgraaf LC, de Bont LG, Boering G, Liem RS.<br />
The structure, biochemistry, <strong>and</strong> metabolism <strong>of</strong><br />
osteoarthritic cartilage: a review <strong>of</strong> the<br />
literature. J Oral Maxill<strong>of</strong>ac Surg. 53: 1182–<br />
1192, 1995.<br />
Dworkin SF, Tuner JA, Mancl L, Wilson L,<br />
Massoth D, Huggins KH, Le Reshe L, Truelove<br />
E. A r<strong>and</strong>omized clinical trial <strong>of</strong> a tailored<br />
comprehensive care treatment program for<br />
temporom<strong>and</strong>ibular disorders. J Orafac<br />
Pain.16:259–276, 2002.<br />
Fujita H, Morisugi T, Tanaka Y, Kawakami T,<br />
Kirita T, Yoshimura Y. MMP-3 activation is a<br />
hallmark indicating an early change in TMJ<br />
disorders, <strong>and</strong> is related to nitration. Int J Oral<br />
Maxill<strong>of</strong>ac Surg. 38: 70–78, 2009.<br />
Kubota E, Kubota T, Matsumoto J, Shibata T,<br />
Murakami KI. Synovial fluid cytokines <strong>and</strong><br />
proteinases as markers <strong>of</strong> temporom<strong>and</strong>ibular<br />
joint disease. J Oral Maxill<strong>of</strong>ac Surg. 56: 192–<br />
198, 1998.<br />
Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J,<br />
Zhang Z, Wang X, Yu L. Polymorphisms in the<br />
promoter regions <strong>of</strong> matrix metalloproteinases 1<br />
<strong>and</strong> 3 <strong>and</strong> cancer risk: a meta- analysis <strong>of</strong> 50<br />
case-control studies. Mutagenesis. 25: 41–48,<br />
2010.<br />
Planello AC, Campos MIG, Meloto CB, Secolin R,<br />
Rizatti-Barbosa CM, Line SRP, de Souza AP.<br />
Association <strong>of</strong> matrix metalloproteinase gene<br />
polymorphism with temporom<strong>and</strong>ibular joint<br />
degeneration. Eur J Oral Sci. 119: 1–6, 2011.<br />
Rutter JL, Mitchell TI, Buttice G, Meyers J,<br />
Gusella JF, Ozelius LJ, Brinckerh<strong>of</strong>f CE. A<br />
single nucleotide polymorphism in the matrix<br />
metalloproteinase-1 promoter creates an Ets<br />
binding site <strong>and</strong> augments transcription. Cancer<br />
Res. 58: 5321–5325, 1998.<br />
Srinivas R, Sorsa T, Tjaderhane L, Niemi E,<br />
Raustia A, Pernu H, Teronen O, Salo T. Matrix<br />
metalloproteinases in mild <strong>and</strong> severe<br />
temporom<strong>and</strong>ibular joint internal derangement<br />
synovial fluid. Oral Surg Oral Med Oral Pathol<br />
Oral Radiol Endod. 91: 517–525, 2001.<br />
Stegenga B. Osteoarthritis <strong>of</strong> the<br />
temporom<strong>and</strong>ibular joint organ <strong>and</strong> its<br />
relationship to disc displacement. J Or<strong>of</strong>ac<br />
Pain. 15: 193–205, 2001.<br />
Terashima M, Akita H, Kanazawa K, Inoue N,
68 Necati TASKIN et al.<br />
Yamada S, Ito K, Matsuda Y, Takai E, Iwai C,<br />
Kurogane H, Yoshida Y, Yokoyama M.<br />
Stromelysin promoter 5A/6A polymorphism is<br />
associated with acute myocardial infarction.<br />
Circulation. 99: 2717–2719, 1999.<br />
Visse R, Nagase H. Matrix metalloproteinases <strong>and</strong><br />
tissue inhibitors <strong>of</strong> metalloproteinases:<br />
structure, function, <strong>and</strong> bio-chemistry. Circ Res.<br />
92: 827–839, 2003.<br />
Wadhwa S, Kapila S. TMJ disorders: future<br />
innovations in diagnostics <strong>and</strong> therapeutics. J<br />
Dent Educ. 72: 930–947, 2008.<br />
Ye S, Eriksson P, Hamsten A, Kurkinen M,<br />
Humphries SE, Henney AM. Progression <strong>of</strong><br />
coronary atherosclerosis is associated with a<br />
common genetic variant <strong>of</strong> the human<br />
stromelysin-1 promoter which results in reduced<br />
gene expression. J Biol Chem. 271: 13055–<br />
13060, 1996.<br />
Ye S. Polymorphism in matrix metalloproteinase<br />
gene promoters: implication in regulation <strong>of</strong><br />
gene expression <strong>and</strong> susceptibility <strong>of</strong> various<br />
diseases. Matrix Biol. 19: 623– 629, 2000.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1):69-74, 2011 Research Article 69<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin<br />
during gestation <strong>and</strong> lactation in Swiss albino mice<br />
Isha BARBER, Ragini SHARMA*, Sheetal MOGRA, Khushbu PANWAR <strong>and</strong> Umesh<br />
GARU<br />
Environmental <strong>and</strong> Developmental Toxicology Research Lab, Department <strong>of</strong> Zoology, M. L. S. University,<br />
Udaipur- 313001 Rajasthan (INDIA)<br />
(* author for correspondence; taurasragini@yahoo.com)<br />
Received: 31 March 2011; Accepted: 20 June 2011<br />
Abstract<br />
Although a number <strong>of</strong> studies in animal models have shown changes in hemoglobin content <strong>and</strong> blood cell<br />
counts after lead administration during gestation <strong>and</strong> lactation, lead induced hematological changes are not<br />
well established. In the present study, hemoglobin content <strong>and</strong> blood cells <strong>of</strong> normal <strong>and</strong> lead exposed<br />
pregnant <strong>and</strong> lactating Swiss mice were compared in which selected pregnant females were treated with lead<br />
acetate by gavages (266.66, 533.33, 1066.66 mg/kg BW) during gestation <strong>and</strong> lactation. Animals were<br />
exposed to heavy metal lead orally from day 10 <strong>of</strong> gestation to 3 rd weeks <strong>of</strong> lactation. Hemoglobin content<br />
<strong>and</strong> blood cell counts were examined on 17 th day <strong>of</strong> gestation <strong>and</strong> on 1 st , 7 th , 14 th <strong>and</strong> 21 st day after birth. The<br />
results indicated that in lead intoxicated pregnant females, hemoglobin content <strong>and</strong> red blood cell (RBC)<br />
counts decreased <strong>and</strong> white blood cell (WBC) counts increased. From the results <strong>of</strong> above study it can be<br />
concluded that high levels <strong>of</strong> lead exposure during gestation <strong>and</strong> lactation can severely damage heme<br />
synthesis <strong>and</strong> alter the number <strong>of</strong> RBC <strong>and</strong> WBC.<br />
Keywords: Lead acetate, Swiss albino mice, hemoglobin, RBC, WBC.<br />
Swiss albino farelerde gebelik ve süt verme süresince kurşun ile tetiklenen<br />
hemoglobin ve kan hücreleri sayılarındaki değişimler<br />
Özet<br />
Pek çok hayvan modeli çalışmalarının gebelik ve süt verme boyunca kurşun yüklemesi sonrasında kan<br />
hücrelerinin sayıları ve hemoglobin miktarlarındaki değişiklikleri göstermesine rağmen, kurşun ile tetiklenen<br />
hematolojik değişiklikler iyi belirlenememiştir. Bu çalışmada normal ve kurşuna maruz kalan hamile ve süt<br />
veren Swiss farelerin hemoglobin miktarı ve kan hücreleri gebelik ve emzirme sırasında gavajla kurşun asetat<br />
(266.66, 533.33, 1066.66 mg/kg BW) uygulanan seçilmiş hamile dişilerinkiyle karşılaştırılmıştır. Hayvanlar<br />
gebeliğin 1. gününden süt vermenin 3. haftasına kadar oral olarak ağır metal kurşuna maruz bırakılmıştır.<br />
Hemoglobin miktarı ve kan hücresi sayıları gebeliğin 17. günü ve doğumdan sonraki 1., 7., 14., ve 21.<br />
günlerde incelenmiştir. Sonuçlar, kurşun ile zehirlenmiş gebe dişilerde hemoglobin miktarının ve kırmızı kan<br />
hücresi (RBC) sayılarının azaldığını ve beyaz kan hücrelerinin (WBC) arttığını göstermiştir. Yukarıda<br />
belirtilen sonuçlardan, gebelik ve süt verme sırasında yüksek miktarda kurşuna maruz kalmanın hem grubu<br />
sentezine ciddi zarar verebileceği ve RBC ve WBC sayılarını değiştireceği sonucuna varılabilir.<br />
Anahtar Sözcükler: Kurşun asetat, Swiss albino fare, hemoglobin, RBC, WBC.
70 Isha BARBER et al.<br />
Introduction<br />
In the modern society, thous<strong>and</strong>s <strong>of</strong> hazardous<br />
chemicals <strong>and</strong> heavy metals are being produced <strong>and</strong><br />
used in a wide variety <strong>of</strong> work places all over the<br />
world. Heavy metals are trace metals that are at<br />
least five times denser than water <strong>and</strong> are taken into<br />
body via inhalation, ingestion <strong>and</strong> skin absorption.<br />
It should be noted that most <strong>of</strong> the pathological<br />
conditions in body arise as a result <strong>of</strong> the exposure<br />
to these injurious substances.<br />
Lead <strong>and</strong> other heavy metals create reactive<br />
radicals which damage cell structure including<br />
DNA <strong>and</strong> cell membrane (Flora et al., 2008). Lead<br />
poisoning can cause a variety <strong>of</strong> symptoms <strong>and</strong><br />
signs which vary depending on the individual <strong>and</strong><br />
the duration <strong>of</strong> lead exposure (Karri et al., 2008;<br />
Kosnett, 2005). Gestational lead exposure has many<br />
adverse effects on development; a few <strong>of</strong> them may<br />
be most pronounced during the first trimester<br />
(Mogra et al., 2009)<br />
Many investigators studied the lower as well as<br />
higher exposure levels to lead. According to<br />
Escribano et al., (1997) 140 mg/ kg BW dose was<br />
an approximate environmental daily-exposure<br />
level. This dose was used as the minimum dose.<br />
Gurber et al. (1997) studied the higher<br />
concentration <strong>of</strong> lead that was 1000 mg/kg BW<br />
exposure in industrial areas.<br />
The amount <strong>of</strong> lead in blood <strong>and</strong> tissues, as well<br />
as the time course <strong>of</strong> exposure, determines the level<br />
<strong>of</strong> toxicity (Pearson <strong>and</strong> Schonfeld, 2003). Blood<br />
<strong>of</strong>ten shows pathological changes before the<br />
external signs <strong>of</strong> poisoning become apparent.<br />
The absorbed lead enters the blood stream<br />
where over 90 percent <strong>of</strong> it is bound to the red cells<br />
with a biological half life <strong>of</strong> 25-28 days (Azar et<br />
al., 1975). Toxicological effects <strong>of</strong> lead have their<br />
origin in perturbation in cell function <strong>of</strong> various<br />
organ systems. The major biochemical effect <strong>of</strong><br />
lead is its interference with heme synthesis which<br />
leads to hematological damage (Awad <strong>and</strong> William,<br />
1997). Despite several published accounts on<br />
pathophysiological alterations <strong>of</strong> lead toxicity <strong>and</strong><br />
the cure <strong>of</strong> lead poisoning by sequestering agents<br />
(Royce <strong>and</strong> Rosenberg, 1993), the approaches are<br />
limited in scope. Therefore the present<br />
investigation was focused to evaluate the changes<br />
in the number <strong>of</strong> blood cells <strong>and</strong> Hb content during<br />
pregnancy <strong>and</strong> lactation followed by comparison <strong>of</strong><br />
this data with the high levels <strong>of</strong> lead intoxication<br />
during gestation <strong>and</strong> lactation.<br />
Materials <strong>and</strong> methods<br />
R<strong>and</strong>om breed Swiss albino mice were used for the<br />
present study. Sexually mature male <strong>and</strong> females<br />
weighing 28-30 gm were put in breeding cages in<br />
the ratio <strong>of</strong> 1:4 <strong>and</strong> provided st<strong>and</strong>ard diet <strong>and</strong><br />
water ad libitum. The cages were checked every<br />
day in the morning <strong>and</strong> females showing vaginal<br />
plug were isolated. The selected pregnant females<br />
were divided into 4 groups <strong>and</strong> exposed orally by<br />
lead acetate (266.66, 533.33 <strong>and</strong> 1066.66 mg/kg<br />
BW) with the help <strong>of</strong> canula. All the experimental<br />
work was approved by the institutional animal<br />
ethics committee (No.CS/Res/07/759).<br />
(1) Group 1- Control (distilled water only)<br />
(2) Group 2- Exposure <strong>of</strong> lead acetate (266.66<br />
mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />
day <strong>of</strong> lactation.<br />
(3) Group 3- Exposure <strong>of</strong> lead acetate (533.33<br />
mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />
day <strong>of</strong> lactation.<br />
(4) Group 4- Exposure <strong>of</strong> lead acetate (1066.66<br />
mg/kg BW) from 10 th day <strong>of</strong> gestation up to 21 st<br />
day <strong>of</strong> lactation.<br />
During the respective tenure <strong>of</strong> experiment,<br />
hemoglobin, RBC <strong>and</strong> WBC counts <strong>of</strong> female<br />
Swiss mice were recorded on 17 th day <strong>of</strong> gestation<br />
<strong>and</strong> on 1 st , 7 th , 14 th <strong>and</strong> 21 st days <strong>of</strong> lactation. Blood<br />
samples for hemoglobin <strong>and</strong> blood cell counts were<br />
obtained from the tail <strong>of</strong> each mouse. The tip <strong>of</strong> the<br />
tail was cleaned with spirit before being cut with a<br />
sharp blade <strong>and</strong> was not squeezed to avoid dilution<br />
<strong>of</strong> blood by tissue fluid. The first few drops <strong>of</strong><br />
blood were discarded <strong>and</strong> the blood was diluted, for<br />
cell counting with the help <strong>of</strong> haemocytometer. The<br />
hemoglobin was estimated by hemoglobinometer.<br />
Number <strong>of</strong> (RBCs) <strong>and</strong> (WBCs) were estimated<br />
with haemocytometer adopting the method<br />
described by Dacie <strong>and</strong> Lewis (1975). The<br />
statistical analysis was performed by using analysis<br />
<strong>of</strong> variance (ANOVA) for the comparison <strong>of</strong> data<br />
between different experimental groups.<br />
Results<br />
Introducing lead acetate to female Swiss mice<br />
during gestation <strong>and</strong> lactation period produced a<br />
significant decrease in the hemoglobin content <strong>and</strong><br />
number <strong>of</strong> RBC. Exposure during the gestation<br />
period produced a significant decrease in WBC<br />
counts at the time <strong>of</strong> birth whereas number <strong>of</strong> cells<br />
increase during lactation period.
Data regarding changes in hemoglobin, RBC<br />
<strong>and</strong> WBC counts among different experimental<br />
groups <strong>and</strong> the results obtained for hemoglobin,<br />
RBC <strong>and</strong> WBC are summarized in Tables 1-3. It is<br />
evident from the tables that control animals have<br />
12.5 g/dL Hb, 9.21×10 6 RBC/mm 3 <strong>and</strong> 8.22×10 3<br />
WBC/mm 3 in their blood on 17 th day <strong>of</strong> gestation.<br />
As compared to controls, hemoglobin content, RBC<br />
<strong>and</strong> WBC counts <strong>of</strong> lead- treated female mice were<br />
significantly decreased at the time <strong>of</strong> birth, after<br />
introduction <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66 mg/kg<br />
BW <strong>of</strong> lead acetate.<br />
Lead induced hematological changes 71<br />
The results collected for the hemoglobin is<br />
summarized in Table 1.<br />
It is evident that control animals have 11.5,<br />
12.0, 13.1 <strong>and</strong> 14.0 g/dL Hb in their blood on 1 st ,<br />
7 th , 14 th <strong>and</strong> 21 st day <strong>of</strong> lactation, respectively.<br />
Introduction <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66mg/kg<br />
BW doses <strong>of</strong> lead acetate produced a significant<br />
decrease (p
72 Isha BARBER et al.<br />
Table 3. WBC count (×10 3 cells/mm 3 ) in pregnant <strong>and</strong> lactating female mice treated with lead acetate.<br />
Treatment group<br />
Prenatal<br />
Days<br />
Postnatal<br />
17 1 7 14 21<br />
Control 8.22±3.92 8.07±3.30 8.33±4.30 8.56±3.56 8.86±3.47<br />
Lead acetate (266.66 mg/kg BW) 8.62±5.00* 8.48±1.79* 8.70±5.77 8.71±7.50 9.18±1.25<br />
Lead acetate (533.33 mg/kg BW) 8.98±9.46* 8.62±2.95* 9.10±1.47* 9.20±2.04* 9.31±2.09*<br />
Lead acetate (1066.66 mg/kg BW) 9.26±1.70* 9.00±1.73* 9.17±8.66* 9.35±1.68* 9.46±1.43*<br />
Values were expressed as means ± S.D., values are significantly different (p
elated to major structural <strong>and</strong> functional changes<br />
<strong>of</strong> the intimate relation between fetus <strong>and</strong> mother.<br />
These structural changes are related to implantation<br />
<strong>and</strong> placentation; <strong>and</strong> the functional changes to<br />
increasing hypoxia in the crowded condition <strong>of</strong> the<br />
gravid uterus (Robert <strong>and</strong> Rosenberg, 1993).<br />
In conclusion, the present study indicates that<br />
lead adversely affects hemoglobin <strong>and</strong> blood cell<br />
counts. Dose dependent significant decrease in<br />
hemoglobin <strong>and</strong> RBC counts were observed after<br />
administration <strong>of</strong> 266.66, 533.33 <strong>and</strong> 1066.66<br />
mg/kg/body weight doses <strong>of</strong> lead acetate. However,<br />
WBC counts showed increase in their number.<br />
The results observed in this paper can be used<br />
as a background information for the evaluation <strong>of</strong><br />
reproductive toxicity induced by lead during<br />
gestation <strong>and</strong> lactation in Swiss mice. Moreover,<br />
the mice seem to be a useful animal model for<br />
investigating the mechanisms <strong>of</strong> alterations in the<br />
blood cells <strong>and</strong> hemoglobin content which is<br />
reported to occur during pregnancy <strong>and</strong> lactation in<br />
mice.<br />
References<br />
Angle CR, McIntire MS <strong>and</strong> Swanson MS.<br />
Erythrocyte nucleotides in children increased<br />
blood lead <strong>and</strong> cytidine triphosphate. Pediatr<br />
Res 16:331-334, 1982.<br />
Awad M <strong>and</strong> William Jr. Textbook <strong>of</strong> biochemistry<br />
with clinical correlation. John Wiley <strong>and</strong><br />
Sons, INC, Newyork. 1997.<br />
Azar A, Snee RD, Habibi K. Lead toxicity in<br />
mammalian blood. In: Griffin TB, Knelson<br />
JH (Ed) Lead. Academic, Newyork. 254,<br />
1975.<br />
Banu R, Sharma R <strong>and</strong> Qureshi N. Amelioration <strong>of</strong><br />
lead induced alterations in body weight <strong>and</strong><br />
blood cell counts by antioxidant vitamins.<br />
<strong>Journal</strong> <strong>of</strong> Herbal Medicine <strong>and</strong> Toxicology<br />
1(2): 59-66, 2007.<br />
Dacie JV <strong>and</strong> Lewis SM. In: Practical Hematology,<br />
5th Edn. J. <strong>and</strong> A. Churchill Ltd. London,<br />
1975.<br />
De Rijk EP, van Esch E <strong>and</strong> Flik G. Pregnancy<br />
dating in the rat: placental morphology <strong>and</strong><br />
maternal blood parameters. Toxicol Pathol<br />
30:271–282, 2002.<br />
Lead induced hematological changes 73<br />
EPA, U.S. Air Quality Criteria for Lead. EPA<br />
600/8-83-028F. Washington, DC: U.S.<br />
Environmental Protection Agency, 1986.<br />
Escribano,A.,Revilla, M., Herna’ndez, E.R., Seco,<br />
C., Gonza’lez-Riola, J., Villa, L.F. <strong>and</strong> Rico,<br />
H. Effect <strong>of</strong> lead on bone development <strong>and</strong><br />
bone mass: a morphometric, densitometric,<br />
<strong>and</strong> histomorphometric study in growing<br />
rats. Calcif Tissue Int. 60: 200-203, 1997.<br />
Flora Sj, Mittal M <strong>and</strong> Mehta A. Heavy metal<br />
induced oxidative stress & its possible<br />
reversal by chelation therapy. The Indian<br />
<strong>Journal</strong> <strong>of</strong> Medical Research 128 (4): 501–<br />
23, 2008.<br />
Fruhman GJ. Blood formation in the pregnant<br />
mouse. Blood J. Hematol. 31: 242-248,<br />
1968.<br />
Gruber, H.E., Gonic, H.C., Khalil-Manesh, F.,<br />
Sanchez, T.V., Matsinger, S., Meyer, M. <strong>and</strong><br />
Sharp, C.F. Osteopenia induced by longterm,<br />
low <strong>and</strong> high-level exposure <strong>of</strong> the<br />
adult rat <strong>of</strong> lead. Miner. Electrolyte Metab.,<br />
23, 65-33,1997.<br />
Harkness JE <strong>and</strong> Wagner JE. Biologia e clínica de<br />
coelhos e roedores. 3ª ed. São Paulo: Roca,<br />
1993.<br />
Howells MR, Jones SE, Napier JA, Saunders K <strong>and</strong><br />
Cavill I. Erythropoiesis in pregnancy. Br J<br />
Haematol 64:595–599, 1986.<br />
Karri Sk, Saper Rb <strong>and</strong> Kales Sn. Lead<br />
encephalopathy due to traditional medicines.<br />
Current Drug Safety 3 (1): 54–9, 2008.<br />
Kosnett MJ. Lead. In Brent, J. Critical Care<br />
Toxicology: Diagnosis <strong>and</strong> Management <strong>of</strong><br />
the Critically Poisoned Patient. Gulf<br />
Pr<strong>of</strong>essional Publishing. 2005.<br />
Mercelina-Roumans PE, Ubachs JM <strong>and</strong> van<br />
Wersch JW. Leukocyte count <strong>and</strong> leukocyte<br />
differential in smoking <strong>and</strong> non-smoking<br />
females during pregnancy. Eur J Obstet<br />
Gynecol Reprod Biol 55:169–173,1994.<br />
Mogra S, Sharma R <strong>and</strong> Qureshi N. Effects <strong>of</strong><br />
maternal lead acetate exposure on prenatal<br />
development <strong>of</strong> Swiss albino mice. Asian J<br />
Environ. Sci. 4(2):216-220, 2009.<br />
Paglia DE, Valentine WN <strong>and</strong> Dahigren JG. Effects<br />
<strong>of</strong> low-level lead exposure on pyrimidine 5'nucleotidase<br />
<strong>and</strong> other erythrocyte enzymes.
74 Isha BARBER et al.<br />
Possible role <strong>of</strong> pyrimidine 5'-nucleotidase<br />
in the pathogenesis <strong>of</strong> lead-induced anemia.<br />
J Clin Invest 56:1164-1169, 1975.<br />
Paglia DE, Valentine WN <strong>and</strong> Fink K. Lead<br />
poisoning. Further observations on<br />
erythrocyte pyrimidine-nucleotidase<br />
deficiency <strong>and</strong> intracellular accumulation <strong>of</strong><br />
pyrimidine nucleotides. J Clin Invest.<br />
60:1362-1366, 1977.<br />
Paprika MV <strong>and</strong> Sharma BB. <strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />
Tissue Research 3(1):12-17, 2003.<br />
Pearson HA, <strong>and</strong> Schonfeld DJ.. Lead. In Rudolph,<br />
C.D.. Rudolph'sPediatrics, 21st edition.<br />
McGraw-Hill Pr<strong>of</strong>essional. 2003<br />
Robbins SL <strong>and</strong> Angell M. In: Basic pathology,<br />
2nd Edn. W.B. Saunders Co. Philadelphia,<br />
3-30, 1976.<br />
Robert R <strong>and</strong> Csilla S. The effect <strong>of</strong> pregnancy on<br />
peripheral blood in the mouse. Biol. Bull.,<br />
136: 454-460, 1969.<br />
Royce S <strong>and</strong> Rosenberg J. Chelation therapy in<br />
workers with lead exposure. Western J Med<br />
158: 371-375, 1993.<br />
Rugh R <strong>and</strong> Somogyi C. Pre-<strong>and</strong> postnatal normal<br />
mouse blood cell counts. Proc Soc Exp Biol<br />
Med 127, 1267-1271, 1968.<br />
Yu MH. Soil <strong>and</strong> water pollution: Environmental<br />
metals <strong>and</strong> metalloids. Environmental<br />
Toxicology: Biological <strong>and</strong> Health Effects <strong>of</strong><br />
Pollutants. CRC Press. 2005.<br />
Zarrow MX. Gestation, In: Edgar Allen, Ed., Sex<br />
<strong>and</strong> Internal Secretion, <strong>Vol</strong>ume II. Williams<br />
<strong>and</strong> Wilkins Co., Baltimore. 958-1031, 1961.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 75-82, 2011 Research Article 75<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia<br />
amygdalina on some vital organs in adult Wistar rats<br />
Spencer NWANGWU 1 , David Adesanya OFUSORI 2,* , Sunday JOSIAH 1 , Osasere Frank<br />
AMEGOR 3 , Helen NJOYA 1 <strong>and</strong> Abiodun Oladele AYOKA 4<br />
1 Department <strong>of</strong> Biochemistry, School <strong>of</strong> Basic Medical Sciences, Igbinedion University, Okada, Edo-State,<br />
Nigeria<br />
2 Department <strong>of</strong> Anatomy <strong>and</strong> <strong>Cell</strong> <strong>Biology</strong>, Faculty <strong>of</strong> Basic Medical Sciences, Obafemi Awolowo University,<br />
Ile-Ife, Osun-State, Nigeria<br />
3 Department <strong>of</strong> Medical Laboratory Science, College <strong>of</strong> Health Sciences, Igbinedion University, Okada, Edo<br />
State, Nigeria<br />
4 Department <strong>of</strong> Physiological Sciences, Faculty <strong>of</strong> Basic Medical Sciences, Obafemi Awolowo University,<br />
Ile-Ife, Osun-State, Nigeria<br />
(* author for correspondence; david<strong>of</strong>us234@yahoo.com<br />
Received: 15 February 2011; Accepted: 20 June 2011<br />
Abstract<br />
The aim <strong>of</strong> this study was to comparatively determine the effects <strong>of</strong> aqueous <strong>and</strong> ethanolic extracts <strong>of</strong><br />
Vernonia amygdalina (Asteraceae) leaves, adopting histological procedures on the liver, stomach <strong>and</strong> kidney<br />
in adult wistar rats.There were four groups <strong>of</strong> animals: A, B, C <strong>and</strong> D. Groups A, B <strong>and</strong> C served as the<br />
treated animals while group D served as the control animals. Each <strong>of</strong> the groups was further subdivided into<br />
two i.e A1 & A2; B1 & B2; C1 & C2 <strong>and</strong> D1 & D2. Animals in groups A1, B1 <strong>and</strong> C1 were administered<br />
orally with aqueous extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong> 300 mg/kg respectively while animals in groups<br />
A2, B2 <strong>and</strong> C2 were administered orally with ethanolic extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong> 300 mg/kg<br />
respectively. The control groups, D1 <strong>and</strong> D2, received equal volume <strong>of</strong> normal saline. There were no<br />
significant derangement in the cytoarchitecture <strong>of</strong> the stomach, liver <strong>and</strong> kidney. Rather, the cytoarchitecture<br />
<strong>of</strong> the animals treated with both the ethanolic <strong>and</strong> aqueous extracts (300mg/kg) <strong>of</strong> V. amygdalina were better<br />
organized when compared with the control. It was therefore concluded that both ethanolic <strong>and</strong> aqueous leaf<br />
extracts <strong>of</strong> V. amygdalina are non-toxic <strong>and</strong> may possess cytoprotective potential.<br />
Keywords: Vernonia amygdalina, histological procedures, liver, stomach, kidney<br />
Vernonia amygdalina yaprağının sulu ve etanolik özütlerinin erişkin Wistar<br />
sıçanlarının bazı hayati organlarına etkileri<br />
Özet<br />
Çalışmanın amacı, erişkin Wistar sıçanlarda Vernonia amygdalina (Asteraceae) yapraklarının sulu ve<br />
etanolik özütlerinin karaciğer, mide ve böbrek üzerindeki etkilerini histolojik yöntemlerle karşılaştırmalı<br />
olarak belirlemektir. Çalışmada dört grup hayvan bulunmaktadır: A, B, C ve D. D grubu kontrol hayvanları<br />
olarak belirlenirken; A, B ve C grupları muamele edilmiş hayvanları göstermektedir. Her bir grup ayrıca iki<br />
alt gruba bölünmüştür; A1 & A2; B1 & B2; C1 & C2, D1 & D2. A1, B1 ve C1 gruplarındaki hayvanlara<br />
sırasıyla 100, 200 ve 300 mg/kg V.amygdalina sulu özütü oral olarak uygulanırken A2, B2 ve C2’ye ise<br />
sırasıyla 100, 200 ve 300 mg/kg V.amygdalina etanolik özütü oral olarak uygulanmıştır. Kontrol grupları<br />
olan D1 ve D2 eşit hacimde normal tuz almışlardır. Mide, karaciğer ve böbreğin hücresel yapısında belirgin<br />
bir bozulma bulunmamıştır. Bilakis hem sulu, hem de etanolik V. amygdalina (300mg/kg) özütü uygulanan
76 Spencer NWANGWU et al.<br />
hayvanların hücresel yapıları kontrollerle karşılaştırıldığında daha iyi organizedir. Bu nedenle sulu ve<br />
etanolik V. amygdalina yaprak özütlerinin her ikisinin de toksik olmadığı ve hücre koruyucu potansiyele<br />
sahip olabileceği sonucuna varılmıştır.<br />
Anahtar Sözcükler: Vernonia amygdalina, histolojik süreçler, karaciğer, mide, böbrek.<br />
Introduction<br />
Vernonia amygdalina (Del. Asteraceae)<br />
commonly known as “bitter leaf” is a valuable<br />
shrub that is widespread in East <strong>and</strong> West Africa.<br />
It is 2-5 m tall with petiolate green leaves <strong>of</strong> about<br />
6 mm diameter (Ojiako <strong>and</strong> Nwanjo, 2006). In<br />
Nigeria the stem is used as chew-sticks, while the<br />
leaves are being used as a popular vegetable for<br />
soups particularly among the Igbos <strong>of</strong> Southern<br />
Nigeria, Africa (Ojiako <strong>and</strong> Nwanjo, 2006). Its<br />
medicinal values for fever, laxative, pile<br />
(haemorrhoids) <strong>and</strong> gastro-intestinal troubles have<br />
been investigated <strong>and</strong> reported by the following<br />
authors: (Oliver, 1960; Ainslie, 1973; Kupcham,<br />
1971; Akah <strong>and</strong> Okafor, 1992; Abosi <strong>and</strong><br />
Raseroka, 2003; Huffman, 2003; Izevbigie et al.,<br />
2004). In fact all parts <strong>of</strong> the plant have been<br />
known to be pharmacologically useful. Oral<br />
administration <strong>of</strong> the aqueous leaf extract <strong>of</strong> the<br />
plant was found to relieve pain (Tekobo et al.,<br />
2002) <strong>and</strong> to lower body temperature (Tekobo et<br />
al., 2002). Atangwho et al. (2010) reported<br />
instantaneous reduction <strong>of</strong> blood glucose <strong>and</strong> a<br />
variation in blood glucose similar to that <strong>of</strong><br />
insulin-treated rats in animals administered with<br />
ethanol extract <strong>of</strong> V. amygdalina.<br />
Nutritionally, V. amygdalina is used mainly in<br />
soup making in the tropics <strong>and</strong> also as an<br />
appetizer <strong>and</strong> febrifuge (Ijeh et al., 1996; Iwu,<br />
1996, Ojiako <strong>and</strong> Nwanjo, 2006) <strong>and</strong> has proven<br />
to be a successful supplement in weaning foods<br />
(Ojiako <strong>and</strong> Nwanjo, 2006). In Nigeria, as in<br />
other tropical countries <strong>of</strong> Africa where the daily<br />
diet is dominated by starchy staple foods,<br />
vegetables are the cheapest <strong>and</strong> most readily<br />
available sources <strong>of</strong> important proteins, vitamins,<br />
minerals <strong>and</strong> essential amino acids (Okafor, 1983,<br />
Ojiako <strong>and</strong> Nwanjo, 2006). The importance <strong>of</strong> V.<br />
amygdalina in animal nutrition in Nigeria has also<br />
been well documented (Onwuka et al., 1989;<br />
Aregheore et al., 1998; Ojiako <strong>and</strong> Nwanjo 2006).<br />
Despite these beneficial uses <strong>of</strong> the plant, there<br />
has been conflicting reports on its exact<br />
toxicological potentials on some visceral organs.<br />
For instance Aregheore et al., (1998) reported the<br />
presence <strong>of</strong> toxic phytochemicals. There are also<br />
reports <strong>of</strong> actual hepatotoxicity in mice (Igile et<br />
al., 1995), also, there was a report on<br />
hepatoprotective effects in rats (Babalola et al.,<br />
2001). Ojiako <strong>and</strong> Nwanjo (2006) reported that V.<br />
amygdalina leaves may be toxic (just like several<br />
other vegetables) if consumed in very large<br />
quantities but the potential danger is not higher<br />
than has been observed for other common<br />
vegetables that are routinely consumed in Africa<br />
in even larger quantities.<br />
In view <strong>of</strong> these conflicting reports, we<br />
therefore set to comparatively determine the<br />
effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> V.<br />
amygdalina, adopting histological procedures on<br />
the stomach, liver <strong>and</strong> kidney in adult wistar rats.<br />
Materials <strong>and</strong> methods<br />
Experimental Site<br />
This research was conducted in the Department <strong>of</strong><br />
Biochemistry, School <strong>of</strong> Basic Medical Sciences,<br />
Igbinedion University, Nigeria.<br />
Experimental Animals<br />
A total <strong>of</strong> forty healthy wistar rats obtained from a<br />
private farm in Benin City were used for the<br />
experiment. These animals were acclimatized for<br />
two weeks before the commencement <strong>of</strong> the<br />
study. The animals were treated in accordance<br />
with the “Guide for the Care <strong>and</strong> Use <strong>of</strong><br />
Laboratory Animals” prepared by the National<br />
Academy <strong>of</strong> Sciences <strong>and</strong> published by the<br />
National Institutes <strong>of</strong> Health (NIH, 1985) .<br />
Experimental Design<br />
There were four groups <strong>of</strong> animals: A, B, C <strong>and</strong><br />
D. Groups A, B <strong>and</strong> C served as the treated<br />
animals while group D served as the control<br />
animals. Each <strong>of</strong> the groups (n=10) was further<br />
subdivided into two i.e A: A1 & A2; B: B1 & B2;
C: C1 & C2 <strong>and</strong> D: D1 & D2. Animals in groups<br />
A1, B1 <strong>and</strong> C1 were administered orally with<br />
aqueous extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong><br />
300 mg/kg respectively while animals in groups<br />
A2, B2 <strong>and</strong> C2 were administered orally with<br />
ethanolic extract <strong>of</strong> V. amygdalina 100, 200 <strong>and</strong><br />
300 mg/kg respectively. The control groups D1<br />
<strong>and</strong> D2 received equal volume <strong>of</strong> normal saline.<br />
Collection <strong>of</strong> plant materials<br />
Fresh but matured leaves <strong>of</strong> Vernonia amygdalina<br />
was procured from a local market in Okada, Edostate.<br />
They were authenticated in the Botany<br />
Department, Igbinedion University, Nigeria. The<br />
leaves were rinsed severally with clean tap water<br />
to remove dust particles <strong>and</strong> debris <strong>and</strong> thereafter<br />
allowed to completely drain.<br />
Preparation <strong>of</strong> plant extracts<br />
Plant materials were separately chopped into bits<br />
with a knife on a chopping board. The leaves<br />
were then air dried <strong>and</strong> one kilogram (1kg) V.<br />
amygdalina was reduced to powder with an<br />
electric blender. The powder was divided into two<br />
portions. One <strong>of</strong> the portions was percolated with<br />
80% ethanol while the other was percolated with<br />
distilled water. The mixtures were allowed for 48<br />
h in the refrigerator at 4 0 C for thorough extraction<br />
<strong>of</strong> the plants active components. These were then<br />
filtered with cheesecloth <strong>and</strong> later with Whatman<br />
No. 1 filter paper to obtain a homogenous filtrate.<br />
These filtrates were then concentrated in vacuo at<br />
low temperature (37- 40 0 C) to about one tenth the<br />
original volume using a rotary evaporator. The<br />
concentrates were allowed open in a water bath<br />
(40 0 C) for complete dryness for both ethanol <strong>and</strong><br />
aqueous extracts <strong>of</strong> V. amygdalina. The extracts<br />
(26.7% yield) were then refrigerated at 2- 8 0 C<br />
until use.<br />
Histological Procedure<br />
Histological study was carried out using the<br />
method <strong>of</strong> Carleton (1967). These procedures<br />
Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 77<br />
involved dehydration <strong>of</strong> the liver, kidney <strong>and</strong><br />
spleen tissues with graded ethanol concentrations<br />
(50%, 70%, 90% <strong>and</strong> 100%, respectively),<br />
clearing in xylene, followed by infiltration in<br />
paraffin wax for 2 h at 56 o C <strong>and</strong> embedding in<br />
paraffin wax for 48 h. Sections (5 μm thick) were<br />
then obtained, using a rotary microtome,<br />
subjected to haematoxylin <strong>and</strong> eosin (H & E)<br />
staining procedure <strong>and</strong> examined under a light<br />
microscope. Permanent photomicrographs <strong>of</strong> the<br />
observations were taken, using an Olympus<br />
Research Microscope (model BX51).<br />
Results<br />
There were no significant derangement in the<br />
cytoarchitecture <strong>of</strong> the stomach, liver <strong>and</strong> kidney.<br />
Rather, the cytoarchitecture <strong>of</strong> the animals treated<br />
with both the ethanolic <strong>and</strong> aqueous extract<br />
(300mg/kg) <strong>of</strong> V. amygdalina were better<br />
organized when compared with the control<br />
(Figures 1-3). In the stomachs <strong>of</strong> treated animals,<br />
there were no disruptions <strong>of</strong> surface epithelium<br />
<strong>and</strong> no presence <strong>of</strong> submucosal edema as well as<br />
leucocytes infiltration as compared with control<br />
groups (Figure 1). There were no hypertrophy <strong>of</strong><br />
the liver <strong>and</strong> no necrosis <strong>of</strong> the hepatocytes in the<br />
treated animals as compared with control groups<br />
(Figure 2). Also, the kidneys <strong>of</strong> animals in the<br />
treated groups presented well preserved renal<br />
corpuscles <strong>and</strong> Bowman’s spaces as compared<br />
with control groups (Figure 3). Animals in both<br />
the treated <strong>and</strong> control groups showed no physical<br />
changes in their appearances. The present study<br />
demonstrated that oral administration <strong>of</strong> both<br />
ethanolic <strong>and</strong> aqueous extracts (300 mg kg -1 )<br />
preserved the hepatic, renal <strong>and</strong> gastric integrity<br />
as compared to animals administered with lesser<br />
dose (200 <strong>and</strong> 100 mg kg -1 ) <strong>and</strong> only distilled<br />
water (Figures 1-3). There were no significant<br />
differences between the cytoprotective abilities <strong>of</strong><br />
the animals treated with ethanolic or aqueous<br />
extracts compared to the animals treated with<br />
control.
78 Spencer NWANGWU et al.<br />
A1 A2<br />
C1<br />
B1 B2<br />
Figure 1. Histological section <strong>of</strong> gastric mucosa treated with A: aqueous extract V. amygdalina (A1-100, B1-<br />
200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note that there<br />
were no disruptions <strong>of</strong> surface epithelium. No presence <strong>of</strong> submucosal edema <strong>and</strong> leucocytes infiltration as<br />
compared with control groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).<br />
C2<br />
D1 D2
Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 79<br />
Figure 2. Histological section <strong>of</strong> hepatic parenchyma treated with A: aqueous extract V. amygdalina (A1-<br />
100, B1-200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note<br />
that there were no hypertrophy <strong>of</strong> the liver <strong>and</strong> no necrosis <strong>of</strong> the hepatocytes as compared with control<br />
groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).
80 Spencer NWANGWU et al.<br />
Figure 3. Histological section <strong>of</strong> renal parenchyma treated with A: aqueous extract V. amygdalina (A1-100,<br />
B1-200, C1-300mg/kg); B: ethanolic extract <strong>of</strong> V. amygdalina (A2-100, B2-200, C2-300mg/kg). Note that<br />
the renal corpuscles <strong>and</strong> Bowman’s spaces were well preserved. Also, there were no evidence <strong>of</strong> cellular<br />
necrosis as compared with control groups D1 <strong>and</strong> D2 (H <strong>and</strong> E stain, 100x).<br />
Discussion<br />
The histopathological changes observed in the<br />
liver, kidney, stomach <strong>of</strong> aqueous <strong>and</strong> ethanolic<br />
extracts <strong>of</strong> V. amygdalina on rats showed no<br />
evidence <strong>of</strong> lesions in the treated animals when<br />
compared with control. Our histological findings<br />
further revealed that the cyto-architecture <strong>of</strong> the<br />
liver parenchyma was better organized in the<br />
groups treated with 300mg/kg <strong>of</strong> both ethanolic <strong>and</strong><br />
aqueous extracts <strong>of</strong> V. amygdalina. The functions<br />
<strong>of</strong> the liver which includes detoxification,<br />
metabolic activities, synthesis <strong>of</strong> plasma protein<br />
<strong>and</strong> destruction <strong>of</strong> spent red blood cells among<br />
other functions will be better enhanced based on
histological evidences from our study. This shows<br />
that administration <strong>of</strong> ethanolic <strong>and</strong> aqueous<br />
extracts <strong>of</strong> V. amygdalina provides a protective role<br />
for the liver which is the first organ susceptible to<br />
any injurious substances in case <strong>of</strong> toxicity. This is<br />
in line with previous work (Ofusori et al. 2008)<br />
who investigated the effect <strong>of</strong> Croton zambesicus<br />
(euphorbiaceae) on the liver. The renal parenchyma<br />
showed no evidence <strong>of</strong> vacuolations or distortion <strong>of</strong><br />
any kind rather, renal corpuscles <strong>and</strong> Bowman’s<br />
spaces were well preserved as compared with<br />
control groups in all the experimental groups. It<br />
was evident on the photomicrograph that the<br />
tubules constitute the bulk <strong>of</strong> the renal parenchyma<br />
with different shapes, diameters <strong>and</strong> staining<br />
intensities. This points to the fact that V.<br />
amygdalina may have a vital role to play in<br />
osmoregulation <strong>and</strong> excretion. Also, the gastric<br />
mucosa <strong>of</strong> the treated groups were better organized<br />
when compared with the control (Figure 1). There<br />
was no evidence <strong>of</strong> ulceration in the surface<br />
epithelium, no presence <strong>of</strong> submucosal edema <strong>and</strong><br />
leucocytes infiltration. Studies have shown that<br />
anti-oxidants significantly strengthen the gastric<br />
walls <strong>and</strong> protect tissue from oxidative damage<br />
(Marins, 1996).<br />
All these evidences revealed that V. amygdalina<br />
is a very important plant that can be exploited for<br />
cyto-protective purposes. The cyto-protective<br />
mechanism may be by moping up free radical there<br />
by protecting the cells <strong>of</strong> the organs from any type<br />
<strong>of</strong> assaults. Several other studies have shown that<br />
the aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> V.<br />
amygdalina is non-hazardous, even when taken for<br />
some time. The potency <strong>of</strong> these extracts may have<br />
been amplified on account <strong>of</strong> increased<br />
concentration or build up <strong>of</strong> specific<br />
phytochemicals, although the chemistry is yet<br />
unknown. Several findings showed that V.<br />
amygdalina has strong antioxidant activity<br />
corresponding to mitigation <strong>of</strong> the generation <strong>of</strong><br />
hydroxyl radicals. Yeh et al., (2003) <strong>and</strong> Battell et<br />
al., (1999) postulated that this antioxidant activity<br />
may provide possible rationale for the observed<br />
therapeutic effects <strong>of</strong> V. amygdalina.<br />
Based on the results obtained, it can be<br />
concluded that ethanolic <strong>and</strong> aqueous leaf extracts<br />
<strong>of</strong> V. amygdalina are non toxic <strong>and</strong> may possess<br />
cytoprotective potential.<br />
Effects <strong>of</strong> Vernonia amygdalina extracts on vital organs 81<br />
References<br />
Abosi AO <strong>and</strong> Raseroka BH. In vivo antimalarial<br />
activity <strong>of</strong> Vernonia amygdalina. Br. J.<br />
Biomedical Sci. 60(2): 89-91, 2003.<br />
Ainslie JR. List <strong>of</strong> plants used in native medicine in<br />
Nigeria. Imperial Forestry Institute, Oxford<br />
Publishing. 42, 1973.<br />
Akah PA <strong>and</strong> Okafor CI. Hypoglycaemic effect <strong>of</strong><br />
Vernonia amygdalina Del, in experimental<br />
rabbits. Plant Med. Res. 1: 6-10, 1992.<br />
Aregheore EMK, Makkar HPS <strong>and</strong> Becker K. Feed<br />
value <strong>of</strong> some browse plants from the central<br />
zone <strong>of</strong> Delta State, Nig. Trop. Sci. 38(2): 97-<br />
104, 1998.<br />
Babalola OO, Anetor JI <strong>and</strong> Adeniyi FA.<br />
Amelioration <strong>of</strong> carbon tetrachloride-induced<br />
hepatotoxicity by terpenoid extract from leaves<br />
<strong>of</strong> Vernonia amydgalina. Afr. J. Med. Sci. 30 (1-<br />
2): 91-93, 2001.<br />
Battell ML, Rodrigues B, Yuen VG <strong>and</strong> McNeill<br />
JH. Treatment <strong>and</strong> pharmacological<br />
interventions in streptozotocin diabetes. In:<br />
Experimental Models <strong>of</strong> Diabetes. (McNeill, J.<br />
H., Ed.), pp.195-216. CRC Press LLC, U.S.A,<br />
1999.<br />
Huffman MA. Animal self-medication <strong>and</strong> ethnomedicine:<br />
exploration <strong>and</strong> exploitation <strong>of</strong> the<br />
medicinal properties <strong>of</strong> plants. Proceedings <strong>of</strong><br />
the Nutr. Society. 62(2):371-81, 2003.<br />
Igile GO, Oleszek W, Jurzysta M, Burda S, Fafunso<br />
M <strong>and</strong> Fasanmade AA. Nutritional assesment <strong>of</strong><br />
Vernonia amygdalina leaves in growing mice.<br />
J. Agric. Food Chem. 43, 2162-2166, 1995.<br />
Ijeh I, Nwugo VO <strong>and</strong> Obidoa O. Comparative<br />
studies on the nutritive Phyto-chemical <strong>and</strong><br />
antimicrobial properties <strong>of</strong> two varieties <strong>of</strong><br />
Vernomia amygdalina. Plant Pros. Res. Comm.<br />
1: 71-75, 1996.<br />
Izevbigie EB, Bryant JL <strong>and</strong> Walker A. A novel<br />
natural inhibitor <strong>of</strong> extracellular signalregulated<br />
kinases <strong>and</strong> human breast cancer cell<br />
growth. Experimental Biol. Med. (Maywood)<br />
229(2): 163-169, 2004.<br />
Iwu MM, Okunji E, Akah PA, Tempesta MS, <strong>and</strong><br />
Carley DG. Dioscoretine: The hypoglycaemic
82 Spencer NWANGWU et al.<br />
principles <strong>of</strong> Dioscorea dumentorium. Plant<br />
Med. 56: 119-126, 1996.<br />
Kupcham SM. Drugs from Natural products. Plant<br />
source in drugs discovery, science <strong>and</strong><br />
development. Am. Chem. Soc. 6: 311-318, 1971.<br />
Martin A. The use <strong>of</strong> antioxidants in healing.<br />
Dermatol. Surg., 22: 156-160, 1996.<br />
Ofusori DA, Adelakun AE <strong>and</strong> Ayoka AO.<br />
Histological Investigation <strong>of</strong> the Effects <strong>of</strong><br />
Croton zambesicus on the Liver <strong>of</strong> Swiss albino<br />
mice. The Int. J. Gastroenterology. (7)1: 2008.<br />
Ojiako OA <strong>and</strong> Nwanjo H. Is Vernonia amygdalina<br />
hepatotoxic or hepatoprotective? Response from<br />
biochemical <strong>and</strong> toxicity studies in rats. Afr J.<br />
Biotech. 5 (18): 1648-1651, 2006.<br />
Okafor JC. Horticulturally promising indigenous<br />
wild plant species <strong>of</strong> the Nigerian forest zone.<br />
Acta Hort. 123: 165-176, 1983.<br />
Oliver B. Medicinal plants in Nigeria. Nig. Coll. Sci<br />
Techn. 50-51, 1960.<br />
Onwuka CFI, Akinsoyinu AO <strong>and</strong> Tewe OO. Feed<br />
value <strong>of</strong> some Nigerian browse plants: chemical<br />
composition <strong>and</strong> in vitro digestibility. East<br />
African Agri. Forestry J. 54: 157 – 163, 1989.<br />
Tekobo AM, Onabanjo AO, Amole OO <strong>and</strong> Emeka<br />
PM . Analgesic <strong>and</strong> antipyretic effects <strong>of</strong> the<br />
aqueous extract <strong>of</strong> Vernonia amygdalina. West<br />
Afri. J. Pharm. 16: 68-74, 2002.<br />
Yeh GY, Eisenberg DM, Kaptcuk TJ <strong>and</strong> Philips<br />
RS. System review <strong>of</strong> herbs <strong>and</strong> dietary<br />
supplements for glycemic control in diabetes.<br />
Diab. Care 26 (4), 1277 – 1294, 2003.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 9(1): 83-86, 2011 Short communication 83<br />
<strong>Haliç</strong> University, Printed in Turkey.<br />
http://jcmb.halic.edu.tr<br />
Investigation <strong>of</strong> the EGFR gene variations in bladder cancer<br />
patients using INFINITI TM Analyzer<br />
Necip Ozan TİRYAKİOĞLU 1 , Özlem KURNAZ 1 , Ömer Onur ÇAKIR 2 , Nagehan ERSOY<br />
TUNALI 1,*<br />
1<br />
<strong>Haliç</strong> University, Faculty <strong>of</strong> Arts <strong>and</strong> Sciences, Department <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong> Genetics, Istanbul,<br />
Turkey<br />
2<br />
T.R. Ministry <strong>of</strong> Health, Bağcılar Training <strong>and</strong> Research Hospital, Istanbul, Turkey<br />
(* author for correspondence; nagehanersoy@halic.edu.tr)<br />
Received: 26 May 2011; Accepted: 22 June 2011<br />
Abstract<br />
Dysregulation <strong>of</strong> epidermal growth factor receptor (EGFR), which leads to increased proliferation, is a<br />
common event in most cancers. Since its recognition as a keyplayer in carcinogenesis, several anti-EGFR<br />
agents have been developed as chemotherapeutic agents. Studies investigating the effect <strong>of</strong> EGFR mutations<br />
on the activity <strong>of</strong> anti-EGFR agents resulted in the discovery <strong>of</strong> a number <strong>of</strong> cancer tissue-specific mutations<br />
which either increase or decrease sensitivity to tyrosine kinase inhibitors (TKI). Determination <strong>of</strong> these<br />
mutations is essential to prognostic processes, but is limited to tissue availability. Being able to determine<br />
tumour specific EGFR mutations by using blood sample as the genotyping material will eliminate the need<br />
for invasive techniques. This study is the first step <strong>of</strong> a wider research with the final goal <strong>of</strong> matching<br />
mutations in tumour tissues with that <strong>of</strong> normal somatic cells from the same individuals. All the known exon<br />
18-21 mutations were screened in 48 bladder cancer patients with INFINITI TM analyzer using leukocytes as<br />
the DNA source. However, none <strong>of</strong> the investigated mutations have been detected in the genomic DNA<br />
samples <strong>of</strong> bladder cancer patients.<br />
Keywords: INFINITI TM , epidermal growth factor receptor, tyrosine kinase inhibitor, drug sensitivity, bladder<br />
cancer.<br />
Mesane kanseri hastalarında EGFR geni varyantlarının INFINITI TM ile incelenmesi<br />
Özet<br />
Artmış çoğalmaya sebep olan epidermal büyüme faktörü reseptörünün (EGFR) düzenlenmesindeki<br />
bozukluklara çoğu kanser türünde rastlanır. Karsinogenezde oynadığı kilit rol farkedildiğinden beri anti-<br />
EGFR etkili bir çok kemoterapötik ajan geliştirilmiştir. EGFR mutasyonlarının anti-EGFR ajanlarının<br />
aktivitesine etkisinin incelendiği araştırmalarda tirozin kinaz inhibitörüne hassasiyetini artıran veya azaltan<br />
bir çok kanser dokusuna özgün mutasyon belirlenmiştir. Bu mutasyonların belirlenmesi tedavi aşamasının<br />
temelini oluşturur, fakat mutasyonların belirlenmesi kanser dokusuna erişebilirlik ile sınırlıdır. Tümör<br />
spesifik EGFR mutasyonlarının genotipleme aracı olarak kan örnekleri kullanılarak belirlenebilmesi invaziv<br />
tekniklere olan gerekliliği ortadan kaldıracaktır. Bu çalışma nihai olarak olarak tümör dokusu<br />
mutasyonlarının normal somatik hücre mutasyonları ile eşlenmesinin amaçl<strong>and</strong>ığı daha geniş bir araştırmanın<br />
ilk aşaması olarak gerçekleştirilmiştir. Bilinen tüm exon 18-21 mutasyonları 48 mesane kanseri hastasında<br />
INFINITI TM cihazı ile DNA kaynağı olarak lökositler kullanılarak taranmıştır. Ancak, araştırılan hiçbir<br />
mutasyon mesane kanseri hastalarının genomik DNA’larında belirlenememiştir.<br />
Anahtar Sözcükler: INFINITI TM , epidermal büyüme faktörü reseptörü, tirozin kinaz inhibitörü, ilaç<br />
hassasiyeti, mesane kanseri.
84 Necip Ozan TİRYAKİOĞLU et al.<br />
Introduction<br />
Epidermal growth factor receptor (EGFR) is a cell<br />
surface receptor that activates signalling cascades<br />
which mainly induce proliferation <strong>and</strong> cell survival.<br />
Human genome codes for four members <strong>of</strong> the<br />
EGFR family, EGFR/ErbB1, HER2/ErbB2/neu-2,<br />
HER3/ErbB3 <strong>and</strong> HER4/ErbB4. All the family<br />
members consists <strong>of</strong> a lig<strong>and</strong>-binding, a<br />
transmembrane <strong>and</strong> a cytoplasmic domain with<br />
tyrosine kinase activity (Gschwind et al., 2004).<br />
EGFR members reside on the cell membrane as<br />
monomers which dimerize upon phosphorylation<br />
by lig<strong>and</strong> binding. Eight different molecules have<br />
been identified as EGFR/ErbB1 lig<strong>and</strong>s. All the<br />
EGFR lig<strong>and</strong>s, except Crypto, are synthesized as<br />
precursor molecules <strong>and</strong> become functional only<br />
after proteolytic clevage. In addition, EGFR family<br />
members have been shown to be activated<br />
indirectly by chemokines, cell adhesion molecules<br />
<strong>and</strong> G-protein coupled receptors (Yarden <strong>and</strong><br />
Sliwkowski, 2001). The dimerisation <strong>of</strong> EGFR<br />
members can occur as homodimerisation or as<br />
heterodimerisation with another member <strong>of</strong> the<br />
family. Following dimerisation,<br />
autophosphorylation in homodimers <strong>and</strong><br />
transphosphorylation in heterodimers occurs.<br />
During this process five tyrosine residues, Y992,<br />
Y1045, Y1068,Y1148 <strong>and</strong> Y1173, located on Cterminal<br />
are phosphorylated. Consequently, EGFRs<br />
activate a multitude <strong>of</strong> transducer <strong>and</strong> adapter<br />
proteins including HP-2, GRB2, PI3K <strong>and</strong> Akt.<br />
Activation <strong>of</strong> these proteins induce a variety <strong>of</strong><br />
cytoplasmic pathways, mainly MAPK <strong>and</strong> JNK,<br />
which trigger cellular events like DNA synthesis<br />
<strong>and</strong> proliferation (Oda et al., 2005).<br />
Dysregulation <strong>of</strong> EGFRs are mainly caused by<br />
overexpression <strong>of</strong> the receptor itself, their lig<strong>and</strong>s<br />
or both. In addition to overexpression, mutations in<br />
the tyrosine kinase domain causing consistent<br />
activation <strong>of</strong> the receptor account for another major<br />
mechanism affecting EGFR signalisation. Such<br />
mutations have been identified in lung, stomach<br />
<strong>and</strong> breast cancer tissues, but not in normal tissues.<br />
Dysregulation <strong>of</strong> EGFR can also be the result <strong>of</strong><br />
HER2/ErB2 heterodimerisation. HER2 does not<br />
have lig<strong>and</strong> binding activity, instead it increases<br />
the lig<strong>and</strong> binding affinity <strong>of</strong> the protein it<br />
dimerises with. Thus, EGFR/HER2 dimerisation<br />
leads to a more active receptor <strong>and</strong> increased<br />
activity <strong>of</strong> the EGFR pathways (Herbst, 2004).<br />
Upon discovery <strong>of</strong> disturbed EGFR functions in<br />
multiple cancers, abundant number <strong>of</strong> studies have<br />
been conducted in order to develop drugs targeting<br />
EGFR. Inhibitory molecules targeting EGFR can be<br />
classified in three main categories; monoclonal<br />
antibodies, chemical inhibitors <strong>and</strong> antisense<br />
oligonucleotides.<br />
Monoclonal antibodies exert their inhibitory<br />
effect by binding to the lig<strong>and</strong> binding domain <strong>and</strong><br />
disrupt activation upon lig<strong>and</strong> binding. Monoclonal<br />
antibodies against EGFR have been showed to<br />
inhibit cell growth <strong>and</strong> induce apoptosis. However,<br />
since they exert their effect only on lig<strong>and</strong> binding<br />
domain, EGFRs with tyrosine domain mutations<br />
are prone to be irresponsive to the inhibitory effects<br />
<strong>of</strong> monoclonal antibodies. In contrast to<br />
monoclonal antibodies, chemical inhibitors target<br />
tyrosine kinase domain <strong>and</strong> inhibit EGFR by<br />
blocking ATP from interacting with the tyrosine<br />
kinase domain. Antisense nucleotides, on the other<br />
h<strong>and</strong>, prevent translation <strong>of</strong> the EGFRs <strong>and</strong> their<br />
lig<strong>and</strong>s <strong>and</strong> carry out their inhibitory effect at a<br />
much essential level.<br />
90% <strong>of</strong> the somatic EGFR mutations are located<br />
in the tyrosine kinase domain, namely exons 18-21<br />
(Table 1). Since tumor cells depend on the<br />
activating mutations on tyrosine kinase domain <strong>of</strong><br />
EGFR for proliferative signals, it has been shown<br />
that tumor cells harboring such mutations are more<br />
sensitive to thymidine kinase inhibitors (TKI).<br />
Thus, determination <strong>of</strong> the EGFR mutations has<br />
both prognostic value as an indicator <strong>of</strong> drug<br />
response <strong>and</strong> diagnostic value as a biomarker<br />
(Lynch et al. , 2004).<br />
Since the determination <strong>of</strong> EGFR mutations<br />
requires tumour samples <strong>and</strong> collecting a tumour<br />
sample is only possible through invasive<br />
techniques, EGFR mutation surveys are limited to<br />
tissue availability. Being able to scan for the EGFR<br />
mutations by using whole blood as an alternative<br />
DNA source may provide information about the<br />
genotype <strong>of</strong> the original tumour tissue without the<br />
need for invasive techniques. Therefore, the study<br />
presented here is initiated as the first step <strong>of</strong> a wider<br />
research with the final goal <strong>of</strong> matching mutations<br />
in tumour tissues with that <strong>of</strong> normal somatic cells<br />
from the same individuals.<br />
Table 1. Common EGFR Mutations<br />
Mutations Frequency Effect<br />
G719A/C/S 3% Increased sensitivity<br />
Ex 19 Deletion 48% Increased sensitivity<br />
Ex20 Deletion 4% Decreased sensitivity<br />
T790M 5% Decreased sensitivity<br />
L858R 43% Increased sensitivity<br />
L861Q 2% Increased sensitivity
EGFR variations in bladder cancer 85<br />
Materials <strong>and</strong> methods<br />
Ethical Committee for Clinical Research. DNA was<br />
As the first step, genomic DNA extracted from the<br />
leukocytes <strong>of</strong> 48 bladder cancer patients have been<br />
surveyed for the total <strong>of</strong> 50 mutations identified to<br />
date in exons 18-21 <strong>of</strong> the EGFR gene. The<br />
selected study population consisted <strong>of</strong> 40 males <strong>and</strong><br />
8 females with bladder cancer. Tumour tissue <strong>and</strong><br />
blood samples were obtained from each induvidial<br />
<strong>and</strong> categorised according to their tumour stage <strong>and</strong><br />
grade. Tumour samples were collected in tubes<br />
containing RNase Later (Invitrogen) solution, while<br />
blood samples were collected in tubes containing<br />
K2EDTA. Ethical approval for his study was<br />
obtained from Istanbul University Medical Faculty,<br />
extracted from blood samples by using QiaAmp<br />
DNA Blood Mini kit (Qiagen) as described in the<br />
package insert.<br />
Extracted DNA samples were surveyed for a<br />
total <strong>of</strong> 50 mutations in exons 18-21 by<br />
INFINITI Analyzer (Table 2). INFINITI<br />
Analyzer has different protocols for different<br />
assays, but the five essential steps are common to<br />
all; 1) multiplex PCR amplification <strong>of</strong> DNA, 2)<br />
fluorescent label incorporation using analyte<br />
specific primer extension (ASPE), 3) hybridization<br />
<strong>of</strong> the ASPE primers to a microarray followed by<br />
washing, 4) scanning <strong>of</strong> the microarray <strong>and</strong> 5)<br />
signal detection <strong>and</strong> analysis.<br />
Table 2. Scanned EGFR Mutations<br />
Exon 18 Exon 19 Exon 20 Exon 21<br />
Glu709 Lys Lys739_Ile744dup Glu762insEAFQ Asn826Ser<br />
Glu709 Gln Lys745_Glu746del Glu762ins His835Leu<br />
Glu709 Ala Glu746_Ala750del Val769Met Leu858Arg<br />
Glu709 Gly Glu746_Thr751delins Val769Leu Leu858Met<br />
Glu709 Val Glu746_Thr751delins Asp770ins Leu858Arg<br />
Gly719 Ser Glu746_Ala750delins Ala767_Val769dup Leu861Gln<br />
Gly719 Arg Glu746_Ala750del Asp770fs Leu861Arg<br />
Gly719 Cys Glu746 Lys Pro772Arg<br />
Gly719 Ala Glu746_Ala750delins Ser768_Asp770dup<br />
Ser720 Phe Glu746_Pro753delins His773Arg<br />
Glu746_Ser752del His773Leu<br />
Glu746_Ser752delins Asn771_His773dup<br />
Glu746_Thr751delins Val774Met<br />
Glu746_Thr751delins Arg776Cys<br />
Glu746_Ser752delins Gly779Phe<br />
Glu746_Thr751delins Thr790Met<br />
Glu746_Ser752delins<br />
Leu747_Glu749del<br />
Leu747_ Thr751delins<br />
Leu747_Ser752del<br />
Leu747_Ser752delins<br />
Leu747_Pro753delins<br />
Glu746_Glu749del<br />
Leu747_Glu749del<br />
Glu746_Thr751del<br />
Leu747_ Thr751del<br />
Leu747_ Thr751delins<br />
Leu747_ Lys754delins<br />
Leu747_Pro753delins<br />
Leu747_Ala750del<br />
Leu747_ Thr751del<br />
Arg748_Thr751delins<br />
Glu749_Thr751del<br />
Thr751_Ile759delins<br />
Ser752_Ile759del
86 Ozan TİRYAKİOĞLU et al.<br />
Results<br />
INFINITI Analyzer detects EGFR mutations<br />
according to the ratio <strong>of</strong> the specific fluorescence<br />
signal emitted from the analyte, represented in<br />
Relative Fluorescence Unit (RFU), to the<br />
fluorescence signal <strong>of</strong> the non-specific<br />
oligonucleotide background control spots. A ratio<br />
<strong>of</strong> 2 <strong>and</strong> higher indicates the existence <strong>of</strong> the<br />
particular EGFR mutation <strong>and</strong> a ratio lower than 2<br />
indicates the absence <strong>of</strong> the particular EGFR<br />
mutation.<br />
According to specific RFUs for each mutation,<br />
none <strong>of</strong> the 48 DNA samples extracted from blood<br />
carry inherited EGFR mutations within the tyrosine<br />
kinase domain (exons 18-21) <strong>of</strong> EGFR.<br />
Discussion<br />
The absence <strong>of</strong> any mutations in the surveyed<br />
specimens might be attributed to the rarity <strong>of</strong> EGFR<br />
mutations in bladder cancer cases as shown by<br />
other studies before (Blehm et al., 2006; Villares et<br />
al., 2007). However, it might also arise from the<br />
fact that using whole blood as a source <strong>of</strong><br />
information for tumour genotype is an inaccurate<br />
method. The underlying reason can only be<br />
identified upon the completion <strong>of</strong> the second step <strong>of</strong><br />
the study, which will provide us the genotype data<br />
obtained directly from tumour tissues <strong>and</strong> thus<br />
enable to perform a cross-comparison between<br />
tumour tissue <strong>and</strong> leukocyte genotype.<br />
Acknowledgements<br />
This study was supported by <strong>Haliç</strong> University <strong>and</strong><br />
CDK Tıbbi Malzeme Tic. Ltd. Şti. (Istanbul,<br />
TURKEY).<br />
References<br />
Gschwind A, Fischer OM <strong>and</strong> Ullrich A. The<br />
discovery <strong>of</strong> receptor tyrosine kinases: targets<br />
for cancer therapy. Nat Rev Cancer. 4 . 361–<br />
370, 2004.<br />
Blehm KN, Spiess PE, Bondaruk JE, Dujka ME,<br />
Villares GJ, Zhao YJ, Bogler O,Aldape KD,<br />
Grossman HB, Adam L, McConkey DJ,<br />
Czerniak BA, Dinney CP <strong>and</strong> Bar-Eli M.<br />
Mutations within the kinase domain <strong>and</strong><br />
truncations <strong>of</strong> the epidermal growth factor<br />
receptor are rare events in bladder cancer:<br />
implications for therapy. Clin Cancer Res.<br />
12(15):4671-7, 2006.<br />
Herbst RS. Review <strong>of</strong> epidermal growth factor<br />
receptor biology. International <strong>Journal</strong> <strong>of</strong><br />
Radiation Oncology .59(2): S21-S26, 2004.<br />
Oda K, Matsuoka Y, Funahashi A <strong>and</strong> Kitano H.<br />
Comprehensive pathway map <strong>of</strong> epidermal<br />
growth factor receptor signaling. Mol Syst Biol.<br />
1: 20050010, Epub 2005, May25.<br />
Lynch TJ, Bell DW, Sordella R, Gurubhagavatula<br />
S, Okimoto RA, Brannigan BW,Harris PL,<br />
Haserlat SM, Supko JG, Haluska FG, Louis<br />
DN, Christiani DC, Settleman J <strong>and</strong> Haber DA.<br />
Activating mutations in the epidermal growth<br />
factor receptor underlying responsiveness <strong>of</strong><br />
non-small-cell lung cancer to gefitinib. N Engl J<br />
Med. 350(21):2129-39, 2004.<br />
Villares GJ, Zigler M, Blehm K, Bogdan C,<br />
McConkey D, Colin D, Bar-Eli M. Targeting<br />
EGFR in bladder cancer.. EGFR in bladder<br />
cancer. World J Urol. 25(6):573-9. 2007<br />
Yarden Y <strong>and</strong> Sliwkowski MX. Untangling the<br />
ErbB signalling network. Nat Rev Mol <strong>Cell</strong><br />
Biol. 2(2):127-37,2001.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> - INSTRUCTIONS for AUTHORS<br />
General<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />
(J<strong>Cell</strong>MolBiol) is an international journal which<br />
covers original works in the field <strong>of</strong> cell biology,<br />
molecular biology, genetics, microbiology,<br />
neurobiology, bioinforma-tics <strong>and</strong> related topics.<br />
The <strong>of</strong>ficial language <strong>of</strong> the journal is English,<br />
however manuscripts in Turkish are accepted as<br />
well.<br />
Conditions for publication<br />
This journal publishes research articles, review<br />
articles, short communications, book/s<strong>of</strong>tware<br />
reviews, case reports <strong>and</strong> letters to the editor.<br />
Research articles: Only original contributions will<br />
be accepted which have not been published<br />
previously. Manuscripts should not exceed 15<br />
papers <strong>of</strong> printed text, including tables, figures <strong>and</strong><br />
references<br />
Review articles: Reviews <strong>of</strong> recent developments in<br />
a research field <strong>and</strong> ideas will be accepted.<br />
Manuscripts should not exceed 15 papers <strong>of</strong> printed<br />
text. Illustrations are encouraged.<br />
Short communications: These include small-scale<br />
investigations or innovative methods, techniques,<br />
clinical trials <strong>and</strong> epidemiological studies. It should<br />
not exceed 3 pages.<br />
Letters to editor: These include opinions, news <strong>and</strong><br />
suggestions. Letters should not exceed 2 papers <strong>of</strong><br />
printed text.<br />
Case Reports: These include individual<br />
observations based on small numbers <strong>of</strong> subjects.<br />
This type <strong>of</strong> research cannot indicate causality but<br />
may indicate areas for further research.<br />
REVISED<br />
June 30 th , 2011<br />
Manuscripts should be submitted by e-mail to:<br />
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong><br />
<strong>Haliç</strong> <strong>Üniversitesi</strong><br />
Fen Edebiyat Fakültesi<br />
Moleküler Biyoloji ve Genetik Bölümü<br />
Sıracevizler Cad. No:29<br />
Bomonti-Şişli 34394, İstanbul-TÜRKİYE<br />
Tel: +90 212 343 08 87, Fax: +90 212 231 06 31<br />
E-Mail: jcmb@halic.edu.tr<br />
87<br />
Book/s<strong>of</strong>tware reviews: Short but concise<br />
description <strong>of</strong> the book/s<strong>of</strong>tware, not exceeding a<br />
page. Book/s<strong>of</strong>tware reviews are not peer reviewed.<br />
Presentation<br />
Papers should be typed clearly, double-spaced with<br />
3 cm wide margins.<br />
Manuscripts should be prepared using Word<br />
Processor.<br />
Cover Letter: You may briefly explain your work<br />
<strong>and</strong> its contribution to present knowledge.<br />
Title Page: The first page <strong>of</strong> your manuscript<br />
should be a title page containing the type <strong>of</strong> paper;<br />
the title; all authors' full names, <strong>and</strong> affiliations;<br />
<strong>and</strong> the corresponding author's contact address<br />
(including phone <strong>and</strong> fax numbers) <strong>and</strong> e-mail<br />
address. The title should be as short as possible, but<br />
should give adequate information regarding the<br />
contents. Authors should also state a running title<br />
<strong>of</strong> no more than 50 characters including spaces.<br />
All pages must be numbered.<br />
Full Paper<br />
The full paper should be divided into the following<br />
parts in the order indicated:
88<br />
Abstract: A brief, informative abstract, not<br />
exceeding 200 words, should be provided in<br />
English <strong>and</strong> in Turkish. For authors who are not<br />
native Turkish speakers, J<strong>Cell</strong>MolBiol can provide<br />
the Turkish abstract.<br />
Keywords: Immediately following the abstract,<br />
authors should provide 5 keywords or phrases that<br />
reflect the content <strong>of</strong> the article.<br />
Introduction should include theory, hypotheses,<br />
prior work<br />
Material <strong>and</strong> methods may include subheadings<br />
Results: If the study consists <strong>of</strong> different parts,<br />
subheadings in this section should be consistent<br />
with subheadings in the methods.<br />
Discussion<br />
Acknowledgements should precede the list <strong>of</strong><br />
references<br />
References: Papers cited in the manuscript should<br />
be listed in alphabetical order according to the first<br />
author's surname.<br />
Tables <strong>and</strong> Figures<br />
Tables <strong>and</strong> figures should be embedded within<br />
the text in their appropriate positions.<br />
Each table should be accompanied by a short<br />
instructive title line plus an explanatory caption at<br />
the top. Indicate footnotes within tables by<br />
superscript letters <strong>and</strong> type footnotes below the<br />
table.<br />
Electronically submitted figures are preferred<br />
in *.jpg or *.tiff (min. 300 dpi) formats. Each figure<br />
should be supplied with a short instructive title line.<br />
Do not give magnification on scales in the figure<br />
titles; instead draw bar scales directly on the<br />
figures.<br />
All the tables <strong>and</strong> figures must be referred to<br />
within the text.<br />
Units, Abbreviations <strong>and</strong> Scientific Names<br />
Only SI units should be used. Current<br />
abbreviations can be used without explanation,<br />
others must be explained.<br />
All acronyms/abbreviations must be explained<br />
in parenthesis after their first occurrence. If many<br />
REVISED<br />
June 30 th , 2011<br />
unfamiliar acronyms/abbreviations are used, please<br />
compile them in an "Abbreviations" section at the<br />
end <strong>of</strong> the paper.<br />
Latin expressions should be underlined or typed<br />
in italics.<br />
Referencing<br />
In the text, citations with two authors should<br />
take the form: Smith <strong>and</strong> Robinson,1990. If several<br />
papers are cited by the same author in the same<br />
year, they should be lettered in sequence (1990a),<br />
(1990b), etc. When papers are by more then two<br />
authors they should be cited as Smith et al.,1990.<br />
In the list, references must be placed in<br />
alphabetical order. The following models for the<br />
reference list cover all situations. The punctuation<br />
given must be exactly followed.<br />
Redford IR. Evidence for a general relationship<br />
between the induced level <strong>of</strong> DNA double<br />
str<strong>and</strong> breakage <strong>and</strong> cell killing after Xirradiation<br />
<strong>of</strong> mammalian cells. Int J Radiat<br />
Biol. 49: 611- 620, 1986.<br />
Tccioli CE, Cottlieb TM, Blund T. Product <strong>of</strong> the<br />
XRCCS gene <strong>and</strong> its role in DNA repair <strong>and</strong><br />
V(D)J recombination. Science. 265: 1442-1445,<br />
1994<br />
Ohlrogge JB. Biochemistry <strong>of</strong> plant acyl carrier<br />
proteins. The Biochemistry <strong>of</strong> Plants: A<br />
Comprehensive Treatise. Stumpf PK <strong>and</strong> Conn<br />
EE (Ed). Academic Press, New York. 137-157,<br />
1987.<br />
Brown LA. How to cope with your supervisor. PhD<br />
Thesis. University <strong>of</strong> New Orleans, 2005.<br />
Web document with no author: Leafy seadragons<br />
<strong>and</strong> weedy seadragons 2001. retrieved<br />
November 13, 2002, from http:// www.<br />
windspeed.net.au/jenny/seadragons/<br />
Web document with author: Dawson J, Smith L,<br />
Deubert K. Referencing, not plagiarism.<br />
Retrieved October 31, 2002 from http:<br />
//studytrekk.lis.curtin.edu.au/<br />
Only papers published or in press should be<br />
cited in the literature list. Unpublished results,<br />
including submitted manuscripts <strong>and</strong> those in<br />
preparation, should be indicated as unpublished<br />
data in the text.
Submission Policies <strong>and</strong> Authorship<br />
Upon submission <strong>of</strong> a manuscript, it is accepted<br />
that all co-authors have approved the contents <strong>of</strong><br />
the manuscript <strong>and</strong> its submission by the<br />
corresponding author, <strong>and</strong> that the corresponding<br />
author is authorized to represent all co-authors in<br />
pre-publication discussions with J<strong>Cell</strong>MolBiol.<br />
The corresponding author is responsible for<br />
ensuring that all the contributors to the relevant<br />
work are listed as authors <strong>and</strong> that all authors have<br />
aggreed to the manuscript’s content <strong>and</strong> its<br />
submission to the J<strong>Cell</strong>MolBiol. In case the <strong>Journal</strong><br />
happens to be aware <strong>of</strong> an authorship dispute,<br />
authorship must be approved in writing by all <strong>of</strong> the<br />
parties.<br />
Cost<br />
There are no submission fees or page charges.<br />
Criteria for the Selection <strong>of</strong> Manuscripts<br />
Manuscripts should meet the following criteria: the<br />
study conducted is material is original <strong>and</strong> ethical,<br />
the writing is clear; the study methods are<br />
appropriate, the data are valid, the conclusions are<br />
reasonable <strong>and</strong> supported by the data; the<br />
information is important; <strong>and</strong> the topic is<br />
interesting to our readership.<br />
Editorial Processes<br />
Researchers may request informal feedback from<br />
the editors in a particular manuscript. The<br />
presubmission process aids in the submission<br />
decision for authors<br />
When J<strong>Cell</strong>MolBiol receives a manuscript, the<br />
Editor <strong>and</strong> Associate Editor will first decide<br />
whether the manuscript meets the formal criteria<br />
specified with “Guidelines for Authors” <strong>and</strong><br />
whether it fits within the scope <strong>of</strong> the <strong>Journal</strong>. In<br />
case <strong>of</strong> doubt on the basis <strong>of</strong> initial review, the<br />
editor will consult other members <strong>of</strong> the Editorial<br />
Board.<br />
Manuscripts that are found suitable for peer<br />
review will be assigned to two expert reviewers.<br />
Reviewers may either be Editorial Board members<br />
or external experts selected by the Editorial Board.<br />
The corresponding author is notified by e-mail<br />
when the editor decides to send a paper for review.<br />
The reviewers will have up to three weeks to<br />
review the submitted article. After peer review, the<br />
REVISED<br />
June 30 th , 2011<br />
89<br />
editor will contact the author. If the author is<br />
required to submit a revised version, the revised<br />
version has to be submitted by the author within<br />
two weeks. Otherwise, the manuscript will be<br />
removed from the manuscript submission queue<br />
<strong>and</strong> will be considered rejected.<br />
In cases where the referees have requested welldefined<br />
changes to the manuscript, editors may<br />
request a revised manuscript that addresses to<br />
referees’ concerns. The revised version is sent back<br />
to the original referees for re-review. In cases<br />
where the referees’ concerns are more wideranging,<br />
editors may reject the manuscript. The<br />
revised manuscript should be accompanied by a<br />
cover letter that includes a point-by-point response<br />
to referees’ comments <strong>and</strong> an explanation <strong>of</strong> how<br />
the manuscript has been changed.<br />
As a matter <strong>of</strong> policy, we do not suppress<br />
referees’ reports, any comments directed to authors<br />
are transmitted regardless <strong>of</strong> what we may think <strong>of</strong><br />
the content. On rare occasions, we may edit a report<br />
to remove <strong>of</strong>fensive language or comments to<br />
reveal confidentiality.<br />
The final decision to accept or reject a<br />
manuscript will be made by the Editor. If it<br />
becomes apparent that there are serious problems<br />
with the scientific content or with violations <strong>of</strong> our<br />
publishing policies, the Editor also reserves the<br />
right to reject a paper even after it has been<br />
accepted<br />
After acceptance, the Editor may make further<br />
changes to the text <strong>and</strong> figures so that the<br />
manuscript is readable <strong>and</strong> clear. Page pro<strong>of</strong>s will<br />
be sent to the corresponding author via email for<br />
checking before publication. Corresponding authors<br />
are sent pro<strong>of</strong>s <strong>and</strong> are welcome to discuss<br />
proposed changes with the Editor, but<br />
J<strong>Cell</strong>MolBiol reserves the right to make the final<br />
decision about the style. Corrected pro<strong>of</strong>s should be<br />
sent back to the Editor within three days <strong>of</strong> receipt,<br />
otherwise the Editor reserves the rights to correct<br />
the pro<strong>of</strong>s himself <strong>and</strong> to send the material for<br />
publication.<br />
Appeals<br />
Authors have the right to ask the Editor to<br />
reconsider a rejection decision, which is considered<br />
an appeal. Decisions are reversed only if the Editor<br />
is convinced that the original decision was a serious<br />
mistake. If an appeal merits further consideration,<br />
the Editor may send the author’s response or the<br />
revised paper to one or more referees, or Editor
90<br />
may ask one referee to comment on the concerns<br />
raised by another referee.<br />
Advance Online Publication<br />
J<strong>Cell</strong>MolBiol provides Advance Online Publication<br />
<strong>of</strong> articles, which benefit authors with an earlier<br />
publication date <strong>and</strong> allows the readers’ access to<br />
accepted papers several weeks before they appear<br />
in print<br />
Ethical Issues<br />
For manuscripts reporting experiments on live<br />
vertebrates or higher invertebrates, authors must<br />
declare that the study was approved by the<br />
institutional ethics committee. Papers describing<br />
investigations on human subjects must include a<br />
statement that informed consent was obtained from<br />
all subjects.<br />
Plagiarism<br />
If portions <strong>of</strong> the manuscript have already been<br />
published by the author on other journals or<br />
websites, J<strong>Cell</strong>MolBiol Editorial Board needs to<br />
know which portions <strong>of</strong> the manuscript have been<br />
previously published <strong>and</strong> where. The author should<br />
include a note in the cover letter indicating which<br />
portions have been published elsewhere.<br />
In case <strong>of</strong> any suspicion on scientific misconduct or<br />
dishonesty in research, J<strong>Cell</strong>MolBiol reserves the<br />
right to forward any submitted manuscript to an<br />
appropriate authori-ty for investigation.<br />
Copyright Notice<br />
It is the responsibility <strong>of</strong> the submitting author to<br />
ensure that the authorship <strong>of</strong> the paper reflects the<br />
contributions <strong>of</strong> the authors to the work described,<br />
<strong>and</strong> that all listed authors have agreed to the<br />
submission <strong>of</strong> the manuscript in its current form.<br />
Conditions <strong>of</strong> publication in J<strong>Cell</strong>MolBiol are<br />
that the paper has not already been published<br />
elsewhere; that it is not currently being considered<br />
for publication else-where; all persons designated<br />
as authors should qualify for authorship, <strong>and</strong> all<br />
those who qualify should be listed. If accepted,<br />
<strong>Haliç</strong> University <strong>and</strong> J<strong>Cell</strong>MolBiol have the<br />
exclusive license to publish.<br />
J<strong>Cell</strong>MolBiol is freely available to individuals<br />
<strong>and</strong> institutions. Copies <strong>of</strong> this <strong>Journal</strong> <strong>and</strong> articles<br />
REVISED<br />
June 30 th , 2011<br />
in this journal may be distributed for research or for<br />
educational purposes free <strong>of</strong> charge. However,<br />
commercial use <strong>of</strong> articles contained herein is<br />
prohibited without the written consent <strong>of</strong> the editor.<br />
Publication Agreement<br />
The corresponing author is required to assign the<br />
Publication Agreement Form in order to publish the<br />
submitted manuscript in J<strong>Cell</strong>MolBiol.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong><br />
<strong>Vol</strong>ume 9 · No 1 · June 2011<br />
Review Articles<br />
<strong>Molecular</strong> <strong>Biology</strong><br />
Decision making mechanism influences the regulatory function <strong>of</strong> Notch in Apoptosis<br />
A.NAIR<br />
Polymorphisms in the xenobiotic genes <strong>and</strong> susceptibility to bladder cancer<br />
N. ERSOY TUNALI <strong>and</strong> N. O. TİRYAKİOĞLU<br />
Research Articles<br />
Identification <strong>of</strong> silencing suppressors <strong>of</strong> potato virus M<br />
R. KRYLDAKOV, R. AKBERGENOV, T. HOHN <strong>and</strong> B. ISKAKOV<br />
Identification <strong>of</strong> a novel dehydration responsive transcript from tossa jute (Corcohrus olitorius L.)<br />
S. SHARMIN, M. M. MOOSA, Md. S. ISLAM, I. KABIR, A. AKTER <strong>and</strong> H. KHAN<br />
Protective effects <strong>of</strong> curcumin on cadmium chloride induced colon toxicity in Swiss albino mice<br />
P. SINGH, P. MOGRA, V. SANKHLA <strong>and</strong> K. DEORA<br />
In vitro regeneration <strong>of</strong> Cleome viscosa – an important medicinal herb<br />
J.ANBURAJ, C. R. SINGH, S. SUNDARRAJ <strong>and</strong> S. KANNAN<br />
Bio-database compression using enhanced suffix array for pairwise sequence alignment<br />
A.KUNTHAVAI <strong>and</strong> S.VASANTHA RATHNA<br />
Cloning <strong>and</strong> expression <strong>of</strong> Lentinula edodes cellobiohydrolase gene in E. coli <strong>and</strong> characterization <strong>of</strong><br />
the recombinant enzyme<br />
S. TAIPAKOVA, B. SMAILOV, G. STANBEKOVA <strong>and</strong> A. BISSENBAEV<br />
Investigation <strong>of</strong> the MMP1 <strong>and</strong> MMP3 promoter polymorphisms in temporom<strong>and</strong>ibular joint<br />
disorder<br />
N. TASKIN, K. ULUCAN, G. DEGIN, A. AKCAY, B. KARATAS <strong>and</strong> T. AKCAY<br />
Lead induced alterations in blood cell counts <strong>and</strong> hemoglobin during gestation <strong>and</strong> lactation in Swiss<br />
albino mice<br />
I. BARBER, R. SHARMA, S. MOGRA, K. PANWAR <strong>and</strong> U. GARU<br />
The effects <strong>of</strong> aqueous <strong>and</strong> ethanolic leaf extracts <strong>of</strong> Vernonia amygdalina on some vital organs in<br />
adult Wistar rats<br />
S. NWANGWU, D. A. OFUSORI, S. JOSIAH, O. F. AMEGOR, H. NJOYA <strong>and</strong> A. O. OYAKA<br />
Short Communication<br />
Investigation <strong>of</strong> the EGFR gene variations in bladder cancer patients using INFINITI TM Analyzer<br />
N. O. TİRYAKİOĞLU, Ö. KURNAZ, Ö. O. ÇAKIR <strong>and</strong> N. ERSOY TUNALI<br />
Instructions for Authors<br />
1<br />
5<br />
15<br />
21<br />
31<br />
37<br />
45<br />
53<br />
63<br />
69<br />
75<br />
83<br />
87